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Propositions 
1. The benefits of intermittent iron supplementation in anaemic children probably outweigh 
the associated risks of adverse effects caused by malaria. 
- This thesis. 
2. Inflammatory processes and the accompanying redistribution of iron to body stores are 
unlikely to play important roles in the pathogenesis of anaemia associated with 
asymptomatic malaria. 
- This thesis. 
3. Until continuous use of contraceptive tablets is proven sufficiently safe, monthly 
menstruation should be considered as the Holy Grail of womanhood ;-) 
- Against: Thomas SL, Ellertson C. Nuisance or natural and healthy: should 
monthly menstruation be optional for women? Lancet 2000; 355: 922-24. 
4. It is unethical, of course, for a scientist to do a physician's job. Experience shows that it 
is also unethical for a physician to do a scientist's job. 
- In response to: Altman DG. The scandal of poor medical research. BMJ 1994; 
308: 283-84. 
5. Research does not have to be original to be worthwhile. 
- In response to: Sommer A. Moving from science to public health programs: 
lessons from vitamin A. Am 3 Clin Nutr 1998; 68 Suppl: 513-16. 
6. Statistics is an anvil on which the scientific mind is bashed into shape. 
7. Development aid fails because those who receive will never own. 
8. The cage of poverty and repression is usually held shut by those inside. 
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Hans Verhoef 
Wageningen, 7 September 2001 
Stellingen 
1. De baten van regelmatig (elke 4 weken) toedienen van ijzer aan kinderen met 
bloedarmoede zijn waarschijnlijk zwaarwegender dan de risico's van bijwerkingen als 
gevolg van malaria. 
- Dit proefschrift. 
2. Onstekingsprocessen spelen waarschijnlijk geen belangrijke rol bij het ontstaan van 
bloedarmoede van asymptomatische malaria. Dit geld evenzeer voor de herverdeling van 
lichaamsijzer naar opslagcompartimenten waarmee ontsteking vergezeld kan gaan. 
- Dit proefschrift. 
3. Totdat is aangetoond dat het doorlopend gebruik van de pil voldoende veilig is, dient 
maandelijkse ongesteldheid beschouwd te worden als de Heilige Graal van vrouw-zijn ;-) 
- Tegen: Thomas SL, Ellertson C. Nuisance or natural and healthy: should 
monthly menstruation be optional for women? Lancet 2000; 355: 922-24. 
4. Het is uiteraard onethisch voor een wetenschapper om het werk te doen van een arts. 
De ervaring leert dat het ook onethisch is voor een arts om het werk van een 
wetenschapper te doen. 
- Naar aanleiding van: Altman DG. The scandal of poor medical research. BMJ 
1994; 308: 283-84. 
5. Onderzoek dat niet origineel is, kan toch de moeite waard zijn. 
- Naar aanleiding van: Sommer A. Moving from science to public health 
programs: lessons from vitamin A. Am J Clin Nutr 1998; 68 Suppl: 513-16. 
6. Statistiek is een aambeeld waarop de wetenschappelijke denkwijze zijn beslag krijgt. 
7. Ontwikkelingshulp faalt omdat zij die krijgen nooit zullen bezitten. 
8. De kooi van armoede en onderdrukking wordt gewoonlijk dichtgehouden door hen die 
daarin opgesloten zijn. 
Stellingen behorend bij het proefschrift 'Iron deficiency and malaria as determinants of 
anaemia in African children' 
Hans Verhoef 
Wageningen, 7 September 2001 
Abstract 
Iron deficiency and malaria as determinants of anaemia in African children. 
PhD thesis by Hans Verhoef, Division of Human Nutrition and Epidemiology, 
Wageningen University, The Netherlands, 7 September 2001. 
Approximately three quarters of east African children <5 y of age suffer from anaemia, 
which is due, at least in part, to malaria and iron deficiency. In children in areas of 
seasonal malaria, the benefits of iron supplementation may not outweigh possible inherent 
risks of adverse effects caused by malaria. Intermittent administration of sulfadoxine-
pyrimethamine (SP) might improve haemoglobin concentrations while allowing children to 
develop protective immunity against severe disease and subsequent death caused by 
malaria. With a view to contribute to the development of programmes for anaemia control 
in preschool children in Africa, the immediate objectives of this thesis were as follows: 1) 
to measure the efficacy in improving haemoglobin concentrations in children aged 2-36 mo 
of intermittent iron supplementation and intermittent administration of SP, either alone or 
when given in combination; 2) to develop and evaluate survey methods for rapid 
assessment at community level of the burden of anaemia and its risk factors; 3) to 
contribute to improved methods for diagnosis of anaemia, iron deficiency, and malaria; 4) 
to evaluate the role of impaired erythropoiesis in the pathogenesis of malarial anaemia. 
In randomised controlled trial (n=328) in anaemic, asymptomatic children aged 2-36 mo, 
the effect on change in haemoglobin concentration in the group receiving iron plus 
sulfadoxine-pyrimethamine relative to the placebo group, adjusted for prognostic factors at 
baseline, was 12.5 g/L (95% CI: 8.5 to 16.4 g/L). In the former group, the estimated 
prevalence of anaemia reduced from 100% at baseline to 36% at 12 w, and prevalence of 
iron deficiency reduced correspondingly from 66% to 8%. Administration of SP in addition 
to iron supplementation gave no haemoglobin response. Survival analysis indicated no 
evidence of increased risk of malaria following iron supplementation. Iron supplementation 
over a 12-week period resulted in a marked improvement of haemoglobin concentrations. 
Analysis of haematological indicators from both the trial and a cross-sectional study 
(n=318) suggested that malaria-induced haemolysis is accompanied by increased 
erythropoiesis, which seemed adequate for the resulting degree of anaemia. Serum 
transferrin receptor concentration is not useful to detect iron deficiency in individuals with 
malaria. Inflammation probably plays no or a minor role in the pathogenesis of anaemia 
associated with asymptomatic malaria. 
A new and inexpensive colour scale to facilitate anaemia diagnosis in developing countries 
performed satisfactory and was for many purposes superior to all other methods for 
detection of anaemia at primary care level. The methodology presented may facilitate 
development of strategies for its use in various target groups. A large proportion of 
unnecessary treatments for febrile diseases can be avoided by teaching mothers to palpate 
their child's forehead, and by confirming the presence of fever by thermometer. 
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Introduction 
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1. Infection and malnutrition in African children 
Few children from poor families in developing countries escape severe health challenges 
posed by infections and malnutrition. Both infections and inadequate supply of nutrients 
may initiate a vicious circle of deteriorating health (figure 1). Infections lead to growth 
faltering and malnutrition by causing anorexia, loss of nutrients, changes in metabolism 
and malabsorption, and changes in feeding practices. Conversely, protein-energy 
malnutrition and deficiency in micronutrients such as iron, vitamin A and zinc are known to 
adversely affect immunity (Dallman 1987, Ross 1996, Wellinghausen et al. 1997, Semba 
1998, Shankar and Prasad 1998, Fraker et al. 2000). This in turn can increase the 
incidence, severity and duration of disease. 
^ 
Inadequate dietary 
intake 
^ 
Appetite loss 
Nutrient loss 
Malabsorption 
Altered metabolism 
> 
Weight loss 
Growth faltering 
Lowered immunity 
Mucosal damage 
^ 
Increased incidence, 
severity and duration 
of disease 
^ 
FIGURE 1. The infection/malnutrition cycle (Tomkins and Watson 1989) 
One in 16 children born in developing countries dies before the age of 1 y, and one in 11 
dies before the age of 5 y. In sub-Saharan Africa, these probabilities are one in nine and 
one in six, respectively (1998 data; UNICEF 2000). The infection/malnutrition complex 
typically accounts for much of this mortality. Of the estimated 12 million deaths in children 
under 5 y in developing countries, 50% are due to four conditions - acute respiratory 
infections, diarrhoea, measles and malaria - and 54% have been attributed directly or 
indirectly to malnutrition (figure 2). 
The health consequences of malnutrition and infections depend on the nutrients and 
pathogens involved. This chapter examines iron deficiency and malaria as determinants of 
anaemia and growth faltering in African children. For this purpose, the following topics will 
be reviewed: the public health importance of growth faltering, anaemia, iron deficiency, 
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and malaria; the causal relationships between these factors, especially in relation to the 
aetiology and pathogenesis of anaemia; and the possibilities for interventions directed at 
solving the anaemia problem. Particular emphasis will be given to preschool children living 
in Kenya, because these are the subjects of studies described in subsequent chapters. 
Anaemia and malaria in pregnant and lactating women are discussed as determinants of 
anaemia and growth of their children. 
Malaria Measles 
FIGURE 2. Relative contribution of infections and malnutrition to mortality in 
children below 5 y of age (Gove 1997) 
2. Growth faltering 
Anthropometric indicators of child growth 
Children in developing countries generally fail to achieve their genetically determined 
potential height because of poor diet and infection (Martorell et al. 1988, Ulijaszek 1994, 
Waterlow 1994). Because short stature and thinness are believed to indicate poor health, 
they are often referred to as stunting and wasting, respectively. For example, growth 
retardation has been associated with an increased incidence, severity and duration of 
disease (Scrimshaw et al. 1968, Black et al. 1984). 
To compare height and weight distribution between populations, children are usually 
compared to a reference population of similar age and sex who have grown up in a 
relatively well-nourished and infection-free environment (the NCHS population: WHO 
1983). Thus, shortness and thinness can be measured by height-for-age and weight-for-
height z-scores (HAZ and WHZ), respectively. A z-score with value 0 (nought) indicates the 
median of the NCHS reference population, while children with HAZ or WHZ below -2 
standard deviations of the median of the NCHS reference population are generally 
considered to be moderately to severely stunted or wasted, respectively (WHO Working 
Group 1986, WHO 1995). 
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Stunting and wasting are used as markers of malnutrition (figure 3). As such they are 
justifiable targets for intervention. Their role in causing morbidity and mortality has long 
been suspected, but is difficult to demonstrate (Waterlow 1994). 
Growth 
faltering 
w Malnutrition 
I 
Impaired 
body functions 
Morbidity and 
mortality 
FIGURE 3. Hypothesised role of growth failure, anaemia and malnutrition as associated 
causes of morbidity and mortality 
Both growth failure and anaemia are considered to be outcomes and markers of malnutrition. There is solid 
evidence that both malnutrition and anaemia may contribute to morbidity and mortality by impairing body 
functions. Such a causal role has also been suspected for growth failure, but is difficult to demonstrate. Note 
the absence of a causal link between growth failure and anaemia (see text for further explanation). 
Magnitude of the problem 
An estimated 182 million children - or one-third of all children <5 y of age in developing 
countries - are stunted (ACC/SCN 2000). The highest prevalence is found in eastern Africa, 
where 48% of children in this age range is stunted, and which is the only region in the 
world where its prevalence is rising (ACC/SCN 2000). Because severe wasting is usually a 
transient condition, its frequency of occurrence is preferably measured by its incidence 
rather than by its prevalence. Unfortunately, no such incidence estimates are available. 
Causes and mechanisms 
Stunting and wasting represent different processes of malnutrition (WHO Working Group 
1986, WHO 1995). Stunting indicates slowing in skeletal growth, which may not be evident 
for years. It takes a long time to correct even in favourable environments, and is the 
cumulative effect of low or inadequate intake of energy, macronutrients or micronutrients 
over a long period, or results from chronic or frequent infections. Stunting does not 
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necessarily indicate low growth rates, as shown by the fact that stunted school children 
usually grow at rates similar to the NCHS reference population. The stunting process starts 
in the first few months of life and slows down at around 3 y of age (WHO 1995). 
Wasting results from failure to gain weight or from weight loss. It usually occurs after 
recent and severe starvation and/or disease, and peaks in the second year of life (WHO 
1995). Severe wasting can develop rapidly and generally can be restored easily after 
refeeding (Young and Jaspers 1995). Wasting and stunting do not necessarily result from 
the same nutritional deficiencies, as is evident from the fact that stunting usually starts 
earlier in life than wasting. 
3. Anaemia 
Manifestations in children 
Anaemia occurs when bodily functions are impaired as a result of low haemoglobin 
concentrations. It develops when the rate of red cell destruction exceeds the capacity of 
the bone marrow to mount a compensatory increase in production. In children aged 6-60 
mo, anaemia is indicated and has been operationally defined by haemoglobin 
concentrations <110 g/L when measured at sea level (WHO/UNICEF/UNU 1997). 
The main function of red cells is to carry haemoglobin-bound oxygen to tissues and return 
carbon dioxide from tissues to the lungs. Symptoms of anaemia are usually shortness of 
breath, weakness, lethargy, palpitations and headaches. Anaemia causes decreased 
physical activity, fitness and work capacity (Haas and Brownlie 2001). The severity of 
symptoms depends on the degree of anaemia and the rate of its development. Adaptation 
may occur in the cardiovascular system (with increased heart rate and stroke volume) and 
in the dissociation characteristics of haemoglobin, so that oxygen is more readily given up 
to the tissues (Hoffbrand and Pettit 1993). Rapid haemolysis - as may occur during acute 
febrile malaria attacks - may cause severe anaemia with little time for adaptation. Children 
with severe anaemia may eventually die. Although it is commonly believed that breathing 
difficulty in a severely anaemic child is due to 'congestive heart failure', recent studies in 
Kenyan children hospitalised for malaria suggest that death in severely anaemic children 
may be rather due to acidosis (English et al. 1997, English 2000, WHO 2000c). Particularly 
in developing countries, blood transfusions administered to patients with severe anaemia 
also carries an increased risk of HIV infection (Hedberg et al. 1993, Fleming 1997, Jager et 
al. 1990, Ryder et al 1992). Mild anaemia often produces no symptoms. In areas of high 
malaria endemicity even children with haemoglobin concentrations <60 g/L can be 
asymptomatic, presumably after prolonged exposure to chronic or repeated infection with 
low levels of parasitaemia (see below). 
Magnitude of the problem 
Approximately half of children <12 y and women of child-bearing age in developing 
countries suffer from anaemia. Children <5 y and pregnant women are at highest risk with 
estimated prevalences of 5 1 % and 59%, respectively. In eastern Africa, the prevalence of 
anaemia in children under 5 y has been estimated at 75% (DeMaeyer and Adiels-Tegman 
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1985). Anaemia is an important cause of childhood death in developing countries, and 
estimates that 20% of maternal deaths in Africa are attributable to anaemia (Ross and 
Thomas 1996) are probably conservative (Gillespie 1998). 
Causes and mechanisms 
There is little support for the common misinterpretation that anaemia is a cause of poor 
growth. Anaemia usually indicates malaria or other underlying infections, deficiencies of 
iron and other nutrients, or genetic disorders. These factors may cause serious adverse 
health effects, including impaired physical growth and mental development, reduced 
physical activity, and death. Thus, anaemia is both an outcome and marker of 
malnutrition, and also contributes directly to morbidity and mortality (figure 3). Successful 
interventions to control anaemia are therefore assumed to lead to better health. 
Anaemia in developing countries may be caused by deficiencies in iron, folate, vitamins A 
and B12, infections such as malaria, HIV infection and tuberculosis and inherited red cell 
disorders (Fleming 1994). Their relative contribution to anaemia depends on age, season, 
geographical area, and other factors, reflecting local and time-dependent patterns in 
infection and nutrient availability. For most of these determinants, major gaps exist in our 
understanding of the pathogenic mechanisms involved, and in our knowledge about the 
degree to which they interact in producing anaemia. The following sections will first 
discuss normal erythropoeisis and iron metabolism, and then review iron deficiency and 
malaria as determinants of anaemia in African children. 
4. Erythropoiesis and iron metabolism 
Red cell development and Its regulation 
The life expectancy of red cells is normally about 120 d, and in adults the marrow must 
normally produce 200 billion red cells every day to replace those lost to senescence or 
damage (Hoffbrand and Pettit 1993). Erythropoiesis is the continuous process whereby 
primitive erythroid progenitor cells proliferate and differentiate into mature, circulating red 
cells (reviewed by Brittenham 1994). This process is principally regulated by 
erythropoietin, a hormone predominantly produced in the kidney in response to hypoxia. 
In normal conditions, increased production of erythropoietin results in erythroid 
hyperplasia and reticulocytosis. The biological effects of erythropoietin and other growth 
factors are mediated through specific receptors on target cells. One action of 
erythropoietin is to stimulate survival of erythroid progenitor cells by inhibiting apoptosis 
(gene-directed cell death). 
The uptake of serum iron that is required for haem synthesis within the erythroblast is 
mediated and regulated by a specific receptor located on the outer cell membrane (Cook 
et al. 1994, 1996). The increased expression of these receptors on the membrane of the 
developing red cells follows the increased expression of erythropoietin receptors but 
precedes the onset of cellular haem synthesis. Erythropoiesis is not entirely efficient, 
because 10-15% of developing erythroblasts normally die within the marrow without 
producing mature cells, whereupon they are ingested by marrow macrophages. Red cells 
Introduction ^ _ _ _ 15 
are taken out of circulation via phagocytosis by macrophages belonging to the 
mononuclear phagocyte system and resident mainly in the spleen, but also in the liver, 
marrow and muscle. 
Iron metabolism and movement 
Body iron comprises metabolically active iron that is required for normal functions, storage 
iron that constitutes a reserve upon which the body can draw, and transport iron (figure 
4). Most body iron is incorporated into haemoglobin. The remainder of the metabolically 
active iron is found as myoglobin iron in muscles and as iron-containing or iron-dependent 
enzymes throughout the cells of the body. Iron released by macrophages from degraded 
haemoglobin into serum is bound to the transport protein transferrin and can be recycled 
for erythropoiesis or used for other functions. Alternatively, macrophages can hold iron in 
storage by binding it to the proteins ferritin or haemosiderin. Storage iron in the 
mononuclear macrophage system is derived almost entirely from phagocytosis of 
senescent red cells or defective developing red cells. The liver also holds ferritin-bound 
iron in reserve in hepatocytes. Most of the iron used for erythropoiesis in the bone marrow 
is derived from recycled iron, and iron supplied by absorption through the intestine makes 
up only a small fraction of the total amount of iron that is used for this purpose. No 
physiological means of iron excretion exist. Iron absorption from the gastrointestinal tract 
is the sole means of regulating iron stores. 
Cellular uptake of iron from the circulation takes place by binding of the transferrin-iron 
complex to receptors in the cell membrane, followed by receptor-mediated endocytosis 
and by dissociation of iron from apotransferrin and its transport across the vesicle 
membrane into the cytoplasm by unknown carrier mechanisms (Pollack 1992a). Endocytic 
vesicles recycle to the cell surface where apotransferrin dissociates from transferrin 
receptors. The number of transferrin receptors expressed on the cell membrane is the 
prime determinant of cellular iron supply. Cellular synthesis and expression of transferrin 
receptors is primarily regulated by intracellular iron concentration, and is coupled to ferritin 
synthesis (Casey et al. 1988, Melefors and Hentze 1993). In cellular iron deficiency, 
translation of ferritin-coding mRNA is repressed, whilst translation of mRNA coding for 
transferrin receptors is accelerated. Conversely, when cellular iron is in excess, synthesis of 
ferritin is increased and production of transferrin receptors is decreased. In addition, there 
is evidence that erythropoietin increases iron uptake into erythroid progenitor cells via 
post-transcriptional induction of transferrin receptor expression on the cell surface (Weiss 
et al. 1997). 
Iron status during infancy and childhood 
The intra-uterine environment is characterised by relative hypoxia, which results in high 
haemoglobin concentrations at birth. Thereafter, oxygenation of the blood improves 
markedly, leading to a cessation of erythropoiesis within days after delivery (Halvorsen 
1963, Clark and Roche 1973). Haemoglobin concentrations drop dramatically over the first 
2 mo of life - from 166 g/L to 112 g/L (Saarinen and Siimes 1978) - as a result of growth-
related haemodilution and elimination of red cells that have reached the end of their life 
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Mononuclear phagocyte system 
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Hepatocytes 
FIGURE 4. Body iron distribution and movement in a healthy adult (adapted from 
Brittenham 1994) 
The area of each circle is proportional to the amount of iron contained in the compartment, and the width of 
each arrow is proportional to the daily flow of iron from one compartment to another. The mononuclear-
phagocyte system is part of the immune system and comprises a diffuse network of macrophages originating 
from circulating monocytes and attached to the epithelium of various organs where they act as a 'sieve' for 
pathogens and foreign antigens. Note that most of the iron used for erythropoiesis in the bone marrow is 
derived from recycled iron, and that iron supplied by absorption from the intestine makes up only a small 
fraction of the total amount of iron that is used for this purpose. Normally, less than 0.5% of the total body iron 
is acquired or lost each day. Also note that the storage iron in the mononuclear phagocyte system is derived 
almost entirely from phagocytosis of senescent red cells or defective developing red cells. 
Malaria can influence iron distribution and movement in several ways. Haemoglobin iron lost because of 
malaria-induced haemolysis can be bound to haptoglobin or haemopexin and removed from the plasma by 
hepatocytes (a) for eventual return to plasma transferrin (b). In addition, ineffective erythropoiesis may occur, 
whereby developing red cells are prematurely phagocytosed (c). 
span. Dietary iron absorption is minimal during this period (FAO/WHO 1988). Iron stores, 
as indicated by serum ferritin concentrations, rise in the first few weeks of life as 
haemoglobin is broken down, but then drop as the child continues to grow and more iron 
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is needed for erythropoiesis and other functions. By the age of 4-6 mo, iron stores are 
marginal or become depleted. Iron deficiency seldom occurs before that period unless the 
child is born prematurely, or if the mother had severe iron deficiency anaemia during 
pregnancy. Mild maternal iron deficiency anaemia has few repercussions on the iron status 
of the newborn (NAS 1991). Normally after 4-6 mo, iron absorption and iron loss become 
the critical factors for maintaining normal haemoglobin concentrations. In infancy, all the 
bone marrow is erythropoietic and reddish in appearance, but during childhood this is 
progressively replaced by fat in the long bones. This fatty marrow is capable of reversion 
to haemapoiesis under conditions of anaemia (erythroid hyperplasia). 
5. Iron deficiency 
A large proportion of the world's children lives in a state of precarious iron balance 
because of low dietary intake of absorbable iron. Relatively large amounts of iron are 
needed for erythropoiesis during periods of bodily growth, while iron supply is limited by 
the intestinal capacity to absorb iron. The decline in body iron is first marked by the 
depletion of iron stores, which indicates the onset of iron deficient erythropoiesis. At this 
stage, iron absorption is insufficient for the bone marrow to mount a compensatory 
increase in haemoglobin production to counter growth-related haemodilution and losses 
due to physiological and pathological processes. Haemoglobin synthesis starts to become 
impaired and haemoglobin concentrations fall. When anaemia ensues, the iron deficiency 
may be severe enough to lead to distortion of newly produced red cells, with microcytosis 
and hypochromia. 
Iron demand may be further increased by losses due to chronic bleeding from intestinal 
wounds caused by schistosomal or intestinal worms. School children are most likely to 
suffer the heaviest worm infections and the associated morbidity. Considerable variation 
has been observed in African preschool children from different geographical locations in 
the prevalence of intestinal worm infections (Brooker et al. 1999, Hautvast et al. 2000, 
Stoltzfus et al. 2000, Tshikuka et al. 1997). This variation is probably due to differences in 
exposure frequency as determined by behaviour, soil microclimate and other factors. 
Manifestations in children 
Iron deficiency in children, when sufficiently severe to cause anaemia, has been associated 
with decreased growth rates (Allen 1994, Chwang et al. 1988, Latham et al. 1990, Lawless 
et al. 1994), decreased appetite (Lawless et al. 1994), impaired immune function (Dallman 
1987, Brock 1994, Oppenheimer 2001) which probably leads to an increased risk of certain 
infectious diseases, reduced physical activity (Haas and Brownlie 2001) and possibly 
impaired performance in a range of mental and physical coordination functions (Gillespie 
1998, Grantham-McGregor and Ani 2001). The latter include cognition (awareness and 
judgement abilities), social and emotional development and school achievement (Draper 
1997, Nokes et al. 1998). Impaired mental and physical coordination functions may be 
more difficult to correct in infants and toddlers than in older children (Draper 1997), and 
possibly develop already in children suffering from iron deficient erythropoiesis (Bruner et 
al. 1996). Girls with deficiencies in iron and other nutrients may have insufficient pelvic 
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development, which has been associated with increased risks of subsequent obstetric 
complications and maternal mortality (Konje and Ladipo 2000). There is little empirical 
evidence of the importance of iron deficiency anaemia as a cause of death in African 
children, in part because of the difficulties in separating these deaths from those caused 
by malaria-associated anaemia. 
Magnitude of the problem 
Young children and women of childbearing age are at greatest risk of iron deficiency, 
particularly those living in areas where cereals are the staple food, little meat is eaten, 
dietary intake of ascorbic acid is low, and high intakes of phytates (e.g. in unprocessed 
cereals) and polyphenols (e.g. tannates in tea) impair iron absorption. A recent estimate of 
more than 3.5 billion people being affected by iron deficiency globally 
(UNICEF/UNU/WHO/MI 1999) is probably an overestimate (Stoltzfus 2001), and may 
furthermore be inaccurate because of difficulties of measuring iron status in developing 
countries (Cook 1994). 
6. Malaria 
Malaria in humans is caused by four species of protozoa. Plasmodium falciparum is by far 
the most pathogenic and accounts for the majority of infections, whereas the other three 
species seldom lead to death. P. malariae and P. ovale only have local or regional 
importance, while P. vivax occurs rarely in sub-Saharan Africa. Contrary to P. v/Vaxand P. 
ovale, there are no dormant liver stages of P. falciparum that upon reactivation lead to 
recurrences. Chemotherapy aimed at asexual blood stages can successfully eradicate P. 
falciparum infection. Recrudescence or persistence of parasitaemia and symptoms may 
occur, however, following insufficient intake or malabsorption of antimalarial drugs, or 
following treatment of patients infected with drug-resistant parasite strains. Prophylactic or 
therapeutic use of antimalarials in individuals with drug-resistant strains probably 
contributes to anaemia as a public health problem. Chloroquine resistance emerged in east 
Africa in 1978 and is now widespread (Charmot et al. 1991). Several countries in the 
region, including Kenya, have included sulfadoxine/pyrimethamine (SP) in their policy for 
first-line treatment of uncomplicated malaria, but this is not yet widely practised. 
Resistance to SP has been reported in many areas, but the occurrence and level of 
resistance vary between and within countries. 
Life cycle 
Malaria parasites are transmitted with the saliva of biting mosquitoes of the genus 
Anopheles. Within half an hour following inoculation by the mosquito, the parasites 
disappear from the blood and enter parenchymal cells of the liver, where they multiply and 
re-enter the blood circulation as merozoites. They then enter red cells, where they develop 
into trophozoites that feed on haemoglobin. Following parasite multiplication, infected 
erythrocytes burst and newly released merozoites invade fresh erythrocytes, in which a 
subsequent generation of parasites is produced by the same process. Some merozoites 
may develop into sexually differentiated forms (gametocytes), which are taken up by 
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mosquitoes, where they undergo further development, mate and eventually make their 
way to the salivary glands. 
Manifestations of malaria 
African children are protected to some degree from malaria by maternal antibodies that 
are conveyed during pregnancy, or by immunity that develops following repeated or 
chronic exposure to infection. There is evidence that immunity against severe disease and 
subsequent death from malaria develops much faster than that against fever and parasite 
densities (Snow and Marsh 1998, Gupta et al. 1999). Thus, in endemic areas, the most 
vulnerable period occurs during early childhood, when maternal antibodies have waned 
and protective levels of immunity have not yet developed (Snow and Marsh 1998). For the 
same reason, parasitaemia may occur without symptoms or signs other than splenomegaly 
and some degree of anaemia (McElroy et al. 2000). For example, in western Kenya 
(Asembo Bay, Nyanza Province), where children are typically exposed to 100-300 infective 
mosquito bites per year, 70% of children aged 2-36 mo were parasitaemic (Ter Kuile, 
personal communication, 2001). In less endemic areas, the vulnerable age starts earlier 
and ends later, and the prevalence of parasitaemia is considerably less. Little is known 
about the functional consequences of mild-to-moderate anaemia caused by malaria other 
than that it probably leads to reduced physical activity (Haas and Brownlie 2001). 
Uncomplicated malaria is characterised by febrile attacks that may be accompanied by 
symptoms of low specificity such as chills, headache, dizziness, pain in the back and limbs, 
malaise, anorexia, nausea, sweating and vomiting (Gilles and Warrell 1993). The level of 
parasitaemia is variable but has been associated with the severity of symptoms. Anaemia 
is a common feature, and may continue to develop for up to two weeks after parasite 
clearance (Menendez et al. 2000). When left untreated, uncomplicated falciparum malaria 
may rapidly (<48 h) progress to severe (acutely life-threatening) malaria and death. 
Demonstration of parasitaemia has low diagnostic value in highly endemic areas, because 
many diseases resemble malaria in their manifestations and asymptomatic infection is 
common. Several new, rapid dipsticks allow for detection of proteins specifically produced 
by P. falciparum, and of proteins produced by all four human malaria parasite species 
(WHO 2000b). 
Malarial deaths have been contributed mostly due to two overlapping syndromes, namely 
cerebral malaria and severe anaemia (Beales et al. 2000). Hospitalisation for severe 
anaemia occurs mostly in children <3 y of age, whilst peak hospitalisations for cerebral 
malaria occurs somewhat later, at 2-7 y of age (Brewster et al. 1990, Snow et al. 1994). 
Findings from recent studies indicate that metabolic acidosis plays a major role in the 
pathogenesis of severe disease and is particularly important in the overlap between the 
aforementioned syndromes (Marsh et al. 1995, Marsh and Snow 1997, English 2000). In 
cerebral malaria, persisting coma and death follow a history of convulsions, impaired 
consciousness, and other manifestations of central nervous dysfunction. Severe malarial 
anaemia may develop after fulminant infection of relatively short duration, or following 
chronic or repeated infection. In the latter case, considerable adaptation may have taken 
place (see above). For this reason, severely anaemic but asymptomatic children may be 
found in community surveys, often with low levels of parasitaemia. The incidence of severe 
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malarial anaemia is probably increasing with the spread of parasite strains that are 
resistant to antimalarial drugs (Bloland et al 1993, Campbell 1991). 
Magnitude of the problem 
Malaria has been estimated to cause 300-500 million symptomatic attacks and over 
750.000-1 million deaths per year globally (Snow et al. 1999, WHO 2000a). Perhaps 90% 
of malarial attacks and deaths occur in children in sub-Saharan Africa (WHO 1998). Most 
community-based studies have shown a malaria-associated reduction in haemoglobin 
concentration of 10-20 g/L (Brabin 1992). 
7. The pathogenesis of malaria-associated anaemia 
Several pathogenic mechanisms have been described to explain the anaemia of malaria 
(Weatherall et al. 1982, 1983, Menendez et al. 2000), although detailed knowledge is 
lacking and the relative importance of these mechanisms in various presentations of 
malaria is poorly understood. 
Genetic red cell disorders 
Abnormal variants exist of haemoglobin and certain enzymes involved in red cell 
metabolism. In tropical areas, these variants may occur in polymorphic gene frequencies, 
presumably because they confer some protection against malaria in heterozygote 
individuals. The degree to which some variants may cause anaemia depends on genotype 
and environmental factors. 
Glucose-6-phosphate dehydrogenase (G6PD) is needed in red cells to prevent oxidative 
damage. The presence of certain abnormal genetic variants of G6PD in red cells is 
associated with low activity or concentration of this enzyme, and this may cause oxidative 
stress in the presence of certain oxidant nutrients, drugs or infections. When induced by 
malaria parasites, this oxidative stress is believed to be the prime mechanism whereby 
infected red cells are selectively cleared and G6PD deficiency confers partial protection 
against malaria. Two abnormal variants (G6PD types A and A") occur in high frequencies in 
sub-Saharan Africa (Bienzle 1981). The A"-variant occurs in gene frequencies of 10%-
25%. Only these genotypes have markedly lower erythrocyte G6PD activity, but even 
individuals with homozygote or hemizygote G6PD A" deficiency have little chronic 
haemolysis and only marginally lower haemoglobin concentrations (May et al. 2000). 
Chloroquine does not usually cause haemolysis in G6PD A- Africans (Abdalla and 
Weatherall 1987). Thus, it would appear that G6PD deficiency - at least in the absence of 
abnormal causes of stress - is not an important cause of anaemia in sub-Saharan Africa. 
Sickle cell disorders occur in high frequencies in parts of Africa. The manifestations of 
sickle cell anaemia result from the presence of two abnormal p-chains in the haemoglobin 
molecule (HbSS). The prevalence of sickle cell anaemia in community surveys is low in 
developing countries because children born with this condition usually die at an early age. 
Sickle cell trait (HbAS) is believed to confer partial protection against malaria, and its 
prevalence may reach 40% in some areas that are highly endemic for malaria (Beutler 
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1995). This condition is usually asymptomatic and has been associated with only marginal 
degrees of anaemia (Rana et al. 1993). 
Thalassaemias are inherited disorders of the rate of synthesis of globin chains of 
haemoglobin. Although (3- and a°-thalassaemia are relatively rare in Africans and their 
descendants outside Africa, oc+-thalassaemia is prevalent in high frequencies in parts of 
Africa (Falusi et al. 1987, Hill 1992, Mockenhaupt et al. 1999, Mouele et al. 2000, Muklwala 
et al. 1989, Serjeant et al. 1986). A study on the Kenyan coast found two-gene deletion oc-
thalassaemia in 26 of 57 subjects (46%) studied without sickle cell disorders (Ojwang et 
al. 1989). Detection of both heterozygotes and homozygotes for a+-thalassaemia is 
difficult, because neither present with symptoms or signs other than perhaps mild anaemia 
(Mockenhaupt et al. 1999). Such anaemia can be microcytic and hypochromic, and is easily 
mistaken for iron deficiency (Mockenhaupt et al. 1999, Weatherall and Provan 2000). 
Conventional electrophoresis of blood samples does not detect these conditions, and the 
diagnostic tests required are specialised and available only in some laboratories. Thus, 
although the importance of a-thalassaemia is often overlooked, it probably contributes to 
the burden of anaemia in large parts of Africa, and may lead to overestimates of the 
prevalence of iron deficiency anaemia. 
Increased red cell destruction 
Haemolysis occurs intravascularly following rupture of parasitised red cells and by 
sequestration and phagocytosis not only of parasitised but also non-parasitised red cells in 
the mononuclear phagocyte system in the spleen and other organs. With uncomplicated 
falciparum malaria, anaemia usually develops within 48 h after onset of fever (Menendez 
et al. 2000). A moderate reduction in survival of red cells has been observed in various 
inflammatory conditions, and is believed to play a minor role in the anaemia of chronic 
disease (Sears 1992). This appears to be due to increased clearance of non-senescent red 
cells rather than to intrinsic red cell defects (Jurado 1997, Feelders 1999). In addition, 
fever may contribute to decreased red cell survival (Karle 1974). 
P. falciparum preferentially but not necessarily exclusively invades young red cells (Pasvol 
et al. 1980, Pasvol and Wilson 1982), and animal studies have shown that reticulocytosis 
may favour the proliferation of malaria parasites (Zuckerman 1958). This has several 
important implications (Weatherall and Abdalla 1982). First, it may provide a mechanism 
that contributes to the observed low incidence of malaria in the first few months of life: 
erythropoiesis is markedly reduced in the first two months after birth and hence there are 
relatively few young red cells in circulation. Second, individuals with raised reticulocyte 
counts, which may occur following iron supplementation, may be particularly prone to 
malaria attacks. Third, transient depression of bone marrow activity as seen in chronic 
infections (see below) may serve to limit parasite proliferation. 
With mild haemolysis, iron released from red cells at the end of their shortened life span is 
usually effectively recycled by phagocytic macrophages for erythropoiesis. There is 
erythroid hyperplasia but delivery of mature red cells to the circulating blood is effective. 
When there is substantial haemolysis, free haemoglobin or haem released into the blood 
stream are bound to haptoglobin and haemopexin, respectively. Haemoglobin-haptoglobin 
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and haem-haemopexin complexes are removed from the plasma by hepatocytes (figure 
4; line a), and iron thus recovered can eventually be returned to plasma transferrin and 
recycled. Free haemoglobin rapidly saturates serum haptoglobin, in which case the excess 
free haemoglobin exceeds the renal reabsorptive capacity. Thus, haemoglobin can be 
excreted through urine (haemoglobinuria), but iron loss through this mechanism is 
probably of minor importance in most acute infections. 
Decreased red cell production 
Malaria causes a shift of iron distribution from functional towards storage compartments. 
Thus, serum iron concentrations, iron-binding capacity and serum transferrin saturation 
are all decreased (Das et al. 1997), while - contrary to iron deficiency - serum ferritin 
concentrations are increased (Das et al. 1997) and stainable iron may be present in bone 
marrow (Abdalla 1990a, Phillips et al. 1986). Reticulocyte counts are normal or increased 
(Abdalla et al. 1980, Abdalla 1990a, Abdalla and Wickramasinghe 1988, Phillips et al. 
1986), but appear inappropriately low for the degree of anaemia (Abdalla et al. 1980). 
These characteristics all indicate that erythropoiesis is decreased, or increased but 
inappropriately low for the degree of anaemia. This is further supported by ferrokinetic 
studies and morphological studies on bone marrow aspirates in patients with acute malaria 
(Srichaikul et al. 1969, Abdalla et al. 1980, Abdalla 1990b, Wickramasinghe et al. 1982). 
Anaemia and the laboratory findings described in the preceding paragraph are observed in 
malaria and a range of other infections. This suggests that the pathogenic mechanisms 
underlying the anaemia of chronic disease (Sears 1992, Means and Krantz 1992, Konijn 
1994, Jurado 1997, Weiss 1999, Spivak 2000) also play a central role in the development 
of malarial anaemia. The anaemia of chronic disease is usually mild but can be severe 
(Sears 1992) and - despite the adjective 'chronic' - may develop rapidly (Olivares et al. 
1989). Evidence is accumulating that it is a consequence of simultaneous suppression of 
both erythropoietin production and the ability of erythroid progenitor cells to proliferate in 
response to erythropoietin (Means and Krantz 1992, Spivak 2000). Both effects are 
probably mediated by proinflammatory cytokines such as tumour necrosis factor (TNF) and 
interleukin (IL)-l. 
It is commonly assumed that infections lead to iron sequestration in the mononuclear 
phagocyte system, thus resulting in iron-limited erythropoiesis. There are several reasons 
to believe that this is not the case. First, the observed presence of iron in bone marrow 
corroborates experimental evidence (Spivak 2000) that iron therapy in patients with 
rheumatoid arthritis, inflammatory bowel disease, cancer or AIDS does not result in 
correction of anaemia, whereas therapy using recombinant erythropoietin can correct the 
anaemia of chronic disease but not of iron deficiency (Mean and Krantz 1992). A partial 
response to iron therapy is possible in patients with coexisting anaemia of chronic disease 
and iron deficiency (Sears 1992). Second, contrary to a state of iron deficiency, iron 
absorption is normal or somewhat decreased in the anaemia of chronic disease (Jurado 
1997). Third, absorbed iron is effectively incorporated in the erythron (Pollack 1992b). 
Instead of being incorporated into haemoglobin, however, it appears that iron taken up in 
developing red cells is stored in ferritin and haemosiderin (Pollack 1992b). Fourth, 
expression of transferrin receptors on individual erythroblasts is increased in iron 
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deficiency but decreased in anaemia of chronic disease (Feelders et al. 1993, Kuiper-
Kramer et al. 1997, 1998). 
Thus, the distinctive abnormalities in body iron distribution as observed in the anaemia of 
inflammation are not central to its pathogenesis (Mean and Krantz 1992, Pollack 1992b, 
Spivak 2000). Iron sequestration in the mononuclear phagocyte system appears a by-
product of the mechanisms that also cause decreased erythropoiesis (Walter et al. 1997). 
The evidence presented in the preceding paragraph also suggests that iron therapy might 
be less effective in improving haemoglobin concentrations in individuals with malaria -
particularly those with persistent, asymptomatic infections and relatively high production of 
proinflammatory cytokines - than in those without malaria. 
Observational evidence further supports a possible role of proinflammatory cytokines in the 
pathogenesis of malarial anaemia (figure 5). Serum erythropoietin concentrations are 
increased in acute malaria (Burchard et al. 1995, Burgmann et al. 1996, Kurtzhals et al. 
1997) but appear lower than expected for the degree of anaemia (Vedovato et al. 1999). 
Proinflammatory cytokines such as TNF, IL-1 and IL-6 are released by monocytes and 
macrophages in response to schizont rupture (Kwiatkowski 1995). They are thought to 
suppress erythropoietin synthesis in adults with malaria (Clark and Chaudri 1988, Clark et 
al. 1989). Similar observations have been made in children with persistent, asymptomatic 
falciparum malaria (Kurtzhals et al. 1999). In the latter study, children with malaria and 
who were asymptomatic and who remained so during 4 mo of observation had lower 
haemoglobin concentrations and higher plasma concentrations of ferritin and TNF at the 
end of the observation period than children who remained uninfected throughout this 
period. In the same study, plasma erythropoietin concentration appeared higher in children 
with asymptomatic and symptomatic malaria than children who remained uninfected 
throughout (Kurtzhals et al. 1999: figure la). 
Morphological studies of bone marrow have also shown that patients with malaria often 
have ineffective erythropoiesis, whereby defective erythroid precursors are prematurely 
phagocytosed (Abdalla et al. 1980, Abdalla 1990b). This has been described in acute 
malaria (Dormer et al. 1983, Phillips et al. 1986, Wickramasinghe et al. 1989) and chronic 
malaria (Abdalla et al. 1980), but appears particularly important in the latter group 
(Abdalla 1990b, Das et al. 1999). Little is known about the underlying causal mechanisms 
(Abdalla 1990b, Phillips and Pasvol 1992). Ineffective erythropoiesis is occasionally 
observed in the anaemia of rheumatoid arthritis (Gerard Vreugdenhil, St Joseph Hospital, 
Veldhoven, The Netherlands: personal communication, 2001). A study in mice suggests 
that TNF may play an important role (Clark and Chaudri 1988). 
High serum concentrations of IL-10 and IL-12, which counteract TNF, IL-1 and IL-6, might 
prevent the development of severe malarial anaemia (Othoro et al. 1999). Insufficient IL-
10 production in response to high plasma TNF concentrations have been reported in 
African children with severe malarial anaemia (Kurtzhals et al. 1998), whereas defective IL-
12 production has been shown experimentally to be a mechanism causing fatal rodent 
malarial anaemia (Mohan and Stevenson 1998, Mohan et al. 1999). 
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FIGURE 5. Pathophysiological mechanisms determining the anaemia of malaria 
Malaria-induced haemolysis of parasitised and non-parasitised red cells leads to a decline of haemoglobin 
concentrations. The ensuing hypoxia is detected and followed by the increased production of erythropoietin in 
the kidneys, which in turn enhances the proliferation and differentiation of developing red cells in the marrow. 
Inflammatory cytokines released by monocytes and macrophages in response to schizont rupture lead to 
decreased production of erythropoietin, decreased responsiveness of red cell precursors in the marrow to 
erythropoietin, and decreased release by macrophages of iron from degraded haemoglobin. See text for further 
explanation. 
8. Measurement of iron status 
Iron deficiency and anaemia of chronic disease 
Diagnosis of iron deficiency is often difficult in African children, because - as described 
above - it may coexist with changes in body iron distribution that are associated with 
malaria and other infections. The gold standard for iron deficiency in persons without 
infection or inflammation is the demonstration of absence of stainable iron stores in 
macrophages in bone marrow aspirates or biopsy specimens. However, this is traumatic 
for patients, relatively expensive and generally deemed unethical in asymptomatic 
individuals. The deficit of functional iron is already profound before red cell abnormalities 
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become manifest (Baynes 1994). As a consequence, mean red cell volume has low 
sensitivity for detecting mild iron deficiency (Skikne et al. 1990). Serum ferritin 
concentration is normally measured as an indirect indicator of the degree of iron 
sufficiency. During infections, however, serum ferritin concentration is increased under 
influence of proinflammatory cytokines (see above). Low serum ferritin concentrations 
almost always have a fairly straightforward interpretation, as concentrations <15 ug/L are 
highly predictive for absent iron stores (Worwood 1994). High values in the absence of 
anaemia normally indicate adequate iron stores or even iron overload. When coupled with 
anaemia, normal or high serum ferritin concentrations indicate the anaemia of chronic 
disease, but this may mask coexisting iron deficiency (Cook 1994, Feelders et al. 1999). In 
the latter situation, a higher cut-off point of serum ferritin can be used to demonstrate iron 
deficiency, but this approach has limited value because of differences in serum ferritin 
measurements between test kits, and because of its poor diagnostic performance (Guyatt 
et al. 1990, Coenen et al. 1991). Several alternative laboratory measures, such as serum 
iron-binding capacity and zinc protoporphyrin concentration in circulating red cells, have 
been evaluated but these have limited capacity to distinguish between iron deficiency and 
anaemia of chronic disease (Sears 1992, Hastka 1993). 
Serum soluble transferrin receptor concentration 
A soluble form of transferrin receptors occurs in serum that provides a new method for 
assessment of iron status (Cook et al. 1993, 1994, 1996; Feelders et al. 1999). The 
physiological function of these serum receptors is not clear, but they presumably result 
from cellular degradation of membrane-bound receptors. Proteolytic cleavage of 
membrane-bound transferrin receptors occurs both at the outer cell surface and 
intracellularly during endocytosis of the iron-transferrin complex. 
The number of transferrin receptors in non-erythroid tissues is constant under normal 
circumstances. In vitro studies have shown that most serum soluble transferrin receptors 
(sTfRs) originate from erythroblasts and reticulocytes. The concentration of sTfR has 
furthermore been shown to be proportional to erythron iron turnover, a ferrokinetic 
estimate of erythroid marrow mass (Huebers et al. 1990). These findings are explained as 
follows. An increased rate of erythropoiesis - such as may occur following haemolysis - is 
accomplished by accelerated red cell development and hyperplasia of the erythroid marrow 
mass. This results in higher sTfR concentration and an increased rate of iron uptake. 
Hence, the rate of erythropoiesis is the major determinant of the total number of 
transferrin receptors. The only notable exception to the rule that the sTfR concentration is 
proportional to erythron iron turnover is in iron deficiency anaemia. The expression of 
receptors on the cell surface can be modified to reflect cellular iron requirements, resulting 
in an increased density of surface transferrin receptors in iron-deficient cells and a 
decreased density of these receptors in iron-replete cells (Cook et al. 1994, Klausner et al. 
1993). 
Hence, sTfR concentration is increased as a result of haemolysis and iron deficiency, but 
not by infection-induced inflammation. In the absence of haemolysis or other causes of 
increased erythroid iron turnover, increased sTfR concentrations reliably indicate iron 
deficiency (Ferguson et al. 1992). Conversely, in the absence of iron deficiency, increased 
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sTfR concentrations indicate an increased rate of erythropoiesis. Concentration of sTfR is 
furthermore more reliable than zinc protoporphyrin or mean corpuscular volume for the 
detection of early tissue iron deficiency (Skikne et al. 1990). In the presence of 
haemolysis, sTfR concentration has no value in diagnosing iron deficiency, because it may 
also indicate increased erythroid iron turnover. In those cases, iron deficiency can be 
excluded by the observation of the absence of a response in haemoglobin concentration to 
experimental iron therapy (figure 6). 
Measurement of sTfR concentration requires little blood that can be obtained through 
finger punctures, which is convenient when used in children in developing countries (see 
below). Various commercial enzyme-linked immunosorbent assay test kits are now 
available to measure sTfR concentration, but at least some of the disparity between the 
results of these assays (Akesson et al. 1999) could be eliminated by using a common 
standard (Cook 1993, Kuiper-Kramer et al. 1996). 
FIGURE 6 (OPPOSITE PAGE). Decision tree for determining iron status in rural African 
children 
* Different cut-off values are require to define anaemia in older age groups (WHO/UNICEF/UNU1997); t cut-off 
values have not been defined because commercial tests presently available to determine serum concentration 
of transferrin receptor are not standardised, see text); § haemolysis may possibly be assessed by serum 
concentrations of haptoglobin, lactate dehydrogenase or bilirubin. 
The proposed procedure is primarily designed to demonstrate the diagnostic value of serum transferrin 
receptor concentration as an indicator of iron status. The scheme may be used to classify young children by 
their iron status in community-based studies in rural Africa. Considerations of cost-efficiency were not taken 
into account. In the design of the scheme, it was presumed that small volumes of blood are available, so that 
few diagnostic tests can be carried out (see text). Larger volumes of blood can be collected through 
venipunctures, in which case additional tests may be carried out and the scheme may be refined. In clinical 
practice, additional tests (including symptoms and signs) are required to diagnose causes underlying anaemia 
or iron deficiency. 
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9. Strategies to reduce anaemia 
Even when successful, public health programmes to control iron deficiency and malaria will 
not eliminate anaemia as a public health problem. Depending on geographical location and 
characteristics of target groups, primary care workers may be faced with other possible 
causes of anaemia such as deficiencies in folate and vitamins A and B i 2 , HIV infection and 
tuberculosis. Thalassaemias and other inherited red cell disorders may be regionally 
important. Better tools and strategies are needed to detect anaemia at primary care levels 
and to differentiate between its underlying causes. Nevertheless, increasing understanding 
and awareness of the public health consequences of iron deficiency and new opportunities 
for its control should lead to renewed efforts to develop anaemia control policies in young 
children and pregnant women. Several of the interventions that can be used in an 
integrated programme will be discussed below. 
Reproductive and obstetric interventions 
Efforts to improve iron status in infants by improving iron status of pregnant or lactating 
women probably have limited efficacy unless these women are severely anaemic (Bothwell 
et al. 1989, Allen 1997, Mahomed 2000). On the other hand, erythrocyte transfer and 
thereby iron transfer to new-born infants can be substantially increased if the umbilical 
cord is not clamped and ligated until it stops pulsating (Grajeda et al. 1997). Meat-
products should be introduced with weaning foods from 4-6 months onwards (Yip 1994), 
although for economic, cultural or religious reasons this is seldom practised. 
Helminth control 
Heavy helminth infections are unlikely to occur in infants even in areas that are highly 
endemic, but even moderate hookworm infection may double iron requirements of children 
and menstruating women (Pawlowski et al. 1991, Stoltzfus and Dreyfuss, 1998). Annual 
presumptive therapy is effective and safe in reducing parasite loads and anaemia in school 
children (Adams et al. 1994, Stephenson et al. 1990, 1989, 1993a,b). More frequent 
treatment may be needed in highly endemic areas (Albonico et al. 1995). In populations 
with endemic hookworm, antihelminthic therapy has been recommended presumptively to 
anyone with severe anaemia, because treatment is considered safe and less expensive 
than diagnosis (Stoltzfus and Dreyfuss, 1998). 
Food-based measures to improve iron status 
Iron absorption depends on the form in which iron occurs in ingested food. When bound to 
haem, as in red meat, up to 20-30% of iron is absorbed (FAO/WHO 1988, IOM 2000). This 
absorption is relatively independent of other food substances. Absorption of non-haem iron 
is enhanced by ascorbic acid, or inhibited by plant factors such as phytates in cereals and 
tannins in tea. For non-haem cereal-based diets, as in developing countries, iron 
absorption may be as low as 5% (Gillespie 1998). In preschool children, this may at best 
be adequate to just prevent iron deficiency anaemia, but not to prevent iron deficiency, or 
to treat iron deficiency anaemia (Gillespie 1998). Thus, food-based approaches need to 
focus not only on increasing iron content of the diet but also on increasing iron 
bioavailability. Economic barriers to increased meat consumption and, in some areas, the 
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lack of iron-containing food items form additional constraints to improving iron status 
through dietary improvement. 
Iron fortification, when feasible and if the right food is selected, is appealing because high 
coverage of target groups that can be achieved, its cost-effectiveness compared to 
supplementation (Lofti et al. 1996), the absence of gastro-intestinal side effects, and 
because little cooperation of individuals is warranted. The choice of centrally processed 
and widely consumed foodstuffs is limited, however, and iron salts - with the exception of 
iron EDTA (INACG 1997) - can readily spoil the appearance or taste of many foods. As 
with dietary improvement, iron fortification may be sufficient to prevent iron deficiency 
anaemia, but is likely to be insufficient for its treatment in populations with high 
physiological requirements (Stoltzfus and Dreyfuss 1998). 
Iron supplementation 
There is growing consensus that iron supplementation should be a component of 
programmes to control iron deficiency in preschool children. Such programmes should not 
be constrained by concerns for iron overload (Gillespie 1998, UNICEF/UNU/WHO/MI1999). 
UNICEF and WHO recommend preventive iron supplementation for all infants and young 
children where the prevalence of iron deficiency anaemia is >30% (UNICEF/WHO 1994), 
and several expert groups subsequently issued similar recommendations (Nestel and 
Alnwick 1997, Stoltzfus and Dreyfuss 1998, UNICEF/UNU/WHO/MI 1999). Current 
guidelines for mass programmes recommend a daily regimen of supplementation (table 
1). Iron is usually given as ferrous sulphate tablets, which are relatively low-cost and easy 
to transport and store. Liquid forms of iron may be more appropriate for children <2 y 
because they are easier to administer and may give fewer adverse gastro-intestinal effects. 
At the time of design of the studies described in this thesis, there was considerable debate 
but little empirical evidence about the efficacy and effectiveness of daily compared with 
weekly or biweekly iron supplementation (Wright and Southon 1990, Galloway and 
McGuire 1994, 1996, Viteri et al. 1995, Cook and Reddy 1995, Viteri 1996, Cook 1996, 
Solomons 1995, Stephenson 1996). 
Measures to control malaria 
Personal protection measures comprise prevention of mosquito bites through the use of 
repellents, protective clothing or mosquito nets. Community protection measures comprise 
environmental management for mosquito control and the use of insecticide-impregnated 
nets. In areas of high endemicity, incidence and severity of symptomatic malaria are 
determined by immunity rather than vector densities or the rate of infection. In such 
areas, environmental management and other vector control measures aimed at a reduction 
of the rate of transmission therefore have limited effect in reducing malarial morbidity. A 
meta-analysis of three randomised trials among African children aged 1-59 mo showed 
that the use of insecticide-treated mosquito nets prevented 6 deaths per 1000 protected 
children per year for the three trials, corresponding to a reduction of overall mortality by 
17% (Lengeler 2000). The use of insecticide-impregnated mosquito nets can also markedly 
improve haemoglobin concentrations or haematocrit levels, either in areas of seasonal 
(D'Alessandro et al. 1995a,b) or stable malaria (Premji et al. 1995, Fraser-Hurt et al. 1999, 
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TABLE 1. Guidelines for iron supplementation * to children aged 6-24 mo (Stoltzfus and 
Dreyfuss 1998) 
Prevalence of 
anaemiaf 
<40% 
> 40% 
Birth-weight 
Normal 
Low (<2,500 g) 
Normal 
Low (<2,500 g) 
Age when supplements 
should be provided 
6-12 mo 
2-24 mo 
6-24 mo 
2-24 mo 
* The dosage is 12.5 mg elemental iron plus 50 u g folic acid daily based on 2 mg iron d' ' kg body weight -' 
t Measured in children 6-24: if prevalence is unknown, it is assumed to be similar to the prevalence of anaemia in pregnant 
women in the same population 
Marbiah et al. 1998, Shiff et al. 1996). Currently, the greatest challenge for research is to 
show that these nets are effective under real life conditions. 
There is little support for chemoprophylaxis as a routine health policy for young children in 
malaria-endemic areas, mainly because of the limited choice of safe and effective drugs, 
fear of selection and spread of drug resistance, poor compliance and the inherent logistic 
problems, and impairment of acquired immunity (WHO 1993). Several studies have shown 
an increased occurrence of malaria attacks following the cessation of chemoprophylaxis 
(Greenwood et al. 1995, Menendez et al. 1997). The mainstay of malaria control in Africa 
is early diagnosis and prompt treatment. Despite the occurrence of drug resistance, 
malaria remains a curable disease, although the number of suitable drugs is limited and 
decreasing. 
Recent findings from studies in Papua New Guinea that oral zinc and vitamin A 
supplementation may result in 32% and 30% reductions, respectively, of malaria-
attributable fevers in children aged 6-60 mo (Black 1998, Shankar et al. 1999, 2000) may 
offer prospects for control but require confirmation of effect in Africa. 
Iron supplementation in malaria-endemic areas 
Several issues must be addressed when considering iron supplementation in malaria-
endemic areas. First, as argued above, iron therapy might be less effective in improving 
haemoglobin concentrations in individuals with malaria - particularly those with persistent, 
asymptomatic infections - than in those without malaria. 
Second, despite considerable evidence for impaired immunity and increased risk of 
infections in iron deficiency (Dallman 1987, Brock 1994), several studies have reported 
increased parasite densities and frequency of attacks following parenteral and oral iron 
supplementation to individuals with asymptomatic malaria infections (Oppenheimer et al. 
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1986, Oppenheimer 1989a, 2001, INACG Expert Panel 1999). In a pooled analysis of these 
studies, it was found that such an effect in preschool children cannot be ruled out, but that 
the evidence is weak (INACG Expert Panel 1999). The usefulness of this meta-analysis is 
limited because of severe flaws in design, implementation and analysis in most of the 
individual studies. In addition, pooling of estimates from individual study results may be 
inappropriate because the presumed effects of iron supplementation are likely to depend 
on the level of immunity in the population studied, with greatest effects to be expected in 
young children living in areas of seasonal malaria. 
Several mechanisms have been proposed to explain increased malaria following iron 
supplementation. First, the shift in body iron distribution towards storage compartments 
and reduced iron absorption that are observed in anaemia of chronic disease have been 
regarded as a non-specific immunological defence by the host, conferring protection from 
pathogen proliferation (Jurado 1997, Kent et al. 1994, Weinberg 1992, 1993). This 'iron-
withholding' has also been presumed to be a defensive mechanism employed by the host 
against malaria, and, vice versa, iron supply can possibly increase iron availability to 
parasites and thereby increase the risk of malaria (Oppenheimer 1989b, Kent et al. 1994, 
Weinberg 1993, Scrimshaw 1991). This might hold truth if iron is supplied in massive 
doses and in relatively labile forms, as when administered parenterally (Brock 1994, 1999, 
Weinberg 1993), but - considering the considerable reserves of iron-binding capacity that 
both transferrin and ferritin have in individuals with the anaemia of chronic disease (Brock 
1999) - this is unlikely to occur when iron is administered orally (Brock 1994). In addition, 
although iron is an essential element for the development of Plasmodium species, there is 
little doubt that the intra-erythrocytic parasite acquires iron from intracellular sources, 
most likely from degraded ferriprotoporphyrin IX (Ginsburg 1999). 
These mechanisms might nevertheless play a role in severely malnourished individuals. 
Broad impairment of protein synthesis might result in decreased serum transferrin 
concentrations (Sears 1992). Increased iron intake in wasted individuals may result in the 
available serum transferrin being overwhelmed. Thus, it has been suggested that in 
severely malnourished individuals a combination of low serum transferrin and a large rise 
in serum iron following treatment may have enhanced iron availability to parasites (Brock 
1994). 
A second and more likely mechanism that has been proposed (Oppenheimer 1989b) 
concerns an increased reticulocytosis following iron supplementation, which might favour 
the proliferation of P. falciparum and P. vivax (see previous sections). Thirdly, iron 
supplementation might increase a small labile pool of iron that may exist in red cells 
(Loyevski et al. 1999) and that possibly provides the parasite with iron (Oppenheimer 
2001). 
The above findings indicate the continued need for a randomised controlled trial with 
sufficient size and a homogenous study population to assess the effects on malaria of 
supplementation in young children living in an area of seasonal transmission, and to 
confirm evidence for such an effect from an earlier trial in severely malnourished 
individuals (Murray et al. 1978). 
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10. The study site in Kenya 
The studies described in this thesis were carried out near the town of Mtito Andei in 
Eastern Province, located halfway along the road and rail link between Nairobi and 
Mombasa (figure 8). Before independence from British colonial rule (1963), this area was 
a national park with few permanent settlements. The present inhabitants almost 
exclusively belong to the Akamba tribe and were resettled in the 1970s and 1980s from 
the highland area around Machakos, a city located 70 km east of Nairobi. No 
epidemiological or entomological studies on malaria had been carried out previously in the 
study area, and no research infrastructure was present. 
The area was selected because it was our purpose to conduct the studies in conditions of 
seasonal malaria transmission. In addition, this study site allowed us to collaborate with an 
existing local network of community health workers who had been trained in preceding 
decades by the African Medical and Research Foundation (AMREF). A similar research 
project to ours but not further described in this thesis was carried out simultaneously 
under conditions of stable, perennial malaria transmission in Western Kenya (coordinator: 
Feiko ter Kuile, University of Amsterdam/Academic Medical Centre, Amsterdam, in 
collaboration with the Kenya Medical Research Institute/Centers for Disease Control and 
Prevention, Atlanta, GA, USA). 
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Figure 8. Location and weather characteristics of the study area 
Source of weather data: FAOCLIM Global Weather Database, release 20 July 1990 (Makindu meteorological 
station; precipitation indicated by bars; maximum and minimum temperatures indicated by lines with open en 
closed squares, respectively). 
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11. Aims and outline of the thesis 
Rationale and design considerations 
The age between the first few months of life and 60 mo is the broad range at which 
children are at greatest risk of iron deficiency, malaria, anaemia and stunting, and for 
which successful interventions would give great health benefits. When designing the 
studies described in this thesis, it was decided to settle on children aged 2-36 mo, because 
this range was expected to provide some degree of homogeneity in the population studied, 
while for practical reasons it was expected not to be overly restrictive. It was furthermore 
hoped that at this age worm infections would not yet interfere with our intention to focus 
our studies on iron deficiency and malaria as causes of anaemia. Care was taken to sample 
all resident children in a fairly large study area, so that inferences from the studies could 
be expected to be reasonably valid for similarly aged children living in areas of seasonal 
malaria transmission. 
Iron supplied in pharmaceutical preparations is readily absorbed. Hence, when 
administered in placebo-controlled randomised trials, iron supplementation is useful to 
determine efficacy, i.e. to measure maximum effect achieved under highly controlled 
conditions. No other study design can achieve this. Observational studies - although 
indispensable for rapid appraisal and to explore hypotheses along the path to proving 
causality - are also more amenable to bias due to confounding factors. Randomised 
controlled trials can thus be used to set goals that can possibly be achieved by 
micronutrient control programmes using more realistic approaches and under Veal-life 
conditions' (effectiveness). 
It might be argued that intervention studies to determine whether or not iron deficiency 
and malaria are causes of anaemia in Africa are redundant. Such an argument is both 
correct and beside the point. The prime reason to measure efficacy is to evaluate 
interventions in terms of health benefits that can be achieved. Thus, the main objective of 
our randomised trial was not formulated in terms of hypothesis testing, but with a view to 
give adequate precision in estimating gains that can be achieved in haemoglobin 
concentration. 
Another particular aspect of this trial concerns its 2x2 factorial design. We chose this 
design because it allows for effect estimation of combined iron supplementation and 
malaria control, and theoretically it allows for testing whether such an effect is greater (or 
less) than the sum of individual interventions (interaction). However, for practical reasons, 
the number of people that can be included is commonly limited in randomised trials. As a 
result of this drawback, the trial described in this thesis was necessarily limited in its power 
to detect existing interaction between interventions, and in its power to measure possible 
adverse effects of iron supplementation. 
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Objectives and outline of the thesis 
The long-term objective of this thesis was to contribute to the development of 
programmes for anaemia control in preschool children in Africa. 
The immediate objectives were as follows: 
1. to measure the efficacy in improving haemoglobin concentrations in children aged 2-
36 mo of intermittent iron supplementation and intermittent administration of 
sulfadoxine-pyrimethamine, either alone or when given in combination; 
2. to develop and evaluate survey methods for rapid assessment at community level of 
the burden of anaemia and its risk factors; 
3. to contribute to improved methods for diagnosis of anaemia, iron deficiency, and 
malaria; 
4. to evaluate the role of impaired erythropoiesis in the pathogenesis of anaemia that is 
associated with asymptomatic malaria. 
The fieldwork undertaken comprised two studies that were conducted in 1997-2000. First, 
a cross-sectional study was carried out to pursue objectives 2-4, and in preparation for 
further studies. Its results are described in chapters 2-4 of this thesis. Second, a 
randomised controlled trial was undertaken to achieve objectives 1 and 4; its results are 
described in chapters 5 and 6 respectively. Several sub-studies were undertaken as part of 
the cross-sectional and intervention studies in fulfilment of objective 3; their results are 
presented in chapters 7-9. One spin-off from the cross-sectional study relevant to the 
occurrence and prevention of anaemia concerned a study into the use of antimalarial 
drugs. The findings of this study are given in chapter 10. Finally, the main findings and 
conclusions of the above studies are discussed in chapter 11, together with our 
recommendations for health policies and further research. Other spin-offs which are not 
necessarily relevant for the study objectives are described in annexes 1-2. 
12. Ethical considerations 
Methods of blood collection 
Consideration for individual study children and cultural perceptions of blood collection 
require only limited volumes to be drawn. Collection of venous blood can be particularly 
difficult in young children who often have ample baby fat, and parents may refuse consent 
or children may be lost to follow-up when venous blood collection is repeated in the same 
children. On the other hand, sufficient blood is needed to arrive at reliable study 
conclusions, which is an ethical goal by itself. These conflicting demands were balanced by 
using collection techniques by finger puncture that may yield up to 1 mL whole blood, by 
thoroughly explaining and discussing procedures with local health personnel, community 
leaders and parents before informed consent was obtained, and by using diagnostic tests 
requiring a minimum volume of blood. 
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Use of placebo groups 
A heated and on-going debate in the medical literature started when Lurie and Wolfe 
(1997) questioned the ethics of using placebo groups in intervention studies undertaken in 
developing countries. Their criticism was triggered by ongoing placebo-controlled trials to 
prevent mother-to-child transmission of human immunodeficiency virus (HIV), despite 
evidence that zidovudine had been clearly shown to substantially prevent vertical 
transmission. Others commented that antiretroviral agents because of their cost and 
logistic constraints could never become the standard of care for developing countries 
(Merson 1998) and that 'the inclusion of placebo controls [will determine] the value of the 
intervention being studied compared to the local standard of care' (Varmus and Satcher 
1997) - they were subsequently supported by some (Gambia Government/Medical 
Research Council Joint Ethical Committee 1998) and criticised by others (Angell 1997). The 
ensuing discussion centred in large part around the interpretation of the word 'best' as 
contained in the following statement in the guiding principles of ethical research, the 
Declaration of Helsinki (WMO 1989): 'In any medical study, every patient - including those 
of a control group, if any - should be assured of the best proven diagnostic and 
therapeutic method.' 
On the basis of the existing evidence at the time of study design, we had doubts whether 
the benefits of iron supplementation in terms of gains in haemoglobin concentrations 
outweighed the possible negative effects posed by malaria. The occurrence and severity of 
possible adverse effects on malaria of iron supplementation depend on the level of 
acquired immunity as determined by geographical locations and age. Also in the case of 
malaria, there is general doubt about whether the benefits of chemoprophylaxis outweigh 
the possible adverse effects (see above). Some children were left untreated for 
asymptomatic malaria during the intervention period, which is associated with mild 
anaemia and possibly with an increased risk of subsequent malaria; on the other hand, 
these children are acquiring immunity that protects them from severe disease and death. 
In this context, we considered the use of placebos in our trial to be justified. 
Perhaps most importantly, we believe that all children taking part in our studies, including 
those in the placebo groups, were better off than children not taking part, and that all 
received substantially better care than practically attainable in the host country 
(Anonymous 1999). This belief is grounded in the fact that intensive supervision was given 
to ensure that any common childhood illness was detected and treated promptly. Lastly, all 
children received treatment for common infections or diseases immediately after the 
intervention period. 
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ANNEX. Glossary of terms used in this thesis 
Chronic malaria 
Erythroblast 
Erythroid hyperplasia 
Erythroid progenitor cell 
Mononuclear phagocyte system 
Preschool children 
Sign 
Symptom 
Malaria with persistent or repeatedly recurring 
parasitaemia, which may occur in low densities over 
long periods of time and often without symptoms 
Human red cell that contains a nucleus 
Increase in the number of developing red cells, usually 
confined to the marrow 
Stem cell giving rise to red cell 
(formerly referred to as the reticuloendothelial system) 
group of phagocytic white cells derived from bone 
marrow stem cells and located outside the vascular 
system in tissues of many organs; their function is to 
engulf particles, including infectious agents, and 
destroy them 
Children <5 y of age 
Manifestation of disease as observed during medical 
examination by health personnel 
Manifestation of disease as reported by patients or 
their caretakers 
2 
Variance estimation when using cluster 
surveys in developing countries to assess 
exposure-health outcome relationships 
Hans Verhoef, Joke Rijlaarsdam, Jan Burema, Clive E West, Frans J Kok 
ABSTRACT 
Purpose: Cluster sampling as advocated by the World Health Organization is by far the 
most common design for health surveys in developing countries. Methodological 
limitations have limited the use of these surveys to descriptive statistics. We evaluated 
whether they can be used to assess relationships between exposures and health 
outcomes. 
Methods: Data were used from a cluster survey on malaria, anemia and anthropometric 
indices in Kenyan children. SUDAAN software was specifically designed for analysis of 
survey data and can take effects of weighting and clustering on variance estimates into 
account. 
Results: When assuming cluster sampling with replacement, estimated design effects 
ranged from 0.8 to 2.7, showing that standard statistical software can lead to biased 
variance estimates. Our findings suggest smaller design effects for regression coefficients 
than for means and proportions. SUDAAN may not yield variance estimates for large 
sampling fractions, but this is a design rather than a software problem. It can be 
overcome by assuming sampling with replacement, although this will yield overestimates 
of standard errors and confidence intervals. 
Conclusions: SUDAAN greatly expands existing analytical capabilities, including 
regression modeling. In most surveys, the sampling fraction of the total population of 
clusters is small, and SUDAAN will yield valid variance estimates. 
Submitted for publication 
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Surveys form attractive tools for health managers who want a rapid assessment at 
relatively low cost of the occurrence of disease or the utilization of health services in a 
population. In the past, surveys in developing countries typically assumed random 
sampling when analysing data from all or a random sample of individuals living in 
arbitrarily selected communities. This yields inaccurate estimates, because it does not take 
into account that variability in health outcomes originates from variability between 
individuals, but also from variability between communities. 
A major improvement was the introduction of the cluster sample methodology, which was 
designed to estimate the proportion of immunized children (Henderson and Sundaresan 
1982, Lemeshow and Robinson 1985), but which has also been adopted for measuring 
other health outcomes (Birmingham et al. 1997, Chirambo et al. 1986, Ferrinho et al. 
1992, Hercberg et al. 1986, Hlady et al. 1994, Katz et al. 1988, 1993, 1994, Legetic et al. 
1996, Materia et al. 1995, Sikosana 1994, Stetler et al. 1980). In the first sampling stage 
of this design, a systematic sample is drawn from all communities (Clusters') in the 
geographical area of interest with probability proportional to size. At the second stage, 
households are selected in a random-like fashion within the selected communities. All 
children within the eligible age range living in these households are included, and selection 
of households continues until a predetermined number of children has been examined. In 
the statistical analysis, it is assumed that each child in the target population has an equal 
probability of being included in the sample, so that valid point and variance estimates can 
be obtained using unweighted data. 
We evaluated whether the cluster survey can also be used for analytical purposes, i.e. to 
assess relationships between exposures and health outcomes at a single point in time. 
Variance estimation should rely on specialized sample survey software to take this design 
into account (Brogan et al. 1994). Survey data on malaria, anemia and anthropometric 
indicators of nutritional status in Kenyan children were used to compare estimates of 
arbitrarily selected parameters and their corresponding standard errors when using three 
different statistical software packages. Clustered data can be described using Epi Info 
software, and analysed using SUDAAN software. SPSS is a commonly used standard 
statistical software, which may lead to biased variance estimates when applied to clustered 
data. Biological interpretation of estimates will be published elsewhere (Verhoef et al. 
1999; accepted). Although we incorporated modifications in the sampling procedures 
(Bennett et al. 1991, Brogan et al. 1994), we tried to retain the simplicity of the original 
design as much as possible. 
Subjects and methods 
Study area and subjects 
The study was conducted in the first annual rainy season (April to June) of 1997 in Mtito 
Andei Division, Eastern Province, Kenya. This area comprises approximately 720 km2 and is 
located halfway on the road and rail link between Nairobi and Mombasa. The inhabitants 
live in widely scattered homesteads. The target population of our study consisted of all 
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resident children born between 15 April 1994 and 15 February 1997, with no symptoms 
reported by mothers or carers of malaria or anemia. 
Local government administrators, community leaders and auxiliary health workers 
(community health workers, traditional birth attendants and traditional herbalists) were 
explained the purpose of the survey and asked to identify communities, and to update a 
household survey that had previously been conducted in each community in the study 
area. For enumeration purposes and as the basic sampling unit, we defined a household as 
a group of people living on the same premises and whose food is prepared by the same 
person(s). Each household was identified by the name of its head, and the number of its 
members was listed. No names or vital data were recorded for individual household 
members at this stage. Small communities were considered jointly with other communities, 
so that their total number of households was greater than the number to be drawn in the 
second sampling stage. This yielded a complete list of all households in the areas of 
interest (7,141 households living in 79 communities, with a total population of more than 
40,000 inhabitants). A systematic sample of 45 communities was drawn from a 
geographically (north to south) ordered list, with probability proportional to size (measured 
as the number of households per community), excluding 'urban' centers, and using 
procedures described by Bennett et al. (1991). The number of households in three out of 
these 45 communities was marginally higher than the sampling interval. In such cases, it is 
possible that the same community is selected twice, in which case the procedure foreseen 
calls for double sampling within the communities concerned (Bennett et al. 1991, 
Lemeshow and Robinson 1985). However, this did not occur in our study. 
From each of the selected communities 12 households were randomly sampled with 
replacement, and for each of these households, the resident children were listed together 
with their dates of birth as ascertained from the child health card. All children thus 
identified without symptoms of malaria or anemia and within the desired age range were 
selected for the study (n=302). Children who in the course of the study migrated with 
some household members were excluded without replacement. Children who migrated 
with all household members, or were still missing after repeated visits, or had parents who 
refused consent were replaced where possible by children from randomly selected 
households within the same community. 
Mothers and study children were invited to pre-arranged meetings in or close to their 
resident communities for anthropometric measurements and a medical examination. Study 
procedures during the examination and laboratory procedures will be described elsewhere. 
Children received medical treatment as necessary. The study was approved by the African 
Medical and Research Foundation and the Kenya Medical Research Foundation whose 
ethical standards were followed. 
Response and missing values 
A total of 302 children were selected for study, of whom 16 were double-selected at the 
second sampling stage (figure 1). Observations for these 16 children were weighted 
twice. Thus 318 children were included in the study, of whom 35 did not participate or 
fully participate for the following reasons: refused consent (26); not home or temporarily 
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absent (7); hospitalized for burns (2). Of these 35 children, 14 were replaced by random 
selection, which brought the total number of children included in the analysis up to 297. 
When non-participating children were not replaced, weighting was used to maintain the 
validity of assuming an equal probability sample. Thus, observations on those who 
participated within the same cluster were inflated by weighting with a multiplication factor 
calculated as the number of selected children in that cluster divided by the number of 
participating children (Bennett et al. 1991, Brogan et al. 1994). This brought this number 
back to 318 children; sample sizes reported below this value are due to missing values. 
79 communities 
1 st sampling stage: 
systematic samDle without reDlacement 
45 communities selected 
2nd sampling stage: 
random sampling with replacement 
12 households selected per community 
318 cases: 302 eligible children of whom 16 double-selected 
J. 
283 cases fully 
participated 
I 
35 did not participate or 
did not fully participate 
I 
random 
Qolortinn 
14 replaced 21 not replaced 
297 cases 
I weighting to correct for non-participation 
318 cases in analysis 
FIGURE 1. Framework for selection and analysis 
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Statistical analyses 
Data were entered into the computer and cleaned using SPSS software (v7.5 for Windows; 
SPSS Inc., Chicago III, USA). Anthropometric indices were calculated using Epi Info (Dean 
1994, Dean et al. 1994) (v6.04; CDC, Atlanta GA, USA). The SPSS data set was also 
imported for calculations by SUDAAN (Shah et al. 1997) (stand-alone V7.5.2A for Windows; 
Research Triangle Institute, Research Triangle Park NC, USA) or Epi Info. 
Estimates were calculated assuming: 1) cluster sampling without replacement at the first 
stage (computations in SUDAAN, DESIGN=UNEQWOR statement); 2) cluster sampling with 
replacement (or with small sampling fractions) at the first stage (computations either in 
SUDAAN with the DESIGN=WR statement, see annex 1, or in Epi Info); and 3) simple 
random sampling (calculations by SPSS or, when computing prevalence ratios, by 
spreadsheet). 
The DESIGN=UNEQWOR design statement in SUDAAN requires the specification of a 
matrix naming the single and joint inclusion probability for each community and each pair 
of communities. A description of our procedures for calculating this matrix is given in 
annex 2. 
By convention, the design effect is defined as the ratio of the actual variance of an 
estimated parameter to the variance based on a simple random sample of the same size. 
It indicates the proportional change in sample size that would yield the same precision of 
the estimated parameter as when using simple random sampling. 
When calculating descriptive statistics, estimates of standard errors using ordered lists of 
clusters (El-Bindari-Hammad and Smith 1992) did not appreciably alter the values obtained 
for non-ordered lists (Bennett et al. 1991), so that only the latter are reported here, thus 
enabling values obtained by SUDAAN and SPSS to be compared. 
When estimating prevalence ratios and the corresponding standard errors under the 
assumption of simple random sampling, the data from all sampled clusters were pooled 
and tabulated in a 2x2 frequency table cross-classifying binary exposure and health 
outcome variables. Estimates were computed using the iterative procedures by Fleiss 
(1981). This provides somewhat larger, but more accurate standard error estimates than 
those based on the log prevalence ratio (Fleiss 1981). 
Results 
When assuming without replacement cluster sampling at the first stage 
(DESIGN=UNEQWOR statement), SUDAAN did not yield estimates of standard errors. The 
Yates-Grundy formula used in this procedure for variance estimation incorporates the term 
Pi*Pj - Pjj where Pj and Pj are single inclusion probabilities for each community, and Py 
denotes the joint inclusion probability for each pair of communities. Whenever this term is 
negative, variance contribution is negative. Thus because estimated standard errors were 
negative in our study, they were not reported by SUDAAN (Dr B Shah, Research Triangle 
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Institute, Research Triangle Park NC, USA; personal communication). Estimates obtained 
with the remaining two design assumptions (with replacement cluster sampling and simple 
random sampling) are shown in tables 1-4. Point estimates were identical under both 
procedures. 
Descriptive statistics 
Estimates of standard errors were identical whether calculated by SUDAAN, Epi Info or as 
in Bennett et al. (1991). Estimates of standard errors were greater, and confidence 
intervals wider, when assuming cluster sampling than when assuming simple random 
sampling (table 1). Consequently, the design effects of prevalences and means varied 
between 1.4 for the prevalence of anemia and 2.7 for the prevalence of children who 
tested positive for chloroquine. The corresponding values for the intracluster correlation 
coefficient, p, varied between 0.06 to 0.29. Epi Info and SUDAAN were found to give 
slightly lower estimates of design effects than reported in table 1 (not shown). 
Differences in means 
Standard errors of the differences in means were all larger, and confidence intervals wider, 
when assuming cluster sampling than when assuming simple random sampling (table 2). 
Prevalence ratios 
Standard errors for prevalence ratios were smaller or larger under cluster sampling with 
replacement than under simple random sampling, depending on the ratio which was 
examined (table 3). As a result, confidence intervals were smaller or wider, respectively. 
Multiple regression 
Results of linear regression of hemoglobin and log ferritin concentrations are given in 
table 4. Again, depending on the point estimate to be examined, standard errors were 
smaller or greater when assuming cluster sampling than assuming simple random 
sampling, resulting in design effects below or above 1, respectively. 
Discussion 
Our study illustrated differences between estimates of standard error when assuming 
cluster or simple random sampling. Design effects varied between 0.8 and 2.7. It also 
showed the use of SUDAAN for estimating measures of association. SUDAAN can take 
weighting and clustering effects of study design into account. When applied to cluster 
surveys of the Expanded Programme on Immunization, however, it did not yield variance 
estimates when assuming sampling from finite populations of clusters. 
The cluster survey of the Expanded Programme on Immunization was originally designed 
to estimate the prevalence of a certain characteristic in a population under study within a 
desired level of precision (Henderson and Sundaresan 1982). It is used increasingly for 
new applications or objectives requiring higher levels of accuracy. For example, the 
success of immunization programs in many developing countries has resulted in relatively 
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high levels of coverage, and many countries now wish to measure relatively small 
increases in coverage beyond levels that are already high (Brogan et al. 1994). Thus, a 
number of improvements have been proposed in the original design. Bennett et al. (1991) 
and Brogan et al. (1994) proposed selection of a fixed number of households at the 
second sampling stage, resulting in a variable number of children per cluster, rather than a 
fixed number of children as in the original design (Henderson and Sundaresan 1982). They 
demonstrated how clustering effects can be taken into account in the estimation of means 
and prevalences, the latter calculated either as a proportion of a fixed number of subjects, 
or as an index with a variable number of children as the denominator. 
Formulae are also available to calculate standard error estimates when, prior to first-stage 
sampling, clusters are ordered according to a criterion that is related to the outcome of 
interest (El-Bindari-Hammad and Smith 1992). This has the effect of stratifying the 
systematic sample and should lead to an increased precision in the estimated prevalence. 
The assumption made in household surveys of equal inclusion probability in the sample for 
each individual child may be violated by non-response. This can be corrected for by 
weighting the observations in the analysis (Bennett et al. 1991, Brogan 1998, Brogan et al. 
1994). 
The procedures developed so far for this survey design had limited capability for analytical 
purposes. Harris and Lemeshow (1991) provide methods for calculating prevalence ratios 
taking the cluster sampling design into account. Katz et al. (1993, 1994) used a new 
technique, called alternating logistic regression (Carey et al. 1993), to examine 
associations between binary variables while allowing for adjustment for other variables; 
however the expertise required is not usually available to workers in the field. SUDAAN 
offers analytic tools for descriptive data analysis, cross-tabulation, and for multivariate 
linear and logistic regression. 
Three effects of our study design should be taken into account, namely weighting, 
clustering and sampling from a finite population. Standard statistical software packages 
such as SPSS or SAS (SAS Institute Inc., Cary NC, USA) are capable of weighted analysis 
and may yield valid point estimates of population parameters. However, estimates of 
standard errors may be biased because these packages presume independent observations 
as obtained by random sampling (Brogan 1998), whereas cluster sample survey data are 
usually dependent. The health status of individuals in the same household or the same 
community is often more alike than that of individuals from different households or 
communities. This may be due to infections spreading through contact between 
individuals, genetic predisposition to certain diseases within families or within communities 
with a high degree of consanguinity, or to common environmental or behavioral factors 
leading to an increased prevalence of the health outcome within certain households or 
communities (Katz et al. 1993). Hence, the observed variability between individuals is 
partly due to variability within clusters, and partly due to variability between clusters. By 
ignoring this issue, standard statistical software packages generally underestimate the 
variance of point estimates by a degree that depends on the spatial clustering of the 
health outcome under consideration. Our data suggest much smaller design effects for 
58 Chapter 2 
regression coefficients than for means and proportions. This has also been suggested in a 
previous health examination survey conducted by the US National Center for Health 
Statistics (1976). 
Although designed to handle observations drawn from finite populations, this option failed 
to work in SUDAAN. In our example, we selected 45 out of 79 communities at the first 
sampling stage. Taking this large sampling fraction into account in the analysis should 
have led to greatly reduced variance estimates. The inability to incorporate a finite 
population correction factor in variance estimates is not limited to SUDAAN, but seems 
inherent to the Yates-Grundy formula that was used for variance estimation in our design 
(annex 2). Many pairs of communities have a considerable overlap in position on the 
shifted interval (figure 1). As a result, their joint inclusion probabilities were larger than 
the product of the single inclusion probability. Our study had an unusually large sampling 
fraction. We expect that in most other surveys this is not the case, so that valid variance 
estimates are obtained when assuming cluster sampling with replacement at the first 
stage. 
Our study may have been unusual because village elders in the entire area of interest had 
enumerated all households in their communities a year before for the purpose of 
emergency food distribution. This list could easily be updated before drawing a sample of 
clusters. In other circumstances, some approximate measure of the number of households 
or residents per community is needed, whereby relative size is more important than 
absolute size. Such information can often be obtained from censuses that were carried out 
previously, from local government or from non-governmental organizations that are locally 
active. 
Calculation of sample size poses more difficulties with cluster sampling than with simple 
random sampling. Ideally, one decides on the precision required and then calculates the 
required number of children, as well as the required number of clusters, m, and the 
required number of households per cluster, h. Decisions as to the exact values of m and h 
to use should be tailored to the outcome under consideration and to assumptions on the 
spatial distribution of this outcome in the study area. To some degree, such decisions can 
be guided by knowledge on the variability of the outcome between clusters, which can be 
expressed as the intracluster correlation coefficient, p (the variability between clusters as 
compared to the variation within clusters), or the design effect, D (Bennett et al. 1991). 
Because we could not find previously published values for these parameters for malaria, 
anemia, or anthropometric indicators of nutritional status, we let ourselves be guided by 
practical considerations. Preliminary analysis of census data suggested that 12 sampled 
households should be included per cluster to arrive at the target of 7 children per cluster, 
which was judged to be the average number that we could comfortably handle in half a 
day of field work. The number of sampled clusters (45) was made as large as possible 
within the operational constraints of the study. 
Although there is no good way in SUDAAN to account for implicit stratification by ordering 
clusters according to the north-south gradient, this could be specified as a categorical 
covariate when analyzing the data. 
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Conclusions and recommendations 
SUDAAN is versatile software that greatly expands the existing capabilities for data analysis 
of the cluster survey methodology. It can take weighting and clustering effects of study 
design into account. The inability to incorporate finite population corrections in variance 
estimation is not limited to SUDAAN, but is unlikely to be an issue in most surveys. Should 
this problem nevertheless occur, then variance estimates can be computed in SUDAAN 
assuming cluster sampling with replacement at the first stage, which will yield 
overestimates of standard errors and confidence intervals. 
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ANNEX 1 Example of SUDAAN design statements 
The left-hand column shows sample input to specify a cluster sample design assuming with 
replacement sampling at the first sampling stage. 
Statements Description 
PROC descript - Requests the procedure for estimating descriptive 
statistics. 
DATA = "c:\\survey.sav" - Specifies the file location of the data set 
FILETYPE = SPSS - Identifies the used data set as an SPSS file 
DESIGN = WR; - Specifies sampling with replacement at the first stage 
WEIGHT weight; - Specifies the variable with the weight for each observation 
NEST _one_ village; - Specifies that, at the first sampling stage, one stratum was 
used from which clusters were drawn, with sampled 
clusters denoted by the variable 'village 
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ANNEX 2. Procedure for calculating the JOINTPROB matrix 
The procedure to select a systematic sample of clusters has been described by Bennett et 
al. (1991). In brief, communities are listed, together with their size and cumulative size, 
where size is preferably measured by the number of households (Brogan et al. 1994). The 
total household size is then divided by the number of clusters to be selected to obtain the 
sampling interval. By selecting a random number within this interval, the first cluster to be 
sampled is identified as the one which includes this number in the cumulative list. 
Additional communities to be included are subsequently identified by successively adding 
the sampling interval. Using this procedure, it is possible that the same community is 
selected twice. If this occurs, then the number of households should be doubled at the 
second sampling stage within the communities concerned (Bennett et al. 1991, Lemeshow 
and Robinson 1985). 
The use of without-replacement sampling at the first stage, as specified in the 
DESIGN=UNEQWOR design statement, requires the specification in SUDAAN of a matrix in 
a 'jointprob' statement naming the single and joint inclusion probability for each 
community and each pair of communities. To illustrate the calculation of these 
probabilities, consider 11 communities Cl-Cll, with sizes 50, 50, 75, 50, 50, 25, 125, 75, 
25, 50, 25 households, respectively. The cumulative size of all households would be 600. If 
6 communities were drawn, then the sampling interval would be 100 (/ =600/6). First, 
communities are fitted, in order of appearance of the original list, onto the shifted interval, 
as in figure 2. The single inclusion probability for each community is calculated as the 
proportion of the shifted interval taken up by that community. For example, the single 
inclusion probabilities for communities CI or C7 are 0.50 (=50/100) and 1.00 (=100/100), 
respectively. To calculate the joint inclusion probabilities, we first determine the interval 
where pairs of communities overlap on the shifted interval. For example, for communities 
C2 and C5 this interval is 25, namely on their positions 50-75 and 250-275, respectively, 
(see figure 2). Hence, the joint inclusion probability of communities C2 and C5 is 0.25 
(=25/100). Similarly, there is no overlap for communities CI and C l l , so that their joint 
inclusion probability is zero. Inclusion of the single and joint inclusion probabilities in the 
matrix depends on the randomly selected starting point. For example, if 64 was selected as 
the starting point, this would result in a 6x6 matrix with the probabilities for the villages 2, 
3, 5, 7, 8 and 10 (see vertical dotted arrow in figure 2). 
An example of computerized calculation of such a matrix in SAS software, based on the 
survey described in this article, is available upon request from the authors. 
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F I G U R E 2 . Visual representation for calculation of J O I N T P R O B matrix (see text) 
Vertical bars: boundaries of successively listed communities with numbers indicating their cumulative size; C1-
C11: identification labels of communities; horizontal shaded bars: overlap between C2 and C5 in their relative 
positions on the sampling interval. 
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Serum transferrin receptor concentration 
indicates increased erythropoiesis in Kenyan 
children with asymptomatic malaria 
Hans Verhoef, Clive E West, Paul Ndeto, Jan Burema, Yves Beguin, Frans 3 Kok 
ABSTRACT 
Background: Serum transferrin receptor concentration indicates both erythropoietic 
activity and the deficit of functional iron in the erythron. Contrary to the serum 
concentration of the iron storage protein ferritin, it is not or only marginally influenced by 
the inflammatory response to infection. 
Objective: To assess iron status and the relationship between serum transferrin receptor 
concentration and malaria in children aged 2-36 mo asymptomatic for malaria. 
Design: Community-based cluster survey (n=318). 
Results: Prevalences of malaria, anemia (hemoglobin concentration^ 10 g/L), iron 
deficiency (serum ferritin concentration <12 ug/L) and iron deficiency anemia were 18%, 
69%, 53% and 46%, respectively. Malaria was associated with lower mean hemoglobin 
concentrations (92.7 compared with 104.1 g/L; p=0.0001), and higher geometric mean 
serum concentrations of transferrin receptor (11.4 compared with 7.8 mg/L; p=0.005), 
ferritin (21.6 compared with 11.9 mg/L; p=0.05) and C-reactive protein (12.5 compared 
with 6.8 mg/L; p=0.004). There was no evidence for an association between serum 
concentrations of C-reactive protein and transferrin receptor. Children with malaria had 
higher serum transferrin receptor concentrations than expected for the degree of anemia, 
also when adjusting for inflammation indicated by serum C-reactive protein concentration 
quartiles (p=0.02). 
Conclusions: Our findings are consistent with the notion that malaria-induced hemolysis 
is accompanied by increased erythropoiesis. Serum transferrin receptor concentration is 
not useful to detect iron deficiency in individuals with malaria. Individuals with high 
concentrations of serum C-reactive protein or similar acute phase reactants should be 
excluded if serum ferritin concentrations": 12 ug/L are to be used for measuring iron 
deficiency in malaria-endemic areas. 
Am J Clin Nutr (accepted) 
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Iron deficiency and malaria are likely causes of anemia in African children (Latham et al. 
1990, Premji et al. 1995, Shiff et al. 1996, Menendez et al. 1997), but little remains known 
about the pathogenic mechanisms involved. Malaria leads to hemolysis, impaired 
erythropoiesis (Abdalla 1990) and possibly iron sequestration and iron deficiency (Brabin 
1992). The relative contributions of these mechanisms is likely to vary with the burden, 
activity and duration of infection. Ferritin is an iron storage protein, and serum 
concentrations <12 ug/L are highly predictive of iron deficiency, defined by absence of iron 
stores (Cook 1994). Serum ferritin also reacts as an acute phase protein (Konijn and 
Hershko 1977). Chronic infections generally cause anemia and a shift of iron distribution 
from functional towards storage compartments (Sears 1992), as reflected by increased 
serum ferritin concentrations. The resulting hypoferremia may occur despite the presence 
of sufficient iron stores (Sears 1992). Until recently, it was believed that anemia of 
infection is primarily due to impaired release by macrophages of iron from degraded 
hemoglobin (Konijn 1994, Lee 1983). Recent evidence suggests rather that the prime 
cause of anemia of infection is decreased responsiveness of erythroid cells to 
erythropoietin and relatively impaired erythropoietin production, both under influence of 
inflammatory cytokines (Means and Krantz 1992, Spivak 2000). 
Observations that serum soluble transferrin receptor (sTfR) concentrations are not or only 
marginally influenced by the inflammatory response to infection (Weiss 1999, Feelders et 
al. 1999) are consistent with the notion that hypoferremia in infection is a non-specific 
consequence of activation of inflammatory cytokines (Spivak 2000) and that erythroblasts 
are not deficient in iron (Kuiper-Kramer et al. 1997). As reviewed by Feelders et al. (1999), 
sTfR concentrations are closely correlated to the number of receptors expressed on the 
surface of erythroblasts, where they transport transferrin-bound iron into the cell. An 
expansion of the erythroid mass results in increased sTfR concentrations, and increased 
transferrin receptor expression takes place on the surface of iron-deficient erythroblasts. 
Hence, sTfR concentrations measure both erythropoietic activity and the deficit in 
functional iron in the erythron. 
We hypothesized that malaria-induced hemolysis results in increased erythropoietic activity 
under influence of stimulated erythropoietin production, and that these and possibly other 
mechanisms lead to increased sTfR concentrations. We also hypothesized that serum 
ferritin concentrations are increased in malaria independent of their association with 
hemoglobin concentration. Using data from a survey among preschool children in an area 
with seasonal malaria transmission, we assessed the iron status of the children and tested 
whether our data are consistent with these hypotheses. 
Subjects and methods 
Study area 
The study was conducted in the first annual rainy season (April to June) of 1997 in three 
administrative areas (Kathekani, Muthingiini and Mangelete) in Mtito Andei Division, Kenya. 
These areas together comprise approximately 720 square kilometers at an altitude of 800-
900 m above sea level, located halfway on the road and rail link between Nairobi and 
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Mombasa. The inhabitants belong almost exclusively to the Akamba tribe, and live in 
widely scattered homesteads. Like elsewhere in rural Africa, communities are defined as 
administrative units, rather than as physically recognizable groups of houses. The vast 
majority of the population are engaged in subsistence farming, with maize and beans 
cultivated as staple foods, and have a diet poor in meat. Malarial infections reported at the 
clinical facilities in the area are exclusively due to Plasmodium falciparum. There is no 
malaria control program active in the area, and no epidemiologic or entomologic studies on 
malaria have been carried out previously. 
Study population and sampling procedures 
The target population comprised children living in the study area and aged 2-36 mo, with 
no sickness with symptoms suggesting malaria or anemia reported by mothers or carers. 
Children were selected using a cluster sampling procedure (Henderson and Sundaresan 
1982), incorporating modifications proposed by Bennett et al. (1991) and Brogan et al. 
(1994). A household survey, conducted with the assistance of local government 
administrators, community leaders and auxiliary health workers, including community 
health workers, traditional birth attendants and traditional herbalists, listed a total of more 
than 40,000 inhabitants spread over 79 communities in the study area. For enumeration 
purposes and as the basic sampling unit, we defined a household as a group of people 
living on the same premises and whose food is prepared by the same person(s). Each 
household was identified by the name of its head, and the number of its members was 
listed. The sample was drawn in two successive stages (figure 1). At the first stage, a 
systematic sample of 45 communities was drawn from a north to south ordered list of all 
79 communities ('clusters') in the study area, with sampling probability proportional to 
size, and excluding urban centers (Mtito Andei town). 
From each of the selected communities, 12 households were randomly sampled with 
replacement, and for each of these households, the resident children were listed together 
with their dates of birth as ascertained from the child health card. All resident children thus 
identified with no symptoms of malaria or anemia and within the desired age range were 
selected for the study (n=302). Children who migrated with only some household 
members between the time of the census and the time of examination were considered 
not to be eligible and were excluded without replacement. Children who migrated with all 
household members, were still missing after repeated visits, or had parents who refused 
consent were replaced where possible by children from randomly selected households 
within the same community. 
Field procedures 
Mothers and their children were invited to pre-arranged meetings in or close to their 
resident communities. Containers for collection of stools were distributed by the auxiliary 
health workers on the day before the clinical examination and stools were examined for 
parasites on the day of the medical examination. For those children who could not produce 
stools on that day, mothers were asked to collect and deliver samples the next day. 
Community leaders, locally active auxiliary health workers and parents of eligible children 
were informed in their preferred language about the purpose and procedures of the study 
and prior written consent was obtained from the parents. Children were treated as deemed 
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necessary upon completion of the survey. Because such treatment occurred after all 
observations were made and samples collected, this had no influence on the data 
collected. The study was approved by the African Medical and Research Foundation and 
the Kenya Medical Research Foundation whose ethical standards were followed. 
Capillary blood samples were taken using finger or heel punctures and an aliquot was 
collected in containers (Microtainer without additives, Becton-Dickinson, Franklin Lakes, NJ, 
USA). Serum was stored in liquid nitrogen (-196°C) within 12 h after blood collection and 
kept on solid carbon dioxide or frozen (-79°C) during and after transport to Europe for 
subsequent biochemical analysis. 
The accuracy of the hemoglobinometer (HemoCue Inc., Angelholm, Sweden) was checked 
every 4 hr during measurements using a control cuvette. Thick and thin blood films were 
stained using Field's stain and examined by experienced microscopists on the day of 
collection and cross-checked independently later. At least 100 high power (x 1000) fields 
of the thick films were examined for malaria parasites before a slide was considered 
negative. Stool samples were collected and examined on the day of stool production in 
saline solution. Additional stool samples were used for making Kato-Katz smears (Ash et al. 
1994) and examined for Schistosoma infections, or stored in 10% formal saline until 
examination for the presence of hookworm, Ascaris lumbricoides or Trichuris trichlura (Ash 
et al. 1994). 
Ferritin concentrations were measured by radioimmunoassay (Ciba-Corning, Brussels, 
Belgium). Concentrations of sTfR were measured by enzyme-linked immunosorbent assay 
(R&D Systems, Minneapolis MN, USA). C-reactive protein concentrations were measured as 
indicators of the activity of infection by a standard turbidimetric method. The intra- and 
interassay coefficients of variation were as follows: serum ferritin concentration, 3.7-5.9% 
and 4.9-9.1%, respectively; sTfR concentration, 4.3-7.1% and 5.4-6.4%, respectively; and 
serum C-reactive protein concentration, 3.1-4.4% and 2.6-5.7%, respectively. 
Response and missing values 
A total of 302 children were eligible and selected for study, of whom 16 were double-
selected at the second sampling stage (figure 1). Observations for these 16 children were 
weighted twice. Thus 318 cases were included in the study, of which 35 did not participate 
or fully participate for the following reasons: refused consent (26); not home or 
temporarily absent (7); hospitalized for bums (2). Of these 35 children, 14 were replaced 
by random selection, which brought the total number included in the analysis to 297. In 
the case of non-participating children who were not replaced, weighting was used to 
maintain the validity of assuming an equal probability sample. Thus, observations on those 
who participated within the same cluster were inflated by weighting with a multiplication 
factor calculated as the number of selected children in that cluster divided by the number 
of participating children (Bennett et al. 1991, Brogan et al. 1994). This brought the 
number back to 318 children; sample sizes reported below this value are due to missing 
values. Only a limited volume of capillary blood could be collected; in the biochemical 
analysis, priority was given to the determination of serum concentration of transferrin 
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1 st sampling stage: 
systematic samDle without reDlacement 
45 communities selected 
2nd sampling stage: 
random sampling with replacement 
12 households selected per community 
318 cases: 302 eligible children of whom 16 double-selected 
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did not fully participate 
283 cases fully 
participated 
I 
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colertinn 
14 replaced 21 not replaced 
297 cases 
weighting to correct for non-participation ^ _ 
318 cases in analysis 
FIGURE 1. Framework for selection and analysis 
receptor, ferritin and C-reactive protein (in this order). Thus, missing values occurred more 
frequently with the latter two variables. 
Statistical analysis 
Data were entered into the computer, cleaned and managed using SPSS v7.5 for Windows 
(SPSS Inc., Chicago IL, USA) and analyzed using SUDAAN v7.5.2a for Windows (Research 
Triangle Institute, Research Triangle Park NC, USA), assuming two-staged cluster sampling 
with replacement at the first sampling stage. The variance estimates under this 
assumption do not take into account that clusters were sampled from a finite population. 
Thus the standard error values and confidence intervals reported here are overestimates, 
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and the statistical tests are conservative in detecting existing associations. Recalculation of 
variance estimates for descriptive statistics using ordered lists of clusters (El-Bindari-
Hammad and Smith 1992) only led to marginally smaller values (not shown). 
Anemia was defined by hemoglobin concentrations <110 g/L (Scrimshaw et al. 1968). 
Intestinal worm infections or schistosomiasis were analyzed as a positive stool test result 
for a particular parasite in any stage of its development, detected by direct saline stool 
examination, or Kato-Katz smear or by formal concentration technique. 
To assess the associations between malaria and indicators of iron status, and to determine 
the activity of the infection, we compared children with and without malaria with respect to 
their hemoglobin concentration and serum concentrations of transferrin receptor, ferritin 
and C-reactive protein, respectively. Distributions of serum concentrations of transferrin 
receptor, ferritin and C-reactive protein were normalized by decimal logarithmic 
transformation prior to analysis. 
The associations between age and indicators of iron status were assessed by estimating 
the prevalences of anemia, iron deficiency and iron deficiency anemia (hemoglobin 
concentration <110 g/L and serum ferritin concentration <12 ug/L) in three age classes 
(2-11, 12-23 and >24 mo). Prevalences for anemia were given separately for children with 
and without malaria. Since serum ferritin concentration is increased in infections, this was 
controlled for in two different ways: namely, by excluding children with malaria and by 
excluding those with serum C-reactive protein concentration >8 mg/L, respectively. 
Individuals without infections usually have serum C-reactive protein concentrations <8 
mg/L (Hoffbrand and Pettit 1993). 
To assess if the activity of infection was associated with indicators of iron status, we 
compared children with relatively low and high serum concentrations of C-reactive protein 
with respect to their hemoglobin concentration and serum concentrations of transferrin 
receptor and ferritin. 
Values of sTfR concentration were normalized by decimal logarithm transformation for use 
as a dependent variable in linear regression models, and re-expressed in their natural units 
for reporting. Malaria-associated changes in the rate of erythropoiesis may depend on 
immune status and therefore on age (Kling et al. 1998). This was examined by testing the 
product term malaria x age class in a multiple regression model that also included malaria 
and age class as main terms. 
To further explore the association between sTfR concentration and malaria, geometric 
mean sTfR concentrations were estimated for each of the cross-tabulated categories of the 
variables malaria and hemoglobin concentration class. Multivariate linear models were 
subsequently used to assess this association when adjusting for possible effects of 
inflammation. Thus, a dependent variable indicating log-transformed sTfR concentrations 
was modelled as a function of hemoglobin concentration class, malaria, and serum C-
reactive protein concentration quartiles. Exclusion of the latter variable did not result in 
different conclusions or substantially different effect estimates. Hemoglobin concentration 
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was entered as a categorical variables with three classes (<100 g/L, 100-110 g/L, >110 
g/L) so as not to impose linear relationships with the outcome. Cut-off values for 
hemoglobin concentration were chosen to optimize sample size distribution between 
categories. Sex, age (categorized as above) and intestinal worm infections were 
considered as potential confounding variables, but their inclusion led to similar conclusions 
and coefficient estimates for the effects of malaria and hemoglobin concentration class 
(not shown), so that these terms were deleted in the final model (model 1; n=88). 
Similar procedures were followed to assess the association between serum ferritin 
concentrations and malaria. The model (model 2; n=90) adjusted for possible effects on 
serum ferritin concentration of inflammation by including serum C-reactive protein 
concentration quartiles. Although exclusion of age class did not substantially affect the 
effect estimate of malaria on serum ferritin concentration, this variable was retained in the 
model because iron stores are known to rapidly decline during and following infancy as a 
result of body growth and associated hemodilution (Yip 1994). 
Results 
Descriptive statistics 
Descriptive statistics for the study population are provided in table 1. All reported malaria 
infections were due to P. falciparum. The prevalence of malaria (17.6%) indicates a 
population of children exposed to seasonal, unstable malaria. Anemia was highly prevalent 
but moderate in degree. Iron deficiency as measured in the total sample occurred in 
41.5% of children. The highest prevalence for any intestinal infection was for A. 
lumbricoides, namely 4.4%. The parasite load for this roundworm was low, ranging 
between 20 and 1100 eggs/g stool. No hookworm infection was found. 
Univariate analyses 
Compared with those without malaria, children with malaria had substantially lower 
hemoglobin concentrations (mean 92.7 compared with 104.1 g/L; table 2), higher sTfR 
concentrations (geometric mean 11.4 compared with 7.8 mg/L), higher ferritin 
concentrations (geometric mean 21.6 compared with 11.9 ug/L) and higher C-reactive 
protein concentrations (geometric mean 12.5 compared with 6.8 mg/L). The prevalence of 
children with serum ferritin concentrations <12 ug/L was 45.1% and 22.4% in children 
without and with malaria, respectively (difference: 22.6%; 95% CI: 6.6-38.7%; p=0.008). 
Children with malaria also had slightly higher axillary temperatures compared to those 
without malaria (36.9°C compared with 36.5°C; difference 0.4°C; 95% CI: 0.1-0.6°C; 
p=0.01). 
Hemoglobin concentrations were not associated with sex (not shown). Of the three age 
classes examined, children aged 12-23 mo had the highest prevalence of anemia, iron 
deficiency and iron deficiency anemia (table 3). The prevalence of anemia increased with 
malaria in all age categories. Exclusion of children with serum C-reactive protein 
concentration >8 mg/L led to higher estimated prevalences of iron deficiency and iron 
deficiency anemia than exclusion of those with malaria. 
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Compared to those with low serum C-reactive protein concentrations (<8 mg/L), children 
with high serum C-reactive protein concentrations (>8 mg/L) had greatly increased serum 
ferritin concentrations (geometric mean of 25.1 compared with 9.4 ug/L; difference: 15.7 
ug/L; 95% CI: 4.4-36.1 ug/L; p=0.002). Concentrations of sTfR were somewhat increased 
in children with high serum concentrations of C-reactive protein (9.3 compared with 7.6 
mg/L) but this difference was not statistically significant (difference: 1.6 mg/L; 95% CI: -
4.0 to 4.2 mg/L; p=0.13) and disappeared altogether when adjusting for malaria (not 
shown). Serum concentrations of C-reactive protein did not correlate with hemoglobin 
concentration. 
STfR concentration was inversely related to hemoglobin concentration. Geometric mean 
sTfR concentrations in children with hemoglobin concentrations <100 g/L, 100-110 g/L 
and >110 g/L were 10.7 mg/L, 7.5 mg/L and 6.8 mg/L, respectively (p<0.0001). 
Multivariate analyses 
The malaria-associated increase in sTfR concentrations did not vary with age class 
(p=0.60). Figure 2 shows the estimated geometric mean concentrations of both sTfR and 
ferritin for each of the cross-tabulated categories of the variables malaria and hemoglobin 
concentration class. 
In children without malaria or inflammation, hemoglobin concentration was inversely 
associated with sTfR concentration (figure 2, top, table 4), and positively associated 
with serum ferritin concentration (figure 2, bottom). When adjusted for malaria and 
serum C-reactive protein concentration quartile, children with hemoglobin concentrations 
of 100-110 g/L and >110 g/L had sTfR concentrations proportionally decreased by factors 
0.77 and 0.67 relative to the reference class of children with hemoglobin concentration 
<100 g/L, whilst their serum ferritin concentrations were elevated by factors 1.31 and 
1,49, respectively (table 4). In these multiple regression models, malaria was associated 
with elevated serum concentrations of both sTfR and ferritin (table 4). Serum C-reactive 
protein concentration showed no consistent or substantial association with sTfR 
concentration, but serum ferritin concentrations were substantially elevated when serum 
C-reactive protein concentration was >8.4 mg/L (table 4). Children aged 12-23 mo and > 
24 mo had serum ferritin concentrations proportionally decreased by a factor 0.48 and 
0.72, respectively, relative to the reference class of children aged 2-11 mo. Table 5 shows 
geometric mean sTfR concentrations that were calculated on the basis of the model 
presented in table 4. 
Discussion 
Malaria is associated with increased sTfR concentrations, both when assessed by crude 
analysis and when the effects of hemoglobin concentration and serum C-reactive protein 
concentration are taken into account. It is also associated with decreased hemoglobin 
concentrations. These findings are consistent with our hypothesis that malaria-associated 
hemolysis results in increased erythopoiesis. The inflammatory response to malaria is 
reflected by increased serum concentrations of C-reactive protein and ferritin. 
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TABLE 4. Multiple regression models of serum concentrations of soluble transferrin 
receptor (model 1; n=88) and ferritin (model 2; n=90) 
Variables Factor* (95%cr) Wald F df* p 
Outcome: serum soluble transferrin receptor 
concentration, mg/L 
Hemoglobin concentration, g/L 5.3 2 0.01 
<100 - (-) 
100-110 0.77 (0.62 - 0.96) 
>110 0.67 (0.53 - 0.86) 
Malaria 1.50 (1.07-2.10) 5.6 1 0.02 
Serum C-reactive concentration quartile, mg/L 0.2 3 0.92 
<4.7 - (-) 
4.7-6.3 1.10 (0.83 - 1.44) 
6.3-8.4 1.04 (0.83 - 1.32) 
>8.4 1.00 (0.82 -1.22) 
Outcome: serum ferritin concentration, yig/L 
Hemoglobin concentration, g/L 1.0 2 0.37 
<100 - (-) 
100-110 1.31 (0.70 - 2.44) 
>110 1.49 (0.86 - 2.56) 
Malaria 2.13 (1.05-4.30) 4.4 1 0.04 
6.0 3 .002 Serum C-reactive protein concentration quartile, mg/L 
<4.7 
4.7-6.3 
6.3-8.4 
>8.4 
Age, mo 
2-12 
12-23 
>24 
-
2.37 
2.13 
5.54 
-
0.48 
0.72 
(-) 
(0.98 - 5.76) 
(0.92 - 4.92) 
(2.33 - 13.20) 
H 
(0.24 - 0.96) 
(0.39 -1.33) 
2.2 2 0.13 
* Effect estimates were first obtained for the regression coefficient (P) indicating changes in 10log sTfR 
concentration; the effect estimates reported here (10p) are proportional instead of additive. Thus, factors 
indicate the proportional change in sTfR concentration relative to children with hemoglobin concentration <100 
g/L and without malaria and in the lowest serum C-reactive protein concentration quartile, or the proportional 
change in serum ferritin concentration relative to infants with hemoglobin concentration <100 g/L, without 
malaria and in the lowest serum C-reactive protein concentration quartile; t CI: confidence interval; * df: 
degrees of freedom. 
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Lack of association between serum C-reactive protein concentration and sTfR 
concentration, also after adjustment for potential confounding by malarial infection, 
suggests that the inflammatory response does not influence sTfR concentrations. It can 
therefore be safely assumed that sTfR concentrations measure both the rate of 
erythropoiesis or the deficit in functional iron in the erythron. 
Sickle cell trait is not substantially associated with hemoglobin concentration (Rana et al. 
1993) and occurs rarely in the Akamba tribe (Foy 1954). Urinary schistosomiasis is seldom 
reported by local medical personnel, and other helminth infections were uncommon. None 
of these factors is likely to have substantially confounded or modified the relationships 
observed. The prevalence of anemia (69%) was high but typical for east African preschool 
children (DeMaeyer and Adiels-Tegman 1985). Hemoglobin concentration and its 
relationship with malaria were not found to be different between those children for whom 
data on sTfR concentration were or were not available (not shown); hence, there was no 
evidence for bias due to missing values. We expect similar results to be found in preschool 
children asymptomatic for malaria in other areas of unstable malaria. 
In malarious areas, it is often difficult to detect iron deficiency in individual children. Serum 
ferritin concentrations <12 ug/L are highly predictive of depleted iron stores (Skikne et al. 
1990), regardless whether infection or inflammation is present or absent. Serum ferritin 
concentrations increase rapidly during malarial infection (Oppenheimer et al. 1984, Phillips 
et al. 1986, Das et al. 1997), probably as part of a host immune response (Kent 1994). 
This was confirmed by our results. Hence, when coupled with anemia, normal or high 
serum ferritin concentrations indicate infection, but this may mask concomitant iron 
deficiency. In these cases, contrary to other infections (Ferguson et al. 1992), sTfR 
concentration is not useful in detecting iron deficiency, because malaria-associated 
hemolysis may also increase sTfR concentration. In the absence of malaria, serum ferritin 
concentrations <12 ug/L often fail to detect existing iron deficiency, as indicated by higher 
estimated prevalences of iron deficiency in children with serum C-reactive protein 
concentrations <8 mg/L than in children without malaria (table 3). This may be due to 
serum ferritin concentrations being increased by asymptomatic infections other than 
malaria, and suggests that iron deficiency can only be accurately diagnosed in children 
with low serum C-reactive protein concentrations. Reports by Stoltzfus et al. (1997, 2000) 
suggest that malaria leads to increased serum ferritin concentrations in young children, but 
not in older children in areas with highly endemic malaria. The latter group may have 
developed partial protective immunity that prevents asymptomatic malaria to affect 
hemoglobin concentrations or serum ferritin concentrations. 
In children without malaria or inflammation, low hemoglobin concentrations were 
associated with increased sTfR concentrations and decreased serum ferritin concentrations 
(table 4). The latter probably occurred because low hemoglobin concentrations in these 
children indicate iron deficiency, which develops in several stages. When iron stores are 
still present, iron depletion results in reduced serum ferritin concentration and a marginal 
increase in sTfR concentration. Beyond this stage, iron depletion results in a marginal 
reduction of serum ferritin concentration and substantial increases in sTfR concentration 
(Skikne et al. 1990). Concentrations of sTfR then indicate the iron deficit in functional 
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compartments in the body (including hemoglobin). In addition, sTfR concentrations in 
these children are likely to have increased due to an increased erythropoietic activity in 
response to the anemia (Beguin et al. 1993). 
Malaria was associated with sTfR concentrations that were as high as or higher than 
expected for the degree of anemia (figure 2, top; tables 4 and 5). Brabin (1992) 
speculated that malaria may induce iron deficiency through iron loss in urine following 
hemolysis, reduced iron absorption, or iron sequestration in macrophages of the 
mononuclear phagocyte system. Iron loss associated with hematuria may occur following 
severe hemolysis, but in mild hemolysis, free heme iron or hemoglobin are probably 
recycled for use in normal body functions. In our study, children were asymptomatic or 
perhaps convalescing from recent malaria attacks, so that none or very few were likely to 
suffer from severe hemolysis. Decreased iron absorption reportedly plays a minor role in 
the anemia of inflammation (Jurado 1997). The shift of iron distribution that has been 
observed in inflammatory diseases and infections has long been believed to be a cause of 
reduced erythropoiesis, but this is not accompanied by an increase in sTfR concentration 
(Ferguson et al. 1992, Feelders et al. 1999). The observed increase in sTfR concentration 
is therefore unlikely to be due to iron deficiency. Together with our finding that malaria is 
associated with decreased hemoglobin concentrations (table 2) and anemia (table 3), 
our observations are consistent with the notion that malaria-induced hemolysis leads to 
lower hemoglobin concentrations, which in turn results in increased erythropoiesis that is 
appropriate for the degree of anemia. 
It cannot be ruled out that, in addition, sTfR concentration is elevated in malaria due to 
ineffective erythropoiesis, whereby developing erythroblasts are prematurely phagocytosed 
in the marrow by macrophages without producing mature red cells. Morphological 
evidence of expanded erythroid mass with ineffective erythropoiesis has been described in 
studies of bone marrows of patients with severe anemia and chronic falciparum malaria 
(Abdalla et al. 1980), uncomplicated falciparum malaria (Phillips et al. 1986) and febrile 
attacks of vivax malaria (Wickramasinghe et al. 1989). These studies found abnormalities 
in developing erythroblasts and evidence of increased phagocytosis of erythroblasts at 
various stages of degradation. Results of studies on cobalamin deficiency support the 
notion that ineffective erythropoiesis may be associated with increased sTfR concentrations 
(Carmel et al. 1992, Rees et al. 1998). Indicators of cobalamin deficiency were not 
routinely studied by us, but no megalocytosis was observed. It also cannot be ruled out 
that sTfR concentrations are increased in malaria because of iron sequestration in 
hemazoin. This is a waste product found in circulating or phagocytosed red cells and 
results from hemoglobin degradation by malaria parasites. 
Several other studies give support to increased sTfR concentration in asymptomatic 
malaria (Mockenhaupt et al. 1999, Stoltzfus et al. 2000). Mockenhaupt et al. (1999) found 
increased sTfR concentrations in asymptomatic and mildly symptomatic falciparum malaria 
when adjusted for hemoglobin concentration. Stoltzfus et al. (2000) found that sTfR 
concentrations increased with parasite density in children with asymptomatic malaria but 
found no evidence for an effect on sTfR concentrations when adjusting for hemoglobin 
concentration. In pregnant women attending antenatal clinics in Malawi, Huddle et al. 
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(1999) found that malaria was associated with marginally and not significantly increased 
sTfR concentrations, despite hemoglobin concentrations being considerably lower. Williams 
et al. (1999) found no difference in sTfR concentration and hemoglobin concentration 
between children in Vanuatu with asymptomatic malaria and children with no malaria. 
A decrease in sTfR concentrations was found in symptomatic malaria in two studies 
(Williams et al. 1999, Beesley et al. 2000) but there was no association in two others 
(Kuvibidila et al. 1995, 1999), possibly because of the small sample size in these studies. 
Williams et al. (1999) interpreted the decrease in sTfR concentrations as evidence for 
decreased erythropoiesis in symptomatic malaria, either as a result from acute 
erythropoietin deficiency (Burgmann et al. 1996) or suppression of marrow response to 
erythropoietin (Miller et al. 1989, Kurtzhals et al. 1997). However, some studies reported 
erythropoiesis in symptomatic malaria to be increased, albeit ineffective and lower than 
expected for the degree of anemia (Abdalla et al. 1980, Phillips et al. 1986, 
Wickramasinghe et al. 1989), whereas others reported marrow hypoplasia and decreased 
red cell production (Srichaikul et al. 1969, Phillips and Pasvol 1992). Available evidence 
also indicates erythropoietin concentrations in malaria to be increased (Burchard et al. 
1995, Burgmann et al. 1996, El Hassan et al. 1997, Kurtzhals et al. 1997, Vedovato et al. 
1999) albeit lower than expected for the degree of anemia (Burgmann et al. 1996, El 
Hassan et al. 1997, Vedovato et al. 1999). 
In summary, asymptomatic malaria was associated with lower hemoglobin concentrations 
and elevated sTfR concentrations, which is consistent with the notion that malaria-induced 
hemolysis leads to increased erythropoiesis. Reported discrepancies about the association 
between malaria and sTfR concentration are likely to remain unclear until further reports 
become available on changes in sTfR concentration following treatment of patients with 
various presentations of malaria. Individuals with high concentrations of serum C-reactive 
protein or similar acute phase reactants should be excluded when serum ferritin 
concentrations <12 ug/L are used for measuring the prevalence of iron deficiency in 
malarious areas. 
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Stunting may determine the severity of 
malaria-associated anemia in African 
children 
Hans Verhoef, Clive E West, Jacobien Veenemans, Yves Beguin, Frans 3 Kok 
ABSTRACT 
Objective: Evidence from previous studies that malnourished children are protected 
against malaria is controversial. Our aim was to evaluate whether observational data 
support the hypothesis that stunting modifies the associations between malaria and 
hematologic indicators such as hemoglobin concentration, and serum concentrations of 
soluble transferrin receptor and C-reactive protein. 
Methodology: Community-based cluster survey among Kenyan children aged 2-36 
months asymptomatic for malaria or anemia (n=318). 
Results: When adjusted for age and wasting, the malaria-associated decrease in mean 
hemoglobin concentration was 8.5 g/L and 15.8 g/L in nonstunted and stunted children, 
respectively (p-value of test for difference: 0.08). The malaria-associated increase in 
geometric mean serum concentrations of soluble transferrin receptor was 1.1-fold and 1.8-
fold in nonstunted and stunted children, respectively (p-value of test for difference: 0.05). 
The malaria-associated increase in geometric mean serum concentrations of C-reactive 
protein was 1.4-fold and 2.3-fold in nonstunted and stunted children, respectively (p-value 
of test for difference: 0.05). Thus, children with malaria and who were stunted suffered 
from more severe anemia, and had higher serum concentrations of C-reactive protein and 
soluble transferrin receptor than would be expected from the combined effect of the two 
working independently. 
Conclusions: Our results are consistent with the notion that the nutritional inadequacies 
causing stunting also impair host immunity, thus increasing the degree to which malaria is 
associated with decreased concentrations of hemoglobin, with increased inflammation, 
and with increased iron demand in developing erythroblasts. Increased intake of 
micronutrients may not only reduce stunting and nutritional anemia, but also reduce 
malaria-associated anemia. 
Pediatrics (conditionally accepted) 
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Children in developing countries generally fail to achieve their genetically determined 
potential height because of poor diet and infection (Ulijaszek 1994, Waterlow 1994). It is 
plausible although unproven so far that the nutritional inadequacies that cause stunting 
also impair host immunity, thereby increasing the incidence, severity, and duration of 
many infectious diseases (Tomkins 1988). 
Individuals with repeated exposure to malaria are protected against severe disease and 
death before they develop the ability to regulate fever, parasite density, and ultimately 
infection in itself. This has led to the hypothesis that immunity develops first against 
severe disease, then against fever, and lastly against parasites (Snow and Marsh 1998). If 
true, this would suggest that reduced immune function such as may exist in stunted 
children exacerbates the severity of malarial signs and symptoms, rather than the 
occurrence of parasitemia. On the other hand, several reports suggest that malnourished 
children are protected to some degree against malaria (Hendrickse et al. 1971, McGregor 
1982, Murray et al. 1975). 
The concentration of soluble transferrin receptor (sTfR) in serum is a new indicator of iron 
demand by the erythroid precursor mass. It provides a measure of both the rate of 
erythropoiesis and the deficit of functional iron in the erythron (Feelders et al. 1999), and 
is influenced little or not at all by the inflammatory response to infection. We recently 
reported increased serum concentrations of sTfR and C-reactive protein in children with 
asymptomatic malaria (Verhoef et al., accepted). These increased serum sTfR 
concentrations may be explained, at least in part, by increased erythropoiesis to 
compensate for malaria-induced hemolysis (Verhoef et al., accepted). 
We carried out a cross-sectional study in children aged 2 to 36 months without symptoms 
of malaria or anemia living in an area with seasonal malaria transmission. The aim of our 
study was to evaluate whether data from this survey give support to the hypothesis that 
the relationship between malarial parasitemia and stunting is synergistic, i.e., that the 
presence of asymptomatic malaria and stunting results in a lower concentration of 
hemoglobin, and higher serum concentrations of sTfR and C-reactive protein, than would 
be expected from the combined effect of the two working independently. 
Subjects and methods 
Study area 
The study was conducted in the first annual rainy season (April to June) of 1997 in an area 
of seasonal malaria in Eastern Province, Kenya. The study area comprises approximately 
720 km2 at an altitude of 800 to 900 m above sea level, located halfway between Nairobi 
and Mombasa on the road and rail link. Malaria infection reported at the clinical facilities in 
the area are due exclusively to Plasmodium falciparum. No malaria control program is 
active in the area, and no epidemiologic or entomologic studies on malaria have been 
carried out previously. 
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Study population and sampling procedures 
The target population comprised children living in the study area aged 2 to 36 mo, with no 
manifestations reported by mothers or caregivers that were compatible with malaria or 
anemia. Few of the children studied suffer from intestinal worm infections or 
schistosomiasis (Verhoef et al., accepted). Sampling procedures have been described in 
detail previously (Verhoef et al., accepted). In brief, children were selected using a 2-stage 
cluster sampling procedure. At the first sampling stage, 45 of 79 communities in the study 
area were sampled systematically, with a sampling probability proportional to size as 
measured by the number of households. At the second sampling stage, 12 households 
were randomly selected within each selected community, and all resident children with no 
symptoms of malaria or anemia and within the desired age range were selected for the 
study. 
Field procedures 
Informed consent was sought and obtained from community leaders, locally active 
auxiliary health workers, and parents of eligible children. Children were treated as deemed 
necessary upon completion of the survey. The study was approved by the African Medical 
and Research Foundation and the Kenya Medical Research Foundation, whose ethical 
standards were followed. 
Field staff were trained in anthropometric techniques, and measurements were 
standardized (Anonymous 1986, Lohman et al. 1988) prior to data collection. Recumbent 
length (< 2 y) or standing height (> 2 y), body weight (Seca 720 baby scale, allowing for 
measurements to be read within 10 g), mid-upper arm circumference and triceps skinfold 
thickness (Harpenden calipers, CMS Weighing Equipment, London, UK) were recorded as 
the average of duplicate measurements, respectively. 
The procedures for collection, handling and analysis of capillary blood samples has been 
described elsewhere (Verhoef et al., accepted). Hemoglobin concentrations were measured 
using a field meter (HemoCue, Angelholm, Sweden) and malaria was detected by 
microscopic examination of Giemsa-stained blood slides. Concentrations of sTfR were 
measured by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis MN, USA). 
C-reactive protein concentrations were interpreted as indicators of the activity of infection 
and measured by a standard turbidimetric method. Intra- and interassay coefficients of 
variation for these biochemical tests are reported elsewhere (Verhoef et al., accepted). 
Response and missing values 
The study included 318 children. Of 35 children who did not participate or fully participate, 
14 were replaced by random selection, and weighting was used to maintain the validity of 
assuming an equal probability sample (Bennett et al. 1991, Brogan et al. 1994). Sample 
sizes reported below 318 are due to missing values. 
Statistical analysis 
Height-for age and weight-for-height z-scores were calculated using Epi Info v6.04 (Dean 
et al. 1994). Being stunted or wasted was defined by height-for-age or weight-for-height 
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z-scores < -2 SD of the median of the NCHS reference population, respectively (WHO 
1983). Data were explored using SPSS (v7.5 for Windows; SPSS Inc. Chicago III., USA) and 
analyzed using SUDAAN (stand-alone software v7.5.2a for Windows; Research Triangle 
Institute, Research Triangle Park NC, USA), assuming two-stage cluster sampling with 
replacement at the first sampling stage. The variance estimates under this assumption do 
not take into account that clusters were sampled from a finite population. Thus the 
standard error values and confidence intervals reported here are overestimates, and 
statistical tests are conservative in detecting existing associations. 
As a first analytic step, the relationships between malaria and height-for-age z-score and 
between malaria and weight-for-height z-score were assessed by logistic regression. 
Serum concentrations of sTfR and C-reactive protein were normalized by decimal logarithm 
transformations, and their relationship with stunting or wasting were assessed by linear 
regression analysis. Associations between height-for-age z-score and age class (2-11 mo, 
12-23 mo, >24 mo) or continuous variables (weight-for-height z-score, hemoglobin 
concentration) were assessed by analysis of variance and linear regression analysis, 
respectively. 
Multiple linear regression was used to compare stunted and nonstunted children regarding 
their associations between malaria and hemoglobin concentration, or between malaria and 
log transformed serum concentrations of sTfR or C-reactive protein, respectively. Possible 
interaction was tested directly by multivariate linear regression analysis. Adjustment for 
age class and sex led to similar conclusions and effect estimates, so that these variables 
were excluded from the final model. 
Results 
The prevalence of children who were stunted or wasted was 38.7% (95% CI: [32.0-45.4] 
and 4.7% (95% CI: [1.6-7.8], respectively. The prevalence of malaria was 17.6% (95% 
CI: [11.3-23.8]; n=318): for age classes 2-11 mo, 12-23 months and >24 mo, these 
figures were 12.6% (n=92), 18.8% (n=116) and 20.4% (n= l l l ) , respectively, and for 
girls and boys they were 16.1% (n=145) and 18.8% (n=173), respectively. Other 
characteristics of the study population, broken down by age class and sex, are given in 
table 1. Stunting was most pronounced in children aged 12-23 mo, whose height-for-age 
z-score was 0.75 below the value of children aged 2-11 mo. 
An increase of one unit z-score of height-for-age was associated with an odds ratio of 
malaria of 0.87 (95% CI: 0.69-1.09; p=0.23), a weight-for-height increase of 0.16 z-scores 
(95% CI: 0.04-0.27; p=0.009), and a hemoglobin concentration increase of 2.0 g/L (95% 
CI: 0.7-3.4 g/L; p=0.004). Each increase of one unit z-score of weight-for-height was 
associated with an odds ratio of malaria of 0.78 (95% CI: 0.58-1.05; p=0.10) and an 
increase in hemoglobin concentration of 2.3 g/L (95% CI: 1.0-3.6 g/L; p=0.001), 
respectively. When adjusted for wasting (weight-for-height z-score quartiles), an increase 
of one unit z-score of height-for-age corresponded to an odds ratio of malaria of 0.93 
(95% CI: 0.73-1.17; p=0.52). When analysed by univariate linear regression techniques, 
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FIGURE 1. Modification by stunting of the relation between malaria and mean hemoglobin 
concentration (top; n=311), and geometric mean serum concentrations of 
transferrin receptor (center; n=222) and C-reactive protein (bottom; n=90). 
When adjusted for age and wasting, p-values indicating significance of the malaria-associated differences in 
these hematologic indicators were 0.08, 0.05, and 0.05, respectively (see text). Absence and presence of 
malaria are indicated by black and white columns respectively; error bars indicate 95% confidence intervals. 
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there was no evidence of a biologically or statistically significant relationship between 
stunting and log transformed serum concentrations of sTfR or C-reactive protein, or 
between wasting and log transformed serum concentrations of sTfR or C-reactive protein 
(data not shown). 
Univariate analysis showed that children with malaria had lower mean hemoglobin 
concentrations than children without malaria (92.7 g/L compared with 104.1 g/L; 
difference 11.3 g/L; 95% CI: 6.4-16.3 g/L; p=0.0001). Children with malaria also had 
higher geometric mean serum concentrations of sTfR (11.4 mg/L compared with 7.8 mg/L; 
ratio 1.4; 95% CI: 1.1-1.9; p=0.005) and C-reactive protein (12.5 mg/L compared with 6.8 
mg/L; ratio 1.8; 95% CI: 1.2-2.7; p=0.004). 
Figure 1 compares stunted and nonstunted children regarding their association between 
malaria and hematological indicators. There was no evidence for substantial effects of 
stunting on these indicators in the absence of malaria. The malaria-associated decrease in 
mean hemoglobin concentration was 8.6 g/L (95% CI: 2.6-14.6 g/L) in nonstunted 
children, and 16.4 g/L (95% CI: 9.3-23.5 g/L) in stunted children (figure 1, top). In 
nonstunted children, geometric mean serum concentrations of sTfR were 1.2-fold (95% 
CI: 0.9-1.6) higher in children with malaria than those without malaria (figure 1, center); 
in stunted children, this ratio was 1.8 (95% CI: 1.3-2.5). Among nonstunted children, 
geometric mean serum concentrations of C-reactive protein were 1.4-fold (95% CI: 0.8-
2.3) higher in children with malaria than those without malaria (figure 1, bottom); 
among stunted children, this ratio was 2.3 (95% CI: 1.2-4.7). 
These relationships were further assessed by multivariate regression analysis, which was 
used to test the significance of product terms directly and to adjust for possible 
confounding by age class and wasting (entered into the model as weight-for-height z-score 
quartiles). When so analysed, the malaria-associated decrease in mean hemoglobin 
concentration was 8.5 g/L and 15.8 g/L in nonstunted and stunted children, respectively 
(p-value of test for difference: 0.08). The malaria-associated increase in geometric mean 
serum sTfR concentrations was 1.1-fold and 1.8-fold in nonstunted and stunted children, 
respectively (p-value of test for difference = 0.05). The malaria-associated increase in 
geometric mean serum concentrations of C-reactive protein was 1.4-fold and 2.3-fold in 
nonstunted and stunted children respectively (p-value of test for difference: 0.05). These 
effect estimates are similar for non-adjusted estimates (see preceeding paragraph), 
indicating little or no confounding by age or wasting. There was no evidence that the 
relationship between malaria and these hematologic indicators was modified by age (data 
not shown). 
Missing data were mostly due to insufficient serum being available to determine serum 
concentrations of sTfR and C-reactive protein. Children with missing data (n=96), and who 
were therefore excluded from the multiple regression analysis, did not have substantially 
different hemoglobin concentrations or height-for-age z-scores from those who were 
included (not shown), although fewer of them sufferered from malaria (14% compared 
with 25%). Selection bias would have occurred if the observed relationships were different 
in children with missing values. 
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Discussion 
Our findings support the hypothesis that in stunted children, malaria is associated with 
lower hemoglobin concentrations and higher serum concentrations of sTfR and C-reactive 
protein than in their nonstunted counterparts. There is no clear evidence that stunting is 
associated with an increased prevalence of malarial infection. 
The prevalences of stunted and wasted children were 39% and 5% respectively. The 
mean hemoglobin concentration was 102 g/L, and we showed earlier that the prevalence 
of anemia in this population was 7 1 % (Verhoef et al., accepted). These values are typical 
for this age group in Kenya and other countries in Africa (DeMaeyer and Adiels-Tegman 
1985, Keller 1988, Victora 1992, Anonymous 1996). Our study confirmed that stunting was 
most pronounced in children aged 12-23 mo. This corroborates findings in most studies 
that stunting in developing countries peaks at the age of 24 months and stabilizes 
thereafter (WHO Working Group 1986). Missing values occurred mainly because of 
insufficient volume of serum being available for biochemical analysis: there is no reason to 
assume that this led to selection bias in the observed relationships. Our conclusions may 
therefore apply to African preschool children who are asymptomatic for anemia and 
malaria and living in areas of seasonal malaria. 
Serum sTfR concentrations are closely correlated to the number of receptors expressed on 
the surface of erythroblasts, where they transport transferrin-bound iron into the cell. An 
expansion of the erythroid mass results in increased serum sTfR concentrations, and 
increased transferrin receptor expression takes place on the surface of iron-deficient 
erythroblasts. Serum sTfR concentrations thus reflect both the rate of erythropoeisis and 
the degree of iron deficiency in the erythron (Feelders et al. 1999). Serum sTfR 
concentrations are not or only marginally influenced by the inflammatory response to 
infection (Feelders et al. 1999, Weiss 1999), and no infections investigated so far except 
for malaria have been shown to be associated with serum sTfR concentrations. We 
proposed earlier that the observed increase in serum sTfR concentration in malaria is due 
in part to hemolysis, which occurs in malaria is not a common feature in other infections 
(Verhoef et al., accepted). Malaria-induced hemolysis leads to lower hemoglobin 
concentrations, which in turn results in increased erythropoeisis under influence of 
increased production of erythropoeitin. Red cell destruction may occur as a result of direct 
action by malaria parasites, or because a malaria-induced immune response leads to lysis 
of parasitized and non-parasitized red cells (Menendez et al. 2000). It cannot be ruled out 
that, in addition, serum sTfR concentration is increased in malaria due to ineffective 
erythropoeisis, whereby developing erythroblasts die prematurely in the marrow without 
producing mature red cells (Verhoef et al., accepted). 
Our findings indicate that malaria-associated anemia, iron demand and inflammation are 
greater in stunted than in nonstunted children. Although it is conceivable that malaria 
causes stunting, we consider it more likely that stunting exacerbates malaria, given that 
malarial infection is a transient condition, and stunting becomes manifest only after a 
prolonged period of slowing in skeletal growth. Nutritional inadequacies that cause 
stunting - such as deficiencies in zinc (Umeta et al. 2000), iron (Angeles et al. 1993, Adish 
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et al. 1999) and possibly vitamin A (Muhilal et al. 1988, Hadi et al. 2000) - are also known 
or suspected to impair host immunity (Dalmann 1987, Brock 1994, Semba 1998, Salgeiro 
et al. 2000, Shankar et al. 1998). As reviewed by Scrimshaw et al. (1968), there is 
compelling evidence that reduced immunity due to nutritional deficiencies reduce host 
capacity to resist the consequences of a wide range of infections. This most likely explains 
the modification by stunting of the effects of malaria as observed in our study. 
Before 1950 it was widely accepted though little supported by epidemiologic evidence, that 
malnutrition is associated with greater frequency and severity of malaria (Shankar 2000). A 
number of influential studies subsequently appeared that in fact suggested that 
malnourished children are to some degree protected against malaria. However, Shankar 
(2000) in a review concluded that these studies suffered from methodologic shortcomings 
and that the available evidence indicates that malnutrition is associated with increased 
occurrence of infection and symptomatic malaria, and considerably higher likelihood of 
malaria mortality in humans. This is in line with our findings, and implies that nutritional 
interventions using micronutrients may not only reduce stunting and nutritional anemia, 
but also reduce malaria-associated anemia. Famine or starvation may be a notable 
exception, because there is strong evidence that refeeding of starved individuals with 
latent infections carries an increased risk of symptomatic malaria. This may suggest that 
parasite proliferation following refeeding temporarily outpaces development of protective 
immunity (Shankar 2000). We could not demonstrate an influence of wasting on malaria or 
malaria-associated anemia (data not shown), perhaps because few of the children studied 
were wasted. 
In summary, our results give observational support to the proposed hypothesis that the 
nutritional inadequacies that cause stunting also impair host immunity, thus increasing the 
degree to which malaria is associated with decreased concentrations of hemoglobin, with 
increased inflammation and with increased iron required for developing erythroblasts. 
Increased intake of micronutrients may not only reduce stunting and nutritional anemia, 
but also reduce malaria-associated anemia. However, longitudinal studies are required to 
confirm causality. 
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Intermittent administration of iron and 
sulfadoxine-pyrimethamine to control 
anaemia in Kenyan children: a randomized 
controlled trial 
Hans Verhoef, Clive E West, Silas M Nzyuko, Stefan de Vogel, Rikkert van der 
Valk, Mike A Wanga, Anneleen Kuijsten, Jacobien Veenemans, Frans J Kok 
SUMMARY 
Background: Iron supplementation is recommended for children at high risk of anaemia, 
but its benefits may not outweigh the associated risk of malaria in areas of seasonal 
transmission. We determined the efficacy in improving haemoglobin concentrations of 
intermittent administration of iron supplements and sulfadoxine-pyrimethamine (SP) in 
asymptomatic children under intense health surveillance. 
Methods: In a trial with a 2x2 factorial design, 328 anaemic Kenyan children were 
randomly assigned to receive either iron or placebo, and SP or placebo. Outcomes 
considered were change in haematological indicators of iron status and inflammation, and 
occurrence of malaria attacks. Morbidity surveillance comprised 4-weekly medical 
examinations, continuous passive case-detection, and twice-weekly visits. 
Findings: Intermittent administration of iron and SP resulted in substantially improved 
haemoglobin concentrations (12.5 g/L, 95% CI: 8.5 to 16.4 g/L; adjusted for prognostic 
factors at baseline) compared with the placebo group. It also reduced the estimated 
prevalence of anaemia from 100% at baseline to 36% at 12 w, and of iron deficiency from 
66% at baseline to 8% at 12 w. Survival analysis indicated no evidence of substantially 
increased risk of malaria following iron supplementation. Intermittent administration of SP, 
either alone or in addition to iron supplementation, gave no or little haematological 
response. 
Interpretation: Iron supplementation gives substantial health benefits, which may 
outweigh possible inherent risks caused by malaria. Further studies should determine the 
benefits and risks of intermittent administration of SP in reducing the incidence of malaria 
attacks in areas of seasonal malaria transmission. 
Submitted for publication 
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Approximately three quarters of children <5 y of age in eastern Africa suffer from 
anaemia, defined by haemoglobin concentrations below 110 g/L (DeMaeyer and Adiels-
Tegman 1985). Iron deficiency, when sufficiently severe to cause anaemia, has been 
associated with impaired physical growth (Chwang et al. 1988, Latham et al. 1990, 
Lawless et al. 1994) and mental development (Grantham-McGregor and Ani 2001), 
decreased appetite (Lawless et al. 1994), reduced physical activity (Haas and Brownlie 
2001), and possibly with increased incidence of some infections (Oppenheimer 2001). 
Routine iron supplementation of children living in communities with a high prevalence of 
anaemia has been advocated (UNICEF/WHO 1994, INACG/WHO/UNICEF 1998) but in 
certain, unknown conditions may lead to increased risks of malaria (INACG Consensus 
Statement 1999, Shankar 2000, Oppenheimer 2001). Oral iron supplementation (2 mg/kg) 
given daily to infants aged 8-24 mo in an area of high, perennial transmission did not 
increase the incidence of malaria (Menendez et al. 1997). In areas of seasonal malaria or 
in somewhat older age groups, children are likely to have less protective immunity, and 
the risk of malaria or malaria-related outcomes associated with iron supplementation may 
accordingly be higher. Comparison of evidence from trials that were conducted in infants 
and preschool children in areas of marked seasonal malaria (Smith 1989, Adam 1997) and 
highly endemic areas (Chippaux et al. 1991, Menendez et al. 1997, Stoltzfus et al. 1998) 
would appear to give some support to this hypothesis. Thus, the benefits of iron 
supplementation may not outweigh the risk of adverse effects in populations with low 
immunity against malaria. 
Although mild-to-moderate anaemia often occurs in asymptomatic malaria (Brabin 1992, 
McElroy et al. 2000), little is known about its functional importance. These infections are 
probably associated with increased risk of malaria attacks (Bouvier et al. 1997) but are 
needed to gain protective immunity against severe disease and subsequent death, which 
develops much faster than against fever and parasite density (Snow and Marsh 1998, 
Gupta et al. 1999). Thus, the effect of treatment on all-cause mortality remains unknown. 
Chemoprophylaxis has been shown to reduce malaria morbidity and all-cause mortality 
(Bradley-Moore et al. 1985, Greenwood et al. 1988, Menon et al. 1990, Menendez et al. 
1997) but is no longer advocated in endemic areas (Greenwood 1991, WHO 1993), mainly 
for fear of accelerated spread of resistance, and of increased risk of malaria attacks 
following cessation of the intervention (Greenwood et al. 1995, Menendez et al. 1997). 
The potential gains in haemoglobin concentrations of iron supplementation and malaria 
control in children in seasonal malaria remain uncertain. Hence, with the aim of 
maximising the beneficial effects of iron supplementation and chemoprophylaxis whilst 
minimizing possible adverse risks, we determined the efficacy in improving iron status of 
intermittent administration of iron and sulfadoxine-pyrimethamine (SP), when given either 
alone or in combination, to Kenyan children in conditions of seasonal malaria. In addition, 
we explored the effects of interventions on the time until first occurrence of a malaria 
attack. 
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Subjects and methods 
Area and population 
The study was conducted in Mtito Andei Division, Eastern Province, Kenya. This area is 
described in more detail elsewhere (Verhoef, 1999; accepted a). An earlier survey among 
children aged 2-36 mo in this area had shown prevalences of malaria, anaemia, Ascaris 
lumbricoides, and Trichuris trichiura of 31%, 72%, 3% and 5%, respectively (Verhoef, 
unpublished results). Reported malaria infections were exclusively due to Plasmodium 
falciparum. No hookworm or schistosomiasis was found. A 14-day in vivo drug sensitivity 
study was carried out in 1997 among children (mean age 4.3 years) in the out-patients 
department of a nearby health centre. Out of 36 studied children treated with SP, 32 
(89%; 95% confidence interval, CI: 79-99%) were found to be sensitive to treatment, 
three showed Rl resistance, and one showed R2 resistance (Piet Kager, University of 
Amsterdam, personal communication). 
The present study was facilitated by community health workers who had been trained to 
provide health education and promotion, but who are not routinely involved in treatment 
of illnesses. A research clinic was established in the area and children were recruited from 
neighbouring communities in three groups, each at the start of a rainy season in the 
period 1998-2000. The study received ethical approval from AMREF and the Kenya Medical 
Research Institute. Informed consent was obtained from community leaders and local 
government officials, and from parents of participating children. Children included in the 
study and their siblings received free medical care for common childhood illnesses. 
Study type and interventions 
The study consisted of a trial with a 2x2 factorial design with an intervention period of 12 
w. Children were randomly assigned to either iron supplement or placebo, and either 
sulfadoxine-pyrimethamine or placebo, and were all under intense health surveillance. 
Both placebos and active compounds were administered as suspensions that were 
indistinguishable by taste and appearance, and were prepared under supervision by an 
experienced pharmacologist (G van der Meer, Gelderse Vallei Hospital, Ede, The 
Netherlands). Bottles were colour-coded, but none of the field investigators was aware of 
the code until after crude analysis and a plan for further analysis had been prepared. 
Iron was administered by community health workers twice weekly as ferrous fumarate in a 
6.25 g/L suspension at a target dose of 6 mg elemental iron kg body weight_1 wk "*. 
Compared to ferrous sulphate tablets, the use of ferrous fumarate suspension has the 
advantages of increased dosing accuracy that can be achieved, a longer shelf-life (up to 6 
wk), it may cause fewer side effects, while it is absorbed at a similar rate (Brise et al. 
1962). No suspension was used beyond 6 w after opening of bottles. 
Sulfadoxine-pyrimethamine was administered by project staff every 4 w at therapeutic 
doses (25 mg and 1.25 mg kg"1 body weight, respectively). When given intermittently to 
infants alongside routine vaccinations against childhood diseases, SP may substantially 
reduce the frequencies of occurrence of malaria attacks and severe anaemia (Schellenberg 
et al. 2001). 
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Eligibility and withdrawal criteria 
Eligibility criteria were: haemoglobin concentrations 60-110 g/L; age 2-36 mo; axillary 
temperature <37.50 °C; absence of symptoms suggestive of malaria or anaemia, or of any 
systemic illness occurring in combination with a blood dipstick test indicating current or 
recent malarial infection; parents reported their intention to stay in the study area during 
the intervention period; parental consent given; absence reported of allergy to sulfa drugs; 
and no sulfa drugs used in the previous 3 w. 
Children were withdrawn and treated as appropriate if haemoglobin concentrations were 
<50 g/L, if they met one or more criteria of severe and complicated malaria (Warrel et al. 
1990), or if they had manifestations of other severe disease. 
Sampling procedures and treatment allocations 
Malaria, anaemia and other factors known or suspected to be geographically or temporally 
clustered (Verhoef et al., see chapter 2) might be prognostic for the effects of treatments. 
Balanced block randomization was expected to give an even distribution over the 
experimental treatment groups of these factors. Thus, children were sampled from an up-
to-date census, and recruitment continued until eight children had been randomly selected 
per community. Interventions were randomly allocated in duplicate within 41 of these 
blocks, using tables with randomised permutations, and only after eligibility for study had 
been established. The study was designed to measure a difference between groups in 
change in haemoglobin concentration within 5 g/L of the true value (a=0.05). 
Held procedures 
Children were medically examined at baseline, and after 4, 8 and 12 w. At each of these 
visits, samples of capillary blood from each child were tested by malaria dipstick, and 
haemoglobin concentration was measured. For each day of the recruitment period, the 
community health worker and mothers from one community were asked to bring invited 
children to the research clinic. A questionnaire was administered to collect vital 
information. Anthropometric measurements were taken at baseline and after 12 w as 
described previously (Verhoef et al., accepted b). Children were then photographed for 
future identification, and their mothers and community health workers received a 
treatment schedule and an identification card. The distance between the homestead of 
each child and the research clinic was measured in duplicate using a global positioning 
system (Model 12, Garmin International Inc., Olathe KS, USA). 
Parents were asked to report immediately to the clinic with their child when suspecting 
fever or other illnesses. Community health workers each supervised one block of eight 
children within their own community through meetings twice per week with each child. At 
these meetings, they administered iron or iron placebo using syringes on which amounts of 
suspension, colour code for each suspension and the name of the child had been pre-
indicated. They also recorded axillary temperature on a one-page questionnaire, together 
with information about whether or not the child had been sick on previous days, and if 
adverse drug reactions had occurred. Questionnaires were handed in and perused within 
one day after completion. Compliance of the work of community health workers was also 
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checked unseen to them by inspecting whether residue of suspension was present in 
syringe tips. 
Sick children 
Children reported sick were medically examined, and blood samples were collected and 
assayed by malaria dipstick test, and to determine haemoglobin concentration. Children 
with malaria attacks, defined by the occurrence of both fever confirmed by thermometer 
and a positive dipstick test result, were treated with amodiaquine or, if this failed, with 
halofantrin under supervision. Afebrile children with a reported history of recent fever were 
tested repeatedly by thermometer and dipstick assay at intervals of several hours until 
positive or a diagnosis of malaria could be excluded. Febrile children with a negative 
dipstick test had their blood slide examined within 24 h at the nearest facility, at 50 km 
distance. Children were always promptly treated for common illnesses, or referred if 
needed. During the intervention period, treatment with sulfa antibiotics was avoided. 
Those with anaemia at the end of the intervention period, or with a positive dipstick test 
result for malaria, were treated with iron, and with amodiaquine and sulfadoxine-
pyrimethamine, respectively. 
Laboratory measurements 
Axillary temperature was measured by electronic thermometer (Model HP 5316; Philips, 
Groningen, The Netherlands). Haemoglobin concentrations were determined by 
photometer (HemoCue, Angelholm, Sweden), and dipstick tests (Model ML02; AMRAD/ICT, 
Sydney, Australia) were used for rapid detection in blood of antigens specific to 
Plasmodium falciparum (Anonymous 2000). In patients with manifestations of malaria, the 
sensitivity and specificity this test is estimated to be >95% in detecting parasitaemia as 
determined by microscopy (Garcia et al. 1996, Kumar et al. 1996, Kilian et al. 1997, 
Durrheim et al. 1998). A negative test result is highly predictive for the absence of malarial 
infection, whilst a positive test result probably has less predictive value for the presence of 
infection (Eisen and Saul 2000). Resources were lacking for routine microscopic 
examination of blood smears. 
Procedures for collection and handling of blood samples have been described elsewhere 
(Verhoef et al., accepted a). Ferritin concentrations were determined using commercial 
reagent kits according to instructions from the manufacturer (Diagnostic Products 
Corporation, Los Angeles CA, USA). C-reactive protein concentration was determined as an 
indicator of inflammation in an assay (Orion Diagnostics, Espoo, Finland) adapted to allow 
measurement in low volumes of ranges from zero to highly elevated values. This method 
correlated excellently with standard methods (Beckman Coulter, Brea CA, USA; Roche 
Diagnostics, Mannheim, Germany). 
Statistical analysis 
Anthropometric indices were calculated by Epi Info (v6.04b; CDC, Atlanta, GA, USA). Data 
cleaning and standard analysis was undertaken using SPSS (v7.5.2; SPSS Inc., Chicago, III, 
USA) on an intention-to-treat basis. Iron deficiency was defined as serum ferritin 
concentrations <12 ug/L, measured in children who concurrently had both negative results 
when their blood was assayed by malaria dipstick test and serum C-reactive protein 
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concentrations <15 mg/L. Lower cut-off values of serum C-reactive protein concentrations 
did not result in appreciably different prevalence estimates. 
Change in haemoglobin concentration was calculated as the difference between values 
before and after intervention. Effects of interventions were measured as the difference in 
change between treatment groups and the placebo group, adjusted for block effects to 
take the study design into account, and with adjustment for imbalances in prognostic 
factors at baseline. Interaction effects were assessed directly by multiple regression. 
Intervention groups were also compared regarding their prevalence at the end of the 
intervention period of anaemia and iron deficiency, or having a positive dipstick test result. 
Kaplan-Meier curves were constructed to examine the effect of the interventions on time 
until first occurrence of a malaria attack, assessed both directly and when stratified by 
malaria dipstick test result at baseline. Logistic regression was used to assess the effects 
on the occurrence of a malaria attack over the 12 w intervention period of interventions 
and malaria dipstick test result at baseline. Adjustments were made for block effects and 
age class. 
Chronic inflammation unrelated to malaria may be an important cause of anaemia. This 
was examined by measuring, in children who received placebo and whose blood sample 
tested negative when assasyed by malaria dipstick tests at all surveys (baseline, 4 w, 8 w, 
and 12 w), the proportion who had serum C-reactive protein concentrations >10 mg/L both 
at baseline and at 12 w. 
Results 
Of 328 children who underwent randomisation (figure 1), 307 (94%) completed the trial, 
and 21 (6%) did not, for the following reasons: migrated or moved temporarily from the 
study area (13), parents withdrew consent (3), withdrawn due to occurrence of severe 
anaemia (1), died (1), developed malaria but parents took the child for treatment 
elsewhere (1), unknown reasons (2). Of all iron or iron placebo doses scheduled until the 
time of censoring, 99% were administered. This estimate was the same whether censoring 
was due to completion of the trial, or due to being either withdrawn from the study or 
being lost to follow-up. All SP or SP placebo doses scheduled until the time of censoring 
were administered. No severe skin reactions were reported in 3824 child-weeks of follow-
up. 
The intervention groups were similar regarding their distribution of baseline characteristics 
(table 1). The effect over the entire intervention period on change in haemoglobin 
concentration of combined iron supplementation and intermittent administration of SP was 
12.2 g/L (table 2; adjusted for block effects). Similarly measured, the effects of either iron 
supplementation alone or intermittent administration of SP alone were 13.1 g/L and 5.0 
g/L. Additional adjustment for differences in prognostic factors at baseline led to similar 
effect estimates (12.5 g/L, 12.7 g/L, and 4.3 g/L, respectively; table 2). Thus, the effect 
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FIGURE 1. Trial profile 
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Randomly allocated 
n=328 
Placebo 
n=82 
Completed: 
n=76 (93%) 
Lost to follow-up: 
n=5 (4 migrated or 
moved temporarily; 1 
taken for treatment 
elsewhere) 
Withdrawn: 
n=1 (died) 
SP 
n=82 
Completed: 
n=77 (94%) 
Lost to follow-up: 
n=5 (4 migrated or 
moved temporarily; 1 
withdrew consent) 
Iron 
n=82 
Completed: 
n=79 (96%) 
Lost to follow-up: 
n=2 (1 migrated or 
moved temporarily; 1 
lost for unknown 
reasons) 
Withdrawn: 
n=1 (severe anaemia) 
Iron plus SP 
n=82 
Completed: 
n=75(91%) 
Lost to follow-up: 
n=7 (4 migrated or 
moved temporarily; 2 
withdrew consent; 1 
lost for unknown 
reasons) 
Placebo: iron placebo and sulfadoxine/pyrimethamine placebo; SP: iron placebo and 
sulfadoxine/pyrimethamine; Iron: iron and sulfadoxine/pyrimethamine placebo; Iron plus SP: iron and 
sulfadoxine/pyrimethamine. Children who completed an intervention were allocated and completed that 
intervention, and were included in the analysis. 
of combined iron supplementation and intermittent administration of SP appeared less 
than the summed effects of the individual interventions (difference: -4.6 g/L; 95% 
confidence interval, CI: -10.2 g/L to 1.1 g/L; p=0.11). There was no evidence that the 
effect of treatment on change in haemoglobin concentration depended on age class or 
haemoglobin concentration at baseline (not shown). The interventions also led to small 
increases in height-for-age z-scores (table 2). 
Results from the repeated surveys suggested that iron supplementation, when 
administered either alone or in combination with SP, continued to increase haemoglobin 
concentrations over the entire intervention period of 12 w (figure 2). Despite these gains, 
anaemia had not been resolved at the end of the intervention in 5 1 % of children who had 
received iron alone, and in 36% of children who had received iron plus SP. The 
corresponding prevalences of anaemia in children who received SP only or placebo were 
73% and 7 1 % , respectively. 
Iron supplementation, when given either alone or with SP, resulted in a marked reduction 
in the prevalence of iron deficiency (table 3). SP did not substantially affect this 
prevalence. 
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FIGURE 2. Haemoglobin response to interventions in the course of the trial 
White bars: SP; light grey bars: Iron; dark grey bars: Iron + SP. Change in haemoglobin concentration was 
measured as the difference between values after and before intervention. Treatment response was measured 
as the difference in change between treatment groups and the placebo group, adjusted for block effects to take 
study design into account, and for prognostic factors at baseline (age class, sex, current or recent malarial 
infection as indicated by dipstick test, and z-scores for height-for-age and weight-for-height). 
TABLE 3. Effect of the interventions on the prevalence of iron deficiency, defined by serum 
ferritin <12 ug/L* 
Experimental treatment group 
Placebo 
S P t 
Iron 
Iron plus S P f 
Prevalence of iron deficiency, % 
(95 confidence interval) 
At baseline At12w 
61 (41-81) 
70 (53-88) 
67 (48-86) 
66 (48-83) 
77 (53-94) 
60 (42-78) 
10(0-24) 
8(0-19) 
* Measured in children with both a negative result when their blood was assayed by malaria dipstick test and 
serum C-reactive protein concentration <15 mg/L (see text); * SP: sulfadoxine-pyrimethamine. 
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TABLE 4. Prognostic factors for the development of malaria, defined by axillary 
temperature >37.50 9C plus a positive malaria dipstick test result; multivariate 
analysis 
Variable 
SP* 
Iron supplementation 
Iron plus SP 
Malaria dipstick test result at baseline 
Odds ratio * 
0.5 
1.3 
1.0 
5.6 
(95% CI) * 
(0.2-1.2) 
(0.5-3.0) 
(0.4-2.4) 
(2.6-12.4) 
P 
0.12 
0.59 
0.99 
<0.001 
* Adjusted for design (block effects) and age class; t CI: confidence interval; * SP: sulfadoxine/pyrimethamine 
In those who completed the trial, estimates for the cumulative incidence of malaria attacks 
were 0.29, 0.30, 0.17, and 0.25 for children receiving placebo, iron alone, SP alone, and 
iron plus SP, respectively. Survival analysis indicated a protective effect of SP (p=0.08; log-
rank test) on the time until first occurrence of a malaria attack, and a smaller, statistically 
insignificant effect of SP when given in combination with iron (not shown). Iron, when 
given alone or in combination with SP, did not appear to have an effect when examined by 
inspection of Kaplan-Meier curves or significance testing (not shown). In addition, we 
found no evidence that iron supplementation led to changed serum C-reactive protein 
concentrations (not shown). 
Stratification by malaria dipstick test result at baseline led to the same conclusions drawn 
in the preceding paragraph whether children tested positive or negative (figure 3), and 
provided strong evidence that a positive test result at baseline markedly reduced the time 
until first occurrence of a malaria attack. This was confirmed by logistic regression (table 
4). Children who received iron supplementation had a marginal and statistically not-
significant increase in the odds of developing a malaria attack (table 4). 
Of 35 children who received placebo and whose blood tested negative for malaria at all 
surveys (baseline, 4 w, 8 w, 12 w), 30 (86%; 95% CI: 74%-97%) had serum C-reactive 
protein concentrations >10 mg/L both at baseline and at 12 w. 
FIGURE 3 (NEXT PAGE). Kaplan-Meier curves for the intervention groups, stratified by 
malaria dipstick test result at baseline (y-axis: proportion of children free from 
malaria attacks; circles: test result negative; squares: test result positive) 
Top: Analysis restricted to children receiving intermittent sulfadoxine-pyrimethamine (SP; closed circles or 
squares) or SP placebo (open circles or squares), thus excluding children receiving intermitted iron 
supplementation. Centre: Analysis restricted to children receiving iron (closed circles or squares) or iron 
placebo (open circles or squares), thus excluding children receiving SP. Bottom: Analysis restricted to 
children receiving iron plus SP (closed circles or squares), or their corresponding placebos (open circles or 
squares), thus excluding children receiving either iron only or SP only. 
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Discussion 
Our findings show that iron supplementation results in a marked improvement of 
haemoglobin concentrations, and substantially reduces the prevalence of both iron 
deficiency and anaemia. There was no evidence that it was accompanied by a substantially 
increased risk of malaria. Intermittent administration of SP alone yielded a marginal 
increase in haemoglobin concentrations but protects substantially against malaria. 
Administration of SP in addition to iron supplementation did not result in further gains of 
haemoglobin concentrations. 
The intervention groups had similar characteristics at baseline, and the number of children 
lost to follow-up in the course of the study was low. Hence, these factors are unlikely to 
have produced substantial bias. Compliance to iron supplementation was excellent, and 
there were no indications that children missed a substantial number of scheduled doses. 
Similar haematological responses may be expected when these interventions are 
implemented in children aged 2-36 mo with mild to moderate anaemia living in areas of 
seasonal malaria. 
Malaria dipstick tests are highly sensitive in detecting parasitaemia, but may have low 
specificity because positive results may be obtained for some time after clearance of 
parasitaemia (Eisen and Saul 2000). As a consequence, the effects on reported survival 
time until first occurrence of a malaria attack (figure 3, squares) may have been 
underestimated in children with a positive test result at baseline. In their counterparts with 
a negative test result at baseline (figure 3, circles), however, the reported survival curves 
validly indicate no or little risk of a malaria attack following iron supplementation. Our 
study was probably limited in statistical power to detect such an effect. Serum C-reactive 
protein concentrations remained unaffected by iron supplementation, indicating that it did 
not lead to increased inflammation. 
We showed earlier that worm infections are relatively rare in similarly-aged children in our 
study area (Verhoef et al, accepted a). Iron status should therefore be improved by 
increasing the intake of absorbable iron. As indicated by the prevalence of anaemia at 12 
w, our interventions were not as efficacious as anticipated. This might possibly be 
improved by using longer intervention periods than the one we maintained, or by 
increasing the frequency of iron administration (Beaton and McCabe 1999). Other possible 
causes of anaemia should also be considered, including deficiencies in vitamin A and other 
micronutrients. We found that the majority (86%) of children who received placebo and 
who remained free of malaria throughout the trial had elevated serum C-reactive protein 
concentrations both at baseline and at 12 w. This indicates that chronic disease due to 
infections other than malaria might be an additional cause of anaemia (Sears 1992, Jurado 
1997, Spivak 2000). 
The age group studied probably represents the range at highest risk of anaemia due to 
either iron deficiency or malaria. Hence, the interventions might have been less efficacious 
in older children. Only one case of severe anaemia was observed. Hence, intermittent 
administration of SP is unlikely to have a future role in public health programmes to control 
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anaemia in areas of seasonal malaria. It may possibly be used, however, to reduce the 
incidence of malaria attacks or - in areas with high, perennial transmission - to prevent 
severe anaemia (Schellenberg et al. 2001). 
We conclude that, when giving iron twice weekly at 6 mg kg"1 body weight wk"1, iron 
supplementation gives substantial health benefits that may outweigh the associated risk of 
adverse effects caused by malaria. Intermittent administration of SP in addition to iron 
supplementation does not result in further gains of haemoglobin concentrations; further 
studies are warranted, however, to determine its possible benefits in reducing the 
incidence of malaria attacks. Future research is needed to evaluate the benefits and risks 
of more frequent administration of iron over longer intervention periods. 
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Malarial anaemia leads to adequately 
increased erythropoiesis in asymptomatic 
Kenyan children 
Hans Verhoef, Clive E West, Rob Kraaijenhagen, Silas M Nzyuko, Rose 
King, Mary M Mbandi, Susanne van Laatum, Roos Hogervorst, Carla 
Schep, Frans J Kok 
SUMMARY 
Background: Malarial anaemia is associated with a shift in iron distribution from 
functional to storage compartments. This suggests a relative deficit in erythropoietin 
production or action similar to that observed in other infections. Our study aimed at 
investigating whether malaria causes increased erythropoiesis in Kenyan children with 
asymptomatic malaria, and whether the erythropoietic response appeared appropriate 
for the degree of resulting anaemia. 
Methods: Longitudinal and baseline data were used from a trial with a 2x2 factorial 
design, in which 328 anaemic Kenyan children were randomly assigned to receive either 
iron or placebo, and SP or placebo. Erythropoiesis was evaluated by serum 
concentrations of erythropoietin and soluble transferrin receptor. 
Findings: Prospectively collected data showed that malarial infection resulted in 
decreased haemoglobin concentrations, and increased serum concentrations of 
erythropoietin and transferrin receptor. Conversely, disappearance of malarial 
antigenaemia resulted in increased haemoglobin concentrations, and decreased 
concentrations of these serum indicators. In addition, our baseline data showed that 
current or recent malarial infection is associated with increased serum concentrations of 
erythropoietin and transferrin receptor, and that these were as high as or perhaps even 
higher than the values of children without malaria and without inflammation. 
Interpretation: Our findings indicate that the erythropoietic response is adequate for 
the degree of anaemia, and that inflammation probably plays no or a minor role in the 
pathogenesis of anaemia associated with asymptomatic malaria. Further research is 
needed to demonstrate the role of deficient erythropoietin production or action in the 
pathogenesis of the anaemia of acute, symptomatic malaria. 
Submitted for publication 
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Impaired erythropoiesis is believed to play an important role in the pathogenesis of 
malarial anaemia, and may exacerbate anaemia due to malaria-induced haemolysis 
(Menendez et al. 2000). Several mechanisms might explain this erythropoietic suppression. 
Malarial anaemia is associated with a shift of iron distribution from functional towards 
storage compartments (Das et al. 1997). This suggests a relative deficit in erythropoietin 
production or decreased marrow responsiveness to erythropoietin in malaria, similar to 
that observed in other infections (Means and Krantz 1992, Spivak 2000). 
Reduced erythropoietin production or action might possibly explain reports (Abdalla 1990a) 
of reduced numbers of red cell precursors in acute malaria. Evidence for erythroid 
hypoplasia is supported by ferrokinetic studies showing reduced incorporation of iron into 
red cells during acute malaria (Srichaikul et al. 1969), and showing decreased serum 
soluble transferrin receptor (sTfR) concentrations during episodes of febrile malaria 
(Williams et al. 1999, Beesley et al. 2000). Concentrations of sTfR measure both 
erythropoietic activity and the deficit in the erythron of iron; they are not influenced by the 
inflammatory response to infections (Cook et al. 1993,1996; Feelders et al. 1999). 
Studies from Zaire, however, failed to show an effect on sTfR concentrations of malaria 
(Kuvibidila et al. 1995, 1999), while reports from cross-sectional studies among non-
hospitalised Africans give support to increased sTfR concentration in malaria (Mockenhaupt 
et al. 1999, Stoltzfus et al. 2000, Verhoef et al., accepted). Erythroid hyperplasia with 
dyserythropoiesis may also occur in malaria, and appears more common in patients with 
severe anaemia and low grade parasitaemia than in those with acute malaria (Abdalla 
1990a). 
We used longitudinal data to investigate whether malaria and iron deficiency 
independently cause increased erythropoiesis in Kenyan children with asymptomatic 
malaria. Erythropoiesis was evaluated by serum concentrations of erythropoietin and sTfR 
(Barosi 1994, Beguin et al. 1993). The data used were collected as part of a randomised 
controlled trial to determine the efficacy in improving iron status of intermittent 
administration of iron and sulfadoxine-pyrimethamine (SP). In addition, we used the 
baseline data from this trial to evaluate whether observational data indicated that the 
erythropoietic response to malaria was appropriate for the degree of resulting anaemia. 
Detailed descriptions of study design and other results will be published elsewhere. 
Subjects and methods 
Area and population 
The study was conducted in Mtito Andei Division, Eastern Province, Kenya, which is 
described in more detail elsewhere (Verhoef et al., in press). An earlier survey among 
children aged 2-36 mo in this area had shown prevalences of malaria, anaemia, and 
Ascaris lumbricoides, and Trichuris trichiura of 3 1 % , 72%, 3% and 5%, respectively 
(Verhoef, unpublished results). Reported malaria infections were exclusively due to 
Plasmodium falciparum. No hookworm was found. 
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A research clinic was established in the area and children were recruited from 
neighbouring communities at the start of rainy seasons in the period 1998-2000. The study 
received ethical approval from AMREF and the Kenya Medical Research Institute. Informed 
consent was obtained from community leaders and local government officials, and from 
parents of participating children. Children included in the study and their siblings received 
free medical care for common childhood illnesses. 
Design and procedures 
The study consisted of a double-blind trial with a 2x2 factorial design with an intervention 
period of 12 w (n=328). Children randomly selected from communities in the study area 
were randomly allocated to receive either iron supplement or placebo, and either 
sulfadoxine-pyrimethamine or placebo. Iron was administered twice weekly as ferrous 
fumarate in a 6.25 g/L suspension at a target dose of 6 mg elemental iron kg _1 body 
weight wk"1. Sulfadoxine-pyrimethamine was administered every 4 w at therapeutic doses 
(25 mg and 1.25 mg kg"1 body weight, respectively). 
Eligibility criteria were: haemoglobin concentrations 60-110 g/L; age 2-36 mo; axillary 
temperature <37.50 °C; absence of symptoms suggestive of malaria or anaemia, or of any 
systemic illness occurring in combination with a dipstick test result indicating current or 
recent malarial infection; parents reported their intention to stay in the study area during 
the intervention period; parental consent given; absence reported of allergy to sulfa drugs; 
and no sulfa drugs used in the previous 3 w. 
Children were withdrawn and treated as appropriate if haemoglobin concentrations were 
<50 g/L, if they met one or more criteria of severe and complicated malaria (Warrell et al. 
1990), or if they had manifestations of other severe disease. 
Children were medically examined at baseline and at 12 w. At both visits, samples of 
capillary blood from each child were assayed by dipstick test to detect current or recent 
malarial infection, and haemoglobin concentration was measured. Children were always 
promptly treated for common illnesses, or referred if needed; details will be described 
elsewhere. 
Laboratory measurements 
Haemoglobin concentrations were determined by photometer (HemoCue, Angelholm, 
Sweden), and dipstick tests (Model ML02; AMRAD/ICT, Sydney, Australia) were used for 
rapid detection in blood of antigens specific to Plasmodium falciparum (Anonymous 2000). 
In patients with manifestations of malaria, this test has sensitivity and specificity estimates 
>95% in detecting parasitaemia as determined by microscopy (Durrheim et al. 1998, 
Garcia et al. 1996, Kilian et al. 1997, Kumar et al. 1996). A negative test result is highly 
predictive for the absence of malarial infection, whilst a positive test result probably has 
less predictive value for the presence of infection (Eisen and Saul 2000). Resources were 
lacking for routine microscopic examination of blood smears. 
Procedures for collection and handling of blood samples have been described elsewhere 
(Verhoef et al., accepted). Ferritin concentrations were measured using commercial 
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reagent kits according to instructions from the manufacturer (Diagnostic Products 
Corporation, Los Angeles, CA, USA). C-reactive protein concentration was determined as 
an indicator of inflammation in an assay (Orion Diagnostics, Espoo, Finland) adapted to 
allow measurement in low volumes of ranges from zero to highly elevated values. This 
method correlated excellently with standard methods (Beckman Coulter, Brea, CA, USA; 
Roche Diagnostics, Mannheim Germany). Insufficient blood was available for determination 
of all haematological indicators in all blood samples: as a result, the total number of 
children included in the subgroups was sometimes less than the total number of children 
investigated (n=328). 
Statistical analysis 
Data cleaning and standard analysis was undertaken using SPSS (v7.5.2; SPSS Inc., 
Chicago, III, USA. Cross-sectional data from the baseline were used to compare blood 
samples testing positive and negative when assayed by malaria dipstick test with regard to 
haemoglobin concentration, and serum concentrations of ferritin, erythropoietin and sTfR. 
Values of serum indicators were normalised before analysis by log-transformation. 
The cross-sectional data were subsequently used to assess serum concentrations of 
ferritin, erythropoietin and sTfR in children with a positive malaria dipstick test in 
comparison with what might be expected for the resulting degrees of anaemia and 
inflammation (Barosi 1994, Beguin et al. 1993). For this purpose, children were divided 
into three groups. Group 1 comprised children whose blood tests indicated the absence of 
both malarial infection and inflammation (serum C-reactive protein concentration <10 
mg/L). Group 2 comprised children without malarial infection as indicated by a negative 
dipstick test result, and with inflammation (serum C-reactive protein concentration >10 
mg/L). Group 3 comprised children with current or recent malarial infection as indicated by 
a positive dipstick test result. Haemoglobin classes were defined using cut-off values that 
were selected to balance the number of children in categories formed by cross-tabulation 
with the groups into which children had been divided. Serum concentrations of ferritin, 
erythropoietin and sTfR from group 3 were subsequently compared with those from groups 
1 and 2, assuming independent t-distributions of log-transformed values. 
In a subsequent analysis, change in haematological indicators was calculated as the 
difference in values after and before intervention. For serum indicators, these changes 
were either positively or negatively skewed within intervention groups and could not be 
normalised. Thus, we could not use linear regression models to evaluate the response of 
these indicators to malaria or iron supplementation. The effects on haematological 
indicators of iron supplementation were assessed in children without malarial infection at 
both baseline and at 12 w, thus excluding children with a positive dipstick test result at 
either of these points in time. In addition, we excluded children receiving SP in this 
analysis, regardless of whether it was given alone or in combination with iron. Significance 
of differences in the distributions was determined by t-test in the case of change in 
haemoglobin concentrations, and by Mann-Whitney U-test in the remaining indicators. 
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Finally, we examined the effects of malaria in children receiving either SP or placebo, thus 
excluding children receiving iron. These children were divided into three groups. Group A 
comprised children without infection at either baseline or at 12 w as assessed by dipstick 
test. Group B contained children who became infected during the trial (dipstick test result 
negative at baseline, and positive at 12 w), whilst group C comprised children with a 
positive dipstick test at baseline, and a negative result at 12 w. The results from the 
groups B and C were both compared with those from group A, and significance of 
differences in the distributions were determined by Mann-Whitney U-test. Data from 
children with a positive dipstick test both at baseline and at 12 w were not considered 
because parasite density might not have been the same at the two time points. Thus, it 
would be difficult to interpret the meaning of any differences in the parameters between 
these time points. 
Results 
Findings from the cross-sectional data of the effect of malaria on haematological indicators 
are shown in table 1. Malaria was associated with a mild reduction of haemoglobin 
concentrations, mild inflammation as indicated by serum C-reactive protein concentration, 
and increased serum concentrations of erythropoietin, sTfR and ferritin. 
Serum concentrations of erythropoietin and sTfR from children with current or recent 
malarial infection as indicated by dipstick test were as high as or perhaps even beyond 
what the values of children without malaria, regardless of whether serum C-reactive 
protein concentration values from children in groups 1 or 2 indicated the presence or 
absence of inflammation (figure 1). Blood samples from children in group 3 had 
somewhat higher serum C-reactive protein concentrations than their counterparts in group 
2 (not shown). 
FIGURE 1 (OPPOSITE PAGE). Serum indicators (geometric means) in relation to haemoglobin 
concentration, for three groups of children 
Group 1 (black bars): children whose blood tests indicated the absence of both malarial infection 
and inflammation; group 2 (open bars): children without malarial infection, and with inflammation; 
group 3 (shaded bars): children with current or recent malarial infection (positive dipstick test 
result). Numbers above bars indicate group sample sizes. See text for further explanation. 
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Haemoglobin concentrations increased more in children who received iron than in their 
counterparts who received iron placebo (16.0 g/L versus 4.1 g/L; difference: 11.9 g/L, 
95% confidence interval: 7.9-15.9 g/L). The corresponding changes in concentrations of 
serum indicators are shown in figure 2. Iron supplementation led to decreased serum 
concentrations of erythropoietin and sTfR, and increased serum ferritin concentrations. 
There was no evidence of an effect of iron on serum C-reactive protein concentrations (not 
shown), or of differences between the groups compared regarding baseline characteristics 
(not shown). 
Children who became infected by malaria in the course of the study had decreased 
haemoglobin concentrations (table 2), and increased serum concentrations of 
erythropoietin, sTfR, C-reactive protein and ferritin at 12 w when compared to baseline 
(figure 3). Conversely, those with a positive and negative dipstick test results at baseline 
and at 12 w, respectively, had increased haemoglobin concentrations (table 2), and 
decreased serum concentrations of erythropoietin, sTfR, C-reactive protein and ferritin at 
12 w when compared to baseline (figure 3). Exclusion of children who received SP did not 
lead to different conclusions (not shown). 
FIGURE 2 (OPPOSITE PAGE). Effect of iron supplementation on change in serum indicators 
Box plots indicate 25th and 75th percentiles (box) and the median (thick line across the box). Lines 
extending from each box indicate highest and lowest values, excluding outliers (five largest and five 
smallest values). Values between brackets indicate group sample size; fractions indicate the level 
of significance when testing for differences in distributions of sampled populations of groups 2 and 
3 relative to group 1 (Mann-Whitney U-test). See text for further explanation. 
FIGURE 3 (NEXT PAGE). Effect of malaria on change in serum indicators 
Group A: children without infection at either baseline or at 12 w; group B: children who became 
infected during the trial; group C: children with a positive dipstick test at baseline, and a negative 
result at 12 w. Fractions indicate the level of significance when testing for differences in 
distributions of sampled populations of groups B and C relative to group A (Mann-Whitney U-test). 
See caption figure 2 and text for further explanation. 
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TABLE 2. Effect of malaria on haemoglobin concentrations; longitudinal data 
Group Dipstick test result n 
At baseline At 12 w 
Change in haemoglobin concentration, g/L 
Difference in values after
 n - _ _ . „ H ,.,ith r>rn„n 1 * 
and before intervention C o m P a r e d W l t h G r o u P 1 
1 Negative Negative 83 5.4 ±8.8 
2 Negative Positive 22 -7.8 ±19.2 
3 Positive Negative 21 20.4 ±11.5 
-13.3 (-4.6 to 22.0) 
15.0 (10.4 to 19.5) 
Mean ± standard deviation (95% confidence interval) 
* Calculated as the change in haemoglobin concentration in either group 2 or 3 minus the corresponding 
change in group 1 
Discussion 
Our findings showed prospectively that the development of malaria resulted in decreased 
haemoglobin concentrations, and increased serum concentrations of erythropoietin and 
transferrin receptor. Conversely, the disappearance of malarial antigenaemia resulted in 
increased haemoglobin concentrations, and decreased concentrations of these serum 
indicators. In addition, our baseline data showed that current or recent malarial infection is 
associated with increased serum concentrations of erythropoietin and transferrin receptor, 
and that these were as high as or perhaps even higher than the values of children without 
malaria and without inflammation. 
Iron supplementation led to decreased serum concentrations of erythropoietin and 
transferrin receptor. This is in agreement with reports that iron deficiency leads to 
increased serum concentrations of erythropoietin and hypoproliferative erythropoiesis 
(Baynes 1994). 
Malaria causes a shift of iron distribution from functional towards storage compartments 
(Das et al. 1997) which has also been observed in a range of other infections (Sears 1992, 
Means and Krantz 1992, Konijn 1994, Jurado 1997, Spivak 2000). Thus in malaria, 
stainable macrophage iron stores are often present in bone marrow (Abdalla 1990b, 
Phillips et al. 1986) while serum ferritin concentrations are increased (Das et al. 1997, 
Oppenheimer et al. 1984, Phillips et al. 1986). Ferritin is an iron storage protein, but its 
serum concentration also increases in infection, probably as part of a host immune 
response (Kent et al. 1994). This was confirmed by our results. Serum ferritin 
concentrations <12 u.g/L are highly predictive of depleted iron stores (Skikne et al. 1990), 
whilst values above this range, when coupled with anaemia, indicate inflammation but may 
mask coexisting iron deficiency (Verhoef et al., accepted). 
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Several authors have raised the possibility that malaria leads to iron sequestration in the 
mononuclear phagocyte system, thus resulting in iron-limited erythropoiesis (Phillips et al. 
1986, Phillips and Pasvol 1992, Weatherall et al. 1983). There are several reasons to 
believe that this is not the case. First, the observed presence of iron in bone marrow 
corroborates experimental evidence (Spivak 2000) that iron therapy in patients with 
inflammatory diseases does not result in correction of anaemia. Second, contrary to a state 
of iron deficiency, iron absorption is normal or somewhat decreased in the anaemia of 
chronic disease (Jurado 1997), and absorbed iron is effectively incorporated in the 
erythron (Pollack 1992). Third, instead of being incorporated into haemoglobin, it appears 
that iron taken up in developing red cells is stored in ferritin and haemosiderin (Pollack 
1992). Fourth, expression of transferrin receptors on individual erythroblasts is increased 
in iron deficiency but decreased in anaemia of chronic disease (Feelders et al. 1993, 
Kuiper-Kramer et al. 1997,1998). 
The anaemia of chronic disease is primarily due to reduced erythropoietin production and 
reduced responsiveness of erythroid progenitor cells to erythropoietin (Means and Krantz 
1992, Spivak 2000) under influence of proinflammatory cytokines such as tumour necrosis 
factor and interleukin-1. Therapy using recombinant erythropoietin can correct the 
anaemia of chronic disease but not of iron deficiency (Mean and Krantz 1992). Thus, the 
distinctive abnormalities in body iron distribution appear to be a by-product of these 
mechanisms (Walter et al. 1997). It cannot be ruled out, however, that some iron 
sequestration occurs in malaria in haemazoin, a product from haemoglobin degradation by 
malaria parasites that is found in circulating or phagocytosed red cells. 
Contrary to what is observed in the anaemia of chronic disease (Means and Krantz 1992, 
Spivak 2000), we found no evidence that erythropoietin production was impaired in 
malaria (figure 1). In addition, serum transferrin receptor concentrations in children with 
current or recent malaria appeared appropriate for the degree of anaemia (figure 1). In a 
study among asymptomatic children, Mockenhaupt et al. (1999) also reported increased 
serum transferrin receptor concentrations when adjusting for haemoglobin concentration. 
These findings provide evidence that the erythropoietic response of asymptomatic malaria 
is adequate for the degree of anaemia, and that inflammation probably plays no or only a 
minor role in the pathogenesis. This indicates that the malaria-associated anaemia 
observed in the present study is primarily due to haemolysis. 
We found that a positive dipstick test result was associated with a minor increase in serum 
C-reactive protein concentration, indicating that malaria was associated with a minor 
degree of inflammation. Acute malaria is probably associated with higher parasite densities 
and thus more intense inflammation. Thus, it seems likely that the decrease in sTfR 
concentrations observed in acute malaria (Williams et al. 1999, Beesley et al. 2000) might 
be due, in addition to haemolysis, to deficient erythropoietin production or suppressed 
marrow response to erythropoietin. 
In summary, our findings indicate that in asymptomatic malaria, the erythropoietic 
response is adequate for the degree of resulting anaemia. Inflammation and the 
pathogenic mechanisms involved in the anaemia of chronic disease probably play no or a 
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minor role. Further research is needed to demonstrate the role of deficient erythropoietin 
production or action in the pathogenesis of the anaemia of acute, symptomatic malaria. 
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Assessment of a simple test to detect 
anaemia in developing countries 
Hans Verhoef, Roos Hogervorst, Clive E West, Nynke R van den Broek, 
Frans 3 Kok 
SUMMARY 
Background: A new and inexpensive colour scale may facilitate anaemia diagnosis in 
developing countries. Previous studies to assess Its use had methodological 
shortcomings. We used data collected in various populations to determine sensitivity and 
specificity of the scale given haemoglobin concentration of any individual. These 
characteristics were used to predict test performance in two populations with different 
distributions of haemoglobin concentration. 
Methods: Blood was collected from populations in Kenya, Malawi and Tanzania, and 
assessed by colour scale and photometer. Logistic regression was used to estimate test 
characteristics of the scale in detecting anaemia or severe anaemia as a continuous 
function of haemoglobin concentration. These findings were applied to predict 
characteristics and performance of the scale in two representative samples of children 
aged 6-24 mo in areas with stable and seasonal malaria, respectively. 
Findings: Scores of the colour scale <10 indicated anaemia (haemoglobin concentration 
<110 g/L) and severe anaemia (haemoglobin concentration <70 g/L) with sensitivities 
>0.68 and >0.99, respectively. When used in populations with a heavy burden of 
anaemia, sensitivity estimates were higher, and the scale could provide valid estimates of 
the prevalence of anaemia. 
Interpretation: The colour scale is satisfactory and for many purposes superior to all 
other methods for detection of anaemia at primary care level. Low scores of the scale 
may give unsatisfactory results when used to detect patients with severe anaemia and to 
decide on their management. The methodology presented in this report may facilitate 
development of strategies for its use in various target groups. 
Submitted for publication 
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Few primary care facilities in developing countries can afford photometric equipment to 
measure blood haemoglobin concentrations accurately. A newly introduced colour scale 
(Lewis et al. 1998, Montresor et al. 2000) is inexpensive and does not require chemical 
reagents or electric power. It is used to compare the colour of a person's blood absorbed 
onto filter paper with a series of standard colours mounted on a rigid card. The version 
presently available comprises six shades of red (indicated by scores 4, 6, 8, 10, 12 and 
14), corresponding to six haemoglobin concentrations between 40 and 140 g/L in 
incremental steps of 20 g/L. Previous studies to assess the scale have suffered from 
methodological shortcomings, and failed to take into account that test characteristics 
(sensitivity and specificity) and performance (predictive values and ability to estimate 
prevalence of anaemia) depend on the distribution of haemoglobin concentration in the 
population considered. 
We used data collected in various populations to determine sensitivity or specificity of the 
scale given haemoglobin concentration in any individual. We then showed how these 
findings can be used in clinical practice, or extrapolated to predict performance of the scale 
in populations with different distributions of haemoglobin concentration. 
Subjects and methods 
An inventory was made of all studies that been carried out up to December 2000 to 
evaluate the utility of the colour scale. For this purpose, a literature search was undertaken 
in the Medline and Current Contents databases, and one of the persons who developed the 
colour scale (SM Lewis, Imperial College School of Medicine, Hammersmith Hospital, 
London, UK) was asked to identify additional, unpublished studies. Of the studies thus 
identified and for which we managed to obtain data, we selected those in which blood 
samples were collected from patients, thereby excluding those in which test blood samples 
were prepared in a laboratory. To standardise the methods employed in various studies, 
we also excluded studies in which haematocrit was used as the gold standard to measure 
the degree of anaemia. This yielded published and unpublished data collected from three 
groups of children and pregnant women. 
The first group comprised children aged 2-36 mo who were studied by two of us (HV and 
RH) during a survey (n=178) and when subsequently reporting sick (n=31) in the course 
of a period of 12 w to a rural research clinic in Eastern Province, Kenya. Children were 
selected by stratified random sampling from 18 rural communities surrounding the 
research clinic. Not all children thus selected were included in the survey, but the 
distribution of haemoglobin concentration in this sample is thought to be representative for 
the population studied. 
The second group comprised patients in Tanzania and Malawi. These included pregnant 
women attending antenatal clinics (n=1086), various other patient groups in outpatient 
and inpatient departments of hospitals (n=1646) and samples of rural preschool children 
(n=510). Some but not all of the findings from these groups were reported elsewhere (Van 
den Broek et al. 1999, Montresor et al. 2000). In addition to these samples, haemoglobin 
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concentrations in other blood samples were diluted with homologous plasma to obtain a 
range of 33-181 g/L as measured by photometer. These aliquots were assessed by various 
observers during a training course in Malawi (n=636). 
The third and last group comprised children aged 6-24 mo selected through simple random 
sampling or cluster sampling from rural populations in Nyanza Province (n=927) and 
Eastern Province (n=185), Kenya, respectively. Whereas malaria is highly endemic in 
Nyanza Province, it is less endemic and seasonal in Eastern Province. 
In the first group, blood collected by finger puncture was used to determine haemoglobin 
concentration by colour scale and photometer (HemoCue Inc., Angelholm, Sweden). 
Instructions given by manufacturers were followed, persons reporting colour scale scores 
were blinded to photometer readings, and the photometer's accuracy was checked every 4 
h by control cuvette. In the second group, haemoglobin concentrations were likewise 
measured, while in the third group, haemoglobin concentrations were only assessed by 
photometer. The photometers used in these two groups were either HemoCue or Coulter 
equipment (Beckman Coulter, Fullerton CA, USA). 
Data were analysed using SPSS (v7.5.2 for Windows; SPSS Inc., Chicago III., USA). 
Measurements of haemoglobin concentrations by photometer were considered as the gold 
standard. In the first group, these concentrations were calculated as the mean of at least 
two measurements. Anaemia and severe anaemia were defined as haemoglobin 
concentrations <110 g/L and <70 g/L, respectively, as determined by photometer. On the 
colour scale, scores <10 and <6 were used to indicate anaemia and severe anaemia, 
respectively. Confidence intervals of proportions were computed assuming a normal 
approximation of the binomial distribution. 
Logistic regression analysis was used to estimate the probability of detecting anaemia by 
colour scale, P, as a continuous function of haemoglobin concentration (see annex). This 
probability was estimated for cut-off values of the score of the colour scale <10 and <6, 
which might be used to indicate anaemia and severe anaemia, respectively. In ranges of 
haemoglobin concentration <110 g/L and >110 g/L, values of P and (1 - P) were 
interpreted as sensitivity and specificity estimates of detecting anaemia by colour scale, 
respectively. In ranges of haemoglobin concentration <70 g/L and >70 g/L, values of P 
and (1 - P) were interpreted as sensitivity and specificity estimates of detecting severe 
anaemia by colour scale, respectively. 
In the graph thus obtained, it was considered that the slope of the inverted S-curve and its 
relative position along the X-axis might vary between individual observers. Thus, the role 
of interobserver variation was assessed by visual inspection and comparing of graphs 
obtained by univariate analysis for individual observers in the first two groups. Data from 
two observers were subsequently excluded because their test characteristics in detecting 
both anaemia and severe anaemia were strikingly inferior to those from other observers. 
The observations of the remaining observers were pooled for further analysis. 
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The findings from this pooled analysis were applied to calculate expected characteristics 
and performance of the scale in detecting anaemia and severe anaemia in children from 
the third group. Thus, the probability of detecting anaemia by colour scale was calculated 
for each child given his or her haemoglobin concentration. The averaged values of these 
probabilities in ranges of haemoglobin concentrations <110 g/L or >110 g/L were 
interpreted as the predicted sensitivity and specificity, respectively, of detecting anaemia 
by colour scale in the populations studied. These values were used to calculate predictive 
values or reporting anaemia by colour scale, and to calculate the prevalence of anaemia as 
estimated by colour scale. Similar procedures were followed to predict test characteristics 
and performance in detecting severe anaemia. 
Results 
Test characteristics and performance of the colour scale in blood samples from the first 
study group are summarised in table 1 (first row). Scores of the colour scale <10 correctly 
identified children with or without anaemia with probabilities of 0.76 and 0.44, 
respectively. Thus assessed, proportions of children correctly reported with or without 
anaemia were 0.67 and 0.56, respectively. 
The logistic function for one single observer in group 1 is shown in figure 1. As predicted 
from this regression curve, scores of the colour scale <10 would have correctly identified 
children with haemoglobin concentrations <120 g/L, <110 g/L or <90 g/L with 
probabilities >0.53, >0.72 and >0.93, respectively. 
Similar test characteristics were found when observations from the first two groups were 
pooled (figure 2, top, right curve). As calculated from this function, scores of the colour 
scale <10 would have correctly identified children with haemoglobin concentrations <110 
g/L, <100 g/L or <70 g/L with probabilities >0.68, >0.84 and >0.99, respectively. Scores 
of the colour scale <6 would have correctly identified children with haemoglobin 
concentrations <70 g/L, <60 g/L or <50 g/L with probabilities >0.57, >0.83 and >0.95, 
respectively (figure 2, top, left curve). 
These logistic functions were applied to predict performance of the colour scale in children 
surveyed in the third group. The cumulative frequency distributions of haemoglobin 
concentration in these populations are shown in figure 2 (bottom). Those in Nyanza 
Province generally suffered from more severe anaemia than their similarly aged 
counterparts in Eastern Province (see also table 2, top). If used in these surveys, scores 
of the colour scale <10 would have been more sensitive in detecting children with anaemia 
in Nyanza Province than those in Eastern Province (0.94 versus 0.85; table 2). Specificity 
estimates were similar for these two areas, and the scale would have given no or 
negligible bias in estimating the prevalence of anaemia as determined by photometer. 
These data also show that scores of the colour scale <10 would have detected virtually all 
children (>99%) with severe anaemia in both surveys. 
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If, in addition, scores of the colour scale <6 would have been used to refer those with 
severe anaemia, then 82% and 87% of those with this condition would have been referred 
in Nyanza and Eastern Provinces, respectively. Of those referred, however, 38% and 65% 
would not be severely anaemic, respectively. Substantial bias would have occurred in both 
populations if the colour scale would have been used to estimate the prevalence of severe 
anaemia, but more so in Eastern Province (estimated versus true prevalences of 33% 
versus 25% in Nyanza Province, and 8% versus 3% in Eastern Province). 
c « 
o 2 
S> o 
•S 8 
S £ 0.4 CD 
Q. c 
CO 
1.0-i 
0.8 
0.6-
0.2 
0.0 
80 90 100 110 
Haemoglobin concentration, g/L 
120 130 
FIGURE 1. Estimated probability of reporting anaemia by colour scale (scores <10), P, as a 
logistic function of haemoglobin concentration for one observer (n=140). 
The equation for this line is given by e<a+p * > / [1 + e < a + p *)], where a and p indicate regression coefficients 
with estimated values of 9.86 and -0.08, respectively. Thin lines indicate confidence bands. The curves are 
only indicated within the 95% range of observed haemoglobin concentrations. Within ranges of haemoglobin 
concentrations <110 g/L and >110 g/L, Pand (1 - P) indicate sensitivity and specificity, respectively (see text) 
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140 
FIGURE 2. 
20 40 60 80 100 
Haemoglobin concentration, g/L 
120 140 
T O P : Estimated probabilities of reporting anaemia (right curve) by scores of colour scale <10, or of 
reporting severe anaemia (left curve) by scores of colour scale <6, as logistic functions of haemoglobin 
concentration (pooled observations; n=4087). 
Estimated values of the regression coefficients a and p were 10.695 and -0.091, respectively, for the right 
curve, and 9.285 and -0.129, respectively, for the left curve (see caption figure 1 for details). 
B O T T O M : Cumulative frequency distribution of haemoglobin concentration in representative samples of rural 
children 6-24 mo of age in Nyanza Province (left curve; n=927) and Eastern Province, Kenya (right curve; 
n=185), areas with stable malaria and perennial transmission, and with unstable malaria and seasonal 
transmission, respectively 
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TABLE 2. Comparison of estimated diagnostic characteristics and performance of the 
colour scale in two populations of Kenyan preschool children (6-24 mo of age) 
with different distributions of haemoglobin concentration 
Estimated parameter Location of the survey * 
Nyanza Province Eastern Provincef 
Measurements Haemoglobin concentration, g/L* 
by photometer _ . . .
 § 
Prevalence of anaemias 
Prevalence of severe anaemia 
82.3 ± 20.1 (927) 100.8 ± 14.5 (185) 
0.90 0.75 
0.25 0.03 
Report scores Sensitivity of detecting anaemia 
of colour scale „ ... .. . .
 t ,. 
Specificity of detecting anaemia 
Positive predictive value 
Negative predictive value 
Estimated prevalence 
Sensitivity of detecting severe 
anaemia 
0.94 
0.49 
0.95 
0.47 
0.90 
0.85 
0.46 
0.83 
0.50 
0.77 
0.99 1.00 
Report scores Sensitivity of detecting severe 
of colour scale anaemia 
^
6
 Specificity of detecting severe 
anaemia 
Positive predictive value 
Negative predictive value 
Estimated prevalence 
0.82 
0.83 
0.87 
0.95 
0.62 
0.93 
0.33 
0.35 
1.00 
0.08 
* Nyanza Province: stable malaria with perennial transmission; Eastern Province: unstable malaria with 
seasonal transmission 
t These data were included in a previous report describing a broader age range (Verhoef et al., accepted) 
* Mean±SD(n) 
§ Anaemia and1 severe anaemia were defined as haemoglobin concentrations <110 g/L and <70 g/L, 
respectively. 
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Discussion 
Our findings indicate that scores of the colour scale <10 have good sensitivity in detecting 
anaemia among young children in areas where this condition is highly prevalent. When 
used in this way and for this purpose, the scale can also provide valid estimates of the 
prevalence of anaemia, and it has excellent sensitivity in detecting persons with severe 
anaemia. The colour scale might thus be useful for excluding severely anaemic individuals 
during the initial screening of possible donors for blood transfusion. 
The distribution of haemoglobin concentrations in the first group is probably representative 
for similarly aged children in many parts of Africa with seasonal malaria transmission. 
Thus, our findings from this group (table 1) may broadly apply to these populations, but 
not to older children, who are more likely to suffer from less severe anaemia. They may 
also not apply to similarly aged children in areas where malaria is highly endemic, and who 
are more likely to suffer from more severe degrees of anaemia. 
When assuming that test characteristics of the colour scale exclusively depend on 
haemoglobin concentration, the results presented in figure 2 (top) may be used to 
predict sensitivity or specificity of the scale given the haemoglobin concentration of any 
individual or group of individuals with the same haemoglobin concentration. For example, 
our model (figure 2, top) predicts that colour scale scores <10 have a sensitivity of 0.99 
in anaemia in an imaginary, selected population in which all individuals have haemoglobin 
concentrations of 70 g/L. Similarly, such scores have a sensitivity of 0.84 of detecting 
anaemia in a population exclusively comprising individuals with haemoglobin 
concentrations of 100 g/L. When applied to populations, diagnostic characteristics and 
performance of the scale vary according to the distribution of haemoglobin concentration 
in the population considered. This principle is illustrated by our findings in table 2. 
Low scores of the scale might give unsatisfactory results to screen and refer patients with 
severe anaemia. Such use has recently been recommended by an Expert Panel convened 
by the International Nutritional Anemia Consultative Group (INACG) in primary care 
settings where determination of haemoglobin concentrations or haematocrit is not feasible 
(Stoltzfus and Dreyfuss 1998). In the primary care setting that we studied, this would have 
resulted in a large proportion of patients with severe anaemia being detected (>0.80), but 
among those referred, a large proportion would not suffer from severe anaemia (figure 2 
and table 2). On theoretical grounds, and as illustrated by the positive predictive values in 
table 1 (population-based studies) and table 2, this proportion is inversely correlated 
with the burden of anaemia. 
The INACG Panel also recommended universal iron supplementation for children aged 6-12 
mo, and for children aged 12-24 mo in areas where the prevalence of anaemia in children 
aged 6-24 mo is >40% (Stolztfus and Dreyfuss 1998). The question might arise how 
accurate the colour scale could estimate this parameter. As indicated by the findings in 
table 2, this accuracy is probably sufficient for large parts of rural Africa, but it may 
provide gross overestimates when used in populations with a low prevalence of anaemia 
(not shown). 
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Initial investigations to assess the colour scale were mostly exploratory; whilst they 
demonstrated its potential diagnostic utility, the reports have several shortcomings. These 
include poor descriptions of populations studied or of sampling procedures (Stott et al. 
1995, Van den Broek et al. 1999, Montresor et al. 2000), selection of samples that are not 
representative for any defined population (Stott and Lewis 1995, Lewis et al. 1998), lack of 
precision estimates of test characteristics (Stott and Lewis 1995, Van den Broek et al. 
1999), inappropriate use of statistical techniques (Stott and Lewis 1995, Lewis et al. 1998, 
Van den Broek et al. 1999, Ingram and Lewis 2000, Montresor et al. 2000), and insufficient 
effort to evaluate test characteristics and performance in the light of previously published 
evidence (Stott and Lewis 1995, Montresor et al. 2000). 
Linear regression and correlation analysis have been used in most reports (Stott and Lewis 
1995, Lewis et al. 1998, Van den Broek et al. 1999, Ingram and Lewis 2000, Montresor et 
al. 2000). These techniques are inappropriate because they presume a continuous and 
normally distributed dependent variable (Kleinbaum et al. 1998), whereas the outcome in 
this case - the score of the scale - concerns a categorical variable with six classes. The 
problem is compounded because correlation coefficients have been interpreted as 
measures of agreement between paired observations made when using two methods of 
determining haemoglobin concentration, whereas they measure the strength of their 
association (Feinstein 1985, Bland and Altman 1986). To overcome the limitations of 
comparing a continuous variable (haemoglobin concentration determined by photometer) 
with a categorical outcome variable, several workers inappropriately pooled observations 
by individual observers for analysis in a Bland-Altman plot (Coetzee et al. 2000, Ingram 
and Lewis 2000). 
The methodology presented in this report overcomes many of these shortcomings. Our 
logistic regression analysis provides a powerful tool to extrapolate previous findings, to 
reconcile their discrepancies, and to judge the usefulness of the scale in other settings or 
for different purposes. For example, the logistic function may be used to predict the 
sensitivity of detecting severe anaemia, which is relatively rare and therefore difficult to 
study in populations with a low to moderate burden of anaemia. Alternatively, if the 
distribution of haemoglobin concentration among women attending antenatal clinics were 
known from previous surveys, then a decision whether or not to use the scale for future 
screening for anaemia in these women might be supported by application of our logistic 
function to predict its performance. In some cases, it might be useful to construct logistic 
regression curves for individual health workers to assess and standardise their 
performance using the scale. Lastly, our techniques allow for meta-analysis of data 
collected in various studies. 
To detect anaemia, health workers commonly rely on pallor assessed in one or various 
anatomical sites. Comparison of our findings with other reports consistently indicates that 
screening for anaemia by colour scale has higher sensitivity in detecting anaemia and 
severe anaemia (table 2) than assessment for pallor of conjunctivae (table 3; see also 
discussion by Van der Broek et al. 1999), of hand palms or pallor at any of several sites 
(Luby et al. 1995, Zucker et al. 1997, Stoltzfus et al. 1999). Hand palm pallor is considered 
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a slightly better sign for detection of severe anaemia and is included in current guidelines 
for clinical management of sick children in developing countries (Anonymous 1997, 2000). 
Available reports also indicate considerable variability between observers - including 
experienced physicians (Gjorup et al. 1986, Nardone et al. 1990) - and between studies 
(Anonymous 1997) in the sensitivity of signs to diagnose anaemia. By providing an external 
reference, this problem may be reduced when using the colour scale, but this remains to 
be confirmed. Several studies have indicated that the relative performance of signs may be 
more consistent when pallor is assessed at multiple anatomical sites (Luby et al. 1995, 
Zucker et al. 1997, Stoltzfus et al. 1999, Kalter et al. 1997) but the performance of such an 
approach still appears to be less (sensitivity of detecting haemoglobin concentration <110 
g/L: 0.11-0.60) than that of the colour scale. Recent changes in the instructions 
accompanying the scale may assist in avoiding errors in its use and thereby improve its 
accuracy (Muenster et al. 1997). Contrary to other available laboratory methods for 
estimating haemoglobin concentration (Stone et al. 1984), the colour scale satisfies the 
criteria of accuracy, ease of use, low-cost and freedom of reliance on regular supplies. 
In summary, the colour scale is satisfactory and for many purposes superior to all other 
available methods for detection and treatment of anaemia at the primary care level. Its 
diagnostic characteristics and performance vary according to the aims of its intended use 
and the distribution of haemoglobin concentration in the population considered. Low 
scores of the scale may give unsatisfactory results when used to detect patients with 
severe anaemia and to decide on their management. The methodology presented in this 
report may facilitate development of strategies for its use in various target groups. Further 
research is needed to show its performance in diagnosing severe anaemia when used in 
combination with signs or symptoms, and when used to estimate the prevalence of 
anaemia in populations with a relatively low burden of anaemia. 
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Annex 
Logistic regression was used to estimate the In-odds of reporting anaemia by colour scale 
as a function of haemoglobin concentration. The In-odds parameter was assumed to be 
normally distributed, and corresponding confidence intervals were calculated from its 
standard error, SE. The latter was estimated (Snedecor and Cochran 1989) as: 
r~T~- 2" nr~~. T I _I . 2 ZT* I 
Vn c(In-odds) =V n l°(a-H3 Hb) I = \n K + H b °p + 2 H b c o v a , p > 
where n indicates sample size, the variable Hb indicates haemoglobin concentration, a and 
p indicate regression coefficients, and cov indicates their estimated covariance. The latter 
was calculated as the product of the standard deviation estimates of the regression 
coefficients and the estimate of the correlation coefficient, which is provided in the 
covariance matrix reported by SPSS. Values for In-odds thus obtained were exponentiated 
and converted to P, the probability of detecting anaemia by colour scale and its 
corresponding confidence interval. 
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Einterz and Bates (1997) report a striking unreliability in the assessment of fever by 
patients or their carers attending an outpatient service in Cameroon, and ask whether 
patients know when they are hot. Their data suggest they do. Recalculation of their data 
shows that a high proportion of respondents correctly identified fever, particularly in 
children (sensitivity; table 1). The proportion of patients correctly identified without fever 
(specificity) was low but constant over the age groups. The proportion of patients who 
correctly reported fever (positive predictive value) varied with the prevalence of fever as 
measured by axillary temperature. Hence, the reported low positive predictive values are 
largely explained by the low prevalences of fever, and to some degree by a low specificity. 
Can fever be diagnosed with an acceptable level of accuracy without using a thermometer? 
We recently carried out a community-based cluster sample survey among children aged 
2.5 - 37 months in Mtito Andei Division, which is an area of seasonal malaria transmission 
in Kenya. A trained interviewer demonstrated to mothers (or carers) how to assess fever 
by feeling the child's forehead and comparing this temperature with that of their own 
forehead. The mother was then asked in her own language if the child suffered from a 
raised body temperature, the expression of which differs from that for malaria or malaria-
like illnesses. The prevalence of fever, defined by concurrent measurement of an axillary 
temperature >37.5°C by electronic thermometer (Philips HP5316), was 0.06 (19/317 
examined children). The sensitivity of this test was similar (0.89; 17 of 19 febrile children) 
to the value reported by Einterz and Bates1, but the specificity was much higher (0.80; 238 
of 298 non-febrile children). The proportion of mothers who correctly reported the absence 
of fever (negative predictive value) of this test was 0.99. The positive predictive value was 
0.22 (17 of 77 children) but would be expected to be higher in a clinical setting, where 
self-selection for fever before presentation would result in a higher prevalence of fever 
than at the community level. For example, using the prevalence data observed by Einterz 
and Bates (1997), the predictive values shown in the above table are obtained. 
Our findings suggest that mothers can accurately diagnose the absence of fever without a 
thermometer. The use of reported fever alone will necessarily result in an unacceptably 
high proportion of false positives, especially at peripheral levels of health care. Patients or 
carers should refer to health workers to confirm diagnosis of fever by thermometer before 
initiating antimalarial treatment, although this should not result in a delay of treatment. 
For this purpose, we believe that thermometers should be made available at the lowest 
level of health care - for example community health workers. We strongly support the 
suggestion by Einterz and Bates (1997) that in the absence of fever on examination, 
history of fever should be supported by other clinical signs before antimalarial treatment is 
prescribed. 
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Maternal screening for fever in African 
children without thermometer 
Hans Verhoef, Jacobien Veenemans, Susanne van Laatum, Clive E West 
SUMMARY 
Diagnostic performance of African mothers in detecting fever in children without 
thermometer was assessed in a randomised trial. Mothers were questioned whether or 
not their child had fever, either directly or after they had palpated the child's forehead. 
Palpation had similar sensitivity (>90%) but better specificity in sick children (50.0% 
versus 33.8%; p=0.05). Fever is more prevalent in children reported sick to a health 
facility than at community level, where early detection takes place. Mothers' reports of 
fever are therefore more reliable in sick children. Regardless of actual body temperature, 
mothers are more likely to report fever in sick children. 
Submitted for publication 
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Early diagnosis and prompt treatment of febrile tropical diseases such as malaria, acute 
respiratory diseases and measles may reduce morbidity and risk of mortality. The 
diagnostic process in children often starts when mothers, who commonly lack 
thermometers, suspect fever. Whereas undetected fever results in diagnostic delay, 
chemotherapy following incorrect diagnosis of current or recent fever may unnecessarily 
expose children to adverse drug effects, and lead to selection and spread of drug-resistant 
parasite strains. 
Because prevalence of fever at household level is low, diagnosis without thermometer 
unavoidably results in a high proportion of children falsely reported with fever (Verhoef et 
al. 1998). Thus, mothers' reports of fever ideally require confirmation by thermometer. In 
practice, however, antimalarial drugs or analgesics are commonly administered at 
household level (Verhoef et al. 1999), without children being presented to health workers. 
Moreover, health workers are often faced with the dilemma of whether to prescribe 
antimalarials to afebrile children with a history of fever (Einterz and Bates 1998). Thus, 
practical means are needed to improve both sensitivity and specificity of detecting fever by 
mothers. We demonstrated how mothers should assess fever by palpating their child's 
forehead with the back of the fingers and comparing this temperature with that of their 
own forehead (Verhoef et al. 1998). Comparison of our results with those from another 
study (Einterz and Bates 1998) suggests that such maternal assessment of fever has 
similar sensitivity, and perhaps higher specificity, than directly questioning mothers 
whether their child has fever. The present study was undertaken to assess this hypothesis 
directly in a randomised trial. In addition, we evaluated whether the proportion of mothers 
who correctly report fever (positive predictive value) is higher in clinical settings, where 
self-selection for fever before presentation presumably results in a higher prevalence of 
fever than at community level (Verhoef et al. 1998). 
The study was conducted during the rainy seasons of 1998-2000. It was based at a rural 
community-based research clinic in Mtito Andei Division, and at Kibwezi Hospital, Eastern 
Province, Kenya, which represents a higher level of referral than the research clinic. 
Children were eligible for study when aged 2-36 mo and if accompanied by their mother. 
Sick children were only included if having current or recent symptoms or signs of systemic 
disease. The study comprised three groups of children. Children studied at the research 
clinic were either randomly selected from each of 22 surrounding communities (first 
group), or presented sick in the course of the study (second group). The third group 
comprised sick children attending the outpatient department of Kibwezi Hospital. 
Within the first and third groups, method of fever assessment - questioning after palpation 
or direct questioning - was randomly allocated to mothers after eligibility of the child for 
study had been ascertained. Axillary temperature was measured by electronic 
thermometer (model HP5316, Philips, Groningen, Netherlands) immediately following the 
mother's judgement. In the second group, fever was assessed during repeated episodes of 
illness by thermometer only. Fever was defined as axillary temperature >37.50°C. 
Duplicate measurements in 311 children showed high correlation between thermometer 
recordings (r=0.90). 
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100 
A: direct questioning 
B: questioning after palpation 
Community survey 
35.0 36.0 37.0 38.0 39.0 
Axillary temperature, °C 
40.0 41.0 
F I G U R E . 
T O P : Cumulative frequency distribution of temperature in children randomly selected in a community survey 
(two virtually overlapping lines at left) and sick children attending Kibwezi hospital (two overlapping lines at 
right). Fever was assessed by mothers who were questioned after palpating their child's forehead (thick lines) 
or by direct asking (thin lines). 
B O T T O M : Probability of fever, P, in relation to body temperature in the study groups above (top two lines: 
children studied at Kibwezi Hospital; bottom two lines: children studied in the community survey). When axillary 
temperatures were >37.5 °C, P was interpreted as an estimator of sensitivity, whereas below this range, (1 -
P) was interpreted as an estimator of specificity (see text for further explanation). Lines are only indicated 
within the 95% temperature range for each group. When measured across all temperatures <37.5°C, 
specificity in sick children was higher when fever was assessed by questioning after palpation than by direct 
questioning (p=0.05; see text). 
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Specificity of fever detection in the community survey was similar when reported after 
palpation or directly (table). There were few fever cases in this population. Sensitivity 
appeared higher after palpation but the observed difference may have been due to chance 
(difference 26.0%; p=0.16; exact test). In sick children, sensitivity was >90% and almost 
identical when assessed after palpation or by direct questioning; specificity was higher 
when fever was assessed after palpation than by direct questioning (difference 16.2%; 
95% confidence interval: -1.1% to 33.5%; p=0.05). 
Sensitivity estimates appear higher, and specificity estimates much lower, in sick children 
than in those in the community survey (table). This may indicate that mothers are more 
likely to report fever in sick children, regardless of a child's body temperature, but may 
also be due to different temperature distributions between the two populations (figure, 
top). The first hypothesis was further explored by logistic regression techniques, which 
were used to estimate the probability of fever being reported, P, as a function of body 
temperature (figure, bottom). When axillary temperatures were >37.5°C, /'was interpreted 
as an estimator of sensitivity, whereas below this range, (1 - P) was interpreted as an 
estimator of specificity. The results confirm that specificity was much lower when fever 
was assessed in sick children than in their counterparts in the community survey, and that 
this was independent of body temperature. Although there were few children with fever, 
extrapolation from the graph shows that - at least within body temperature ranges 
indicating mild fever - sensitivity is much higher in the former group, even when 
differences due to body temperature were taken into account. The results also confirm 
that in sick children, questioning after palpation provided similar sensitivity but higher 
specificity than direct questioning. 
Although these and other reports (Einterz and Bates 1998, Verhoef et al. 1998) show that 
African mothers are remarkably good at detecting fever, their reports of fever are not 
reliable when assessed in populations with low prevalence of fever. Fever is more 
prevalent in sick children brought to health facilities, so that a mother's report of fever is 
more reliable. Our results show, however, that mothers are much more likely to report 
fever in sick children, regardless of the actual body temperature of their child. This leads to 
improved sensitivity, but much lower specificity of detecting fever as compared to children 
who are not perceived to be sick. Teaching mothers to palpate their child's forehead 
cannot improve the sensitivity of detecting fever in sick children, but is likely to increase 
specificity, thus avoiding unnecessary treatment for febrile diseases. 
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Anti-malarial drug use among preschool 
children in an area of seasonal malaria 
transmission in Kenya 
Hans Verhoef, Elsa Hodgins, Teunis A Eggelte, Jane Y Carter, Organes 
Lema, Clive E West, Frans Kok 
SUMMARY 
The aims of this study were to estimate the proportion of asymptomatic Kenyan 
preschool children using antimalarial drugs; to identify factors associated with 
chloroquine use; and to assess the validity of frequency of febrile episodes and drug use 
reported by mothers or carers. Of 318 children studied, 38% (95% CI: 30-47%) tested 
positive for chloroquine or sulfadoxine. Of chloroquine-positive children, 15% had 
concentrations exceeding the estimated minimum therapeutically effective values. 
Among those testing negative for sulfadoxine, chloroquine-positive children were more 
frequently parasitemic (odds ratio = 2.6, 95% CI: 1.3-5.2), and had lower mean 
hemoglobin concentrations (6.1 g/L, 95% CI: 2.1-10.1), than chloroquine-negative 
children. Mothers overreported the frequency of malaria or fever episodes as usually 
defined in medical studies, and underreported antimalarial drug use. We conclude that 
antimalarials are frequently given for treatment of malaria or malaria-associated illness, 
rather than prophylactically or for symptoms unrelated to malaria. Questionnaire surveys 
cannot replace biochemical markers to obtain information on antimalarial drug use. 
Am J Trop Med Hyg 1999; 61:770-75. 
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In developing countries, drugs are often used without prescription. They may be 
purchased from local shops, markets or street vendors, obtained by sharing with other 
users or used when left over from previous treatments. Home treatment or prophylaxis of 
illnesses with anti-malarials is more often the rule than the exception in many endemic 
countries (Foster 1991a,b, 1995). Little is known about the administration of anti-malarial 
drugs to children by their parents. Whilst early diagnosis and prompt treatment is one of 
the elements of the global strategy for malaria control (WHO 1993), overuse may lead 
unnecessarily to the intensification and spread of drug-resistance and to increased risk of 
adverse effects associated with these drugs. 
Studies in eastern Africa up to now exclusively used interviews to obtain information on 
antimalarial use. In one such study in Western Kenya, where malaria is holoendemic, 
Ruebush et al. (1995) estimated that antimalarial drugs, mostly chloroquine, were used for 
67% of incident febrile episodes self-diagnosed as malaria, and for 28% of those 
diagnosed otherwise. On the Kenyan coast, where malaria endemicity is much lower, Snow 
et al. (1992) conducted a community survey to study treatment and prevention of 
childhood malaria by mothers. When asked what they would do in a hypothetical situation 
where their child had fever, 72% of mothers reported that they would purchase 
antimalarials at a shops for self-treatment, while 67% of these claimed they would buy 
chloroquine-based drugs. In the same area, Mwenesi et al. (1995) found that of 118 
mothers who had diagnosed their child as having malaria currently or in the two weeks 
prior to questioning, 26% had given anti-malarials, 27% had given antipyretics or other 
medications, 23% said they had taken the child to a health facility, 6% had given a home 
remedy, and 18% had not given any treatment or had done nothing about treatment. 
Little is known about the validity of questionnaires surveys in studying reported self-
medication with antimalarial drugs. We studied antimalarial drug use by blood test and by 
questionnaire among asymptomatic preschool children living in an area of seasonal 
transmission in Kenya. The aims of the study were to estimate the proportion of children 
testing positive for antimalarial drugs in their blood, to identify factors associated with 
chloroquine use, and to assess the validity of the frequency of febrile episodes and drug 
use reported by mothers or carers. The study was conducted as part of a larger cross-
sectional study on the prevalence and risk factors for anemia. 
Subjects and methods 
Study area 
Data were collected in the first annual rainy season (April to June) of 1997 in three 
administrative areas (Kathekani, Muthingiini and Mangelete) in Mtito Andei Division, 
Makueni District, Kenya. The area is located halfway along the road between Nairobi and 
Mombasa. Taken together, the study area comprises approximately 720 km2 with more 
than 40,000 inhabitants living in scattered homesteads. No entomological or 
epidemiological data on malaria had been collected previously in the area. The study was 
conducted before the harvest, and after a wet season (November-December 1996) that 
failed to produce rain. As a result, many people were probably short of cash. Muthingiini 
and Mangelete each have a dispensary staffed with a nurse, and there are a government 
clinic and a pharmacy in Mtito Andei town, located within 30 km of each homestead in the 
study population. The nearest health center with microscopic facilities for malaria diagnosis 
is in Kibwezi town, located about 40 km west of Mtito Andei. Malarial infections reported at 
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this facility are exclusively due to Plasmodium falciparum. Through a project implemented 
in the study area by the African Medical and Research Foundation over the last few 
decades, hundreds of community health workers and traditional birth attendants have 
been trained in basic health issues. Most villages have one or more of these auxiliary 
health workers, but they have not been trained in malaria diagnosis and treatment, and 
they are not usually involved in dispensing antimalarial drugs. Many communities in the 
study area have shops or kiosks selling drugs, including chloroquine and analgesics. 
Amodiaquine and combination drugs containing a sulfa compound and pyrimethamine are 
only available in a few larger communities. No mosquito net distribution program is in 
place, but nets are for sale in Mtito Andei. 
Sampling procedures 
A cluster sampling procedure (Henderson and Sundaresan 1982), incorporating 
modifications proposed by Bennett et al. (1991) and Brogan et al. (1994), was used to 
draw a sample representative of all asymptomatic children living in the study area and 
born between 15 April 1994 and 15 February 1997. The sample was drawn in two 
successive stages (figure 1). At the first stage, a systematic sample of 45 communities 
was drawn from a north to south ordered list of all 79 communities ('clusters') in the study 
area, with probability proportional to size, and excluding urban centers (Mtito Andei town). 
At the second sampling stage, 12 households were randomly drawn with replacement from 
each of the selected communities. For each of these households, the resident children 
were listed and their dates of birth were recorded from the child health card. All resident 
children thus identified who were asymptomatic (without illness reported by the mother) 
and within the desired age range were selected for the study (n=302). Some children 
migrated with only part of their household between the time of the census and the time of 
examination. These households were considered not to have eligible children. Where 
possible, children who migrated with all of their household, were still missing after 
repeated visits, or had parents who refused consent, were replaced by children from 
randomly selected households within the same community. 
Field procedures 
An inventory of over-the-counter antimalarial drugs and analgesics in the area was made 
by visiting the only pharmacy in Kibwezi town plus five shops that were well-stocked with 
these drugs. Visits to other shops did not yield additional brands or types of drugs. All 
brands and types of antimalarial drugs and analgesics in stock were purchased and made 
into a visual display of drug packaging and contents for use during interviews. Mothers or 
their primary carers were interviewed separately by lay native speakers in their own 
language. They were questioned using structured interviews with closed-ended questions 
without additional prompts. When asked to identify drugs, mothers were presented with 
the visual display. The distance between the child's residence and the nearest health 
facility was estimated by asking respondents for the time that would be needed to take the 
child to the nearest health care facility, using means of transport that would normally be 
used if the child was sick. Responses were recorded on precoded questionnaire forms, 
which were designed in English, translated into local language, translated back into English 
by a different person and compared with the original. All questions contained a precoded 
category 'do not know, or no answer'. Questionnaires were field-tested by four 
interviewers on a limited number of mothers attending Kibwezi Rural Health Centre 
outpatient department, and modified to ensure that respondents understood the 
questions. Blood samples were taken from children by finger or heel puncture and 
collected on filter paper, dried out of direct sunlight and kept at ambient temperature until 
laboratory analysis. Additional blood samples were taken for microscopic examination for 
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malaria parasites and for immediate determination in the field of hemoglobin concentration 
using a HemoCue field meter (HemoCue Inc., Mission Viejo CA, USA). Prior consent for the 
study was obtained from the communities and the parents involved. Children were treated 
as deemed necessary upon completion of the survey; because such treatment was carried 
out after all observations were made, this had no influence on the data collected. The 
study was approved by the African Medical and Research Foundation and the Kenya 
Medical Research Institute whose ethical standards were followed. 
Laboratory procedures 
The enzyme-linked immunosorbent assay to detect whole blood chloroquine has been 
described by Eggelte (1990). The monoclonal antibodies used (F149) show no (< 0.1%), 
or hardly any cross-reactivity with amodiaquine. The limits of detection for chloroquine and 
sulfadoxine were 10 ug/L and 10 ug/L, respectively. 
Blood slides were stained using Field's stain, and thick films were examined by experienced 
microscopists and crosschecked independently. At least 100 high power fields were 
examined before the slide was considered negative. 
Response and missing values 
A total of 302 children were selected for study of whom 16 were double-selected at the 
second sampling stage (figure 1). Observations for these 16 children were weighted 
twice. Thus 318 cases were included in the study of which 35 did not participate or fully 
participate for the following reasons: refused consent (26); not home or temporarily 
absent (7); hospitalized for burns (2). Of these 35 children, 14 were replaced by random 
selection, which brought the total number included in the analysis to 297. In the case of 
non-participating children who were not replaced, weighting was used to maintain the 
validity of assuming of an equal probability sample. Thus, observations on those who 
participated within the same cluster were inflated by weighting with a multiplication factor 
calculated as the number of selected children in that cluster divided by the number of 
participating children (Bennett et al. 1991, Brogan et al. 1994). This brought the number 
back to 318 children; sample sizes reported below this value are due to missing values. 
Statistical analysis 
Data were entered, cleaned and managed on a personal computer using SPSS (v7.5 for 
Windows; SPSS Inc., Chicago IL, USA). Computations were performed in SUDAAN, stand-
alone v7.5.2a for Windows (Research Triangle Institute, Research Triangle Park NC, USA), 
assuming two-staged cluster sampling with replacement at the first sampling stage. 
Because the variance estimates under this assumption do not take account that clusters 
were sampled from a finite population, the standard error values and confidence intervals 
reported here are overestimates, and the statistical tests are less sensitive in detecting an 
existing effect. 
Results 
Interviews 
Of the various brands and types of antimalarial drugs available in the stores in Kibwezi, 
seven contained chloroquine, three contained amodiaquine and five contained 
combinations of sulfa compounds with pyrimethamine. The brands with sulfa drugs 
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79 communities 
1st sampling stage: 
systematic sample without replacement 
45 communities selected 
2nd sampling stage: 
random sampling with replacement 
12 households selected per community 
318 cases: 302 eligible children of whom 16 double-selected 
35 did not participate or 
did not fully participate 
283 cases fully 
participated 
I 
random 
, selection 
14 replaced 21 not replaced 
297 cases 
weighting to correct for non-participation ^ 
318 cases in analysis 
FIGURE 1 . Framework for selection and analysis 
contained sulfadoxine, except for two brands that contained other sulfa compounds 
(Medikelfin contains 3-sulphanilamido-6-methoxy-pyridazine, whilst Metakelfin contains 2-
sulphanilamido-3-methoxy-pyrazine). Sulfadoxine was exclusively available in combination 
with pyrimethamine. Out of 317 respondents, 58 (18%) reported that the child had 
received antimalarials in the two weeks prior to the interview (table 1). No child was 
reported having received a sulfa compound-pyrimethamine drug, and only 2 were reported 
having received amodiaquine. When asked to indicate what they considered to be the best 
medicine for malaria, 186 (54%) out of 314 respondents named an analgesic, 97 (31%) a 
drug containing chloroquine, 2 (1%) a sulfa compound-pyrimethamine drug and 29 (9%) 
did not know, or named other drugs. 
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In the local language, Kikamba, there are words or expressions to distinguish malaria or 
malaria-like illnesses Cndetema') from the physical phenomenon of an elevated body 
temperature. When asked if the child had suffered from 'ndetema' in the two weeks prior 
to the interview, 190 (60%) out of 316 respondents answered positively (table 2). Of the 
same respondents, 226 (71%) answered positively when asked if the child had suffered 
from an elevated body temperature, and 178 (56%) reported that the child had suffered 
both from 'ndetema' and an elevated body temperature. 
When asked if the respondent had discussed the child's health with anyone, and if so, with 
whom, 213 out of 316 respondents reported not to have discussed it with anyone. Out of 
103 respondents who had consulted someone, 10 had seen a relative, 10 a community 
health worker, 16 a traditional birth attendant, 40 a government health facility, 7 a non-
governmental health facility, 30 a private health facility and 2 had used other sources 
(respondents could name more than one source). 
Antimalarial blood tests and parasitemia 
The results of the blood tests for chloroquine and sulfadoxine are summarized in table 3. 
Out of 314 children, 37% tested positive for the presence in blood of chloroquine (95% 
confidence interval, CI: 29-46%), 4% tested positive for sulfadoxine (95%CI: 2-7%) and 
38% tested positive for either chloroquine or sulfadoxine (95%CI: 30-47%). Sulfadoxine 
was reported to have been taken by 11% children whose blood tested positive for 
antimalarial drugs, and most of these had taken sulfadoxine in combination with 
chloroquine. Figure 2 shows the relative distribution of children in relation to estimated 
chloroquine concentrations. The median blood concentration of children testing positive 
was 56 ug/L for chloroquine and 9.9 mg/L for sulfadoxine. To examine the relationships of 
a positive chloroquine test with malaria or hemoglobin concentration, we excluded children 
testing positive for sulfadoxine. In the remaining children (table 4), the odds ratio of 
malaria for testing positive to testing negative for chloroquine was 2.6 (95%CI: 1.3-5.2). 
In the same group, children testing positive for chloroquine had lower mean hemoglobin 
concentrations than children testing negative for chloroquine (98.3 ± 6.5 (mean ± S.D.) 
compared with 104.4 ± 3.8 g/L; difference 6.1 g/L , 95%CI: 2.1-10.1). Whether or not 
children tested positive for chloroquine was not statistically significantly influenced by sex, 
the presence or absence of the mother, father or grandmother in the household, or 
whether or not the mother had activities to support her income. Children with a positive 
blood test for chloroquine were not found to live at a greater distance from the nearest 
health facility than children with a negative blood test (Chi-square=7.01, df=5, p=0.24; 
figure 3). 
Discussion 
To our knowledge, this is the first report to assess antimalarial drug use in eastern Africa 
by blood tests. We found 37% of children to be positive for chloroquine, 4% for 
sulfadoxine and 38% for either of these drugs. When those testing positive for sulfadoxine 
were excluded from analysis, children who tested positive for chloroquine had more 
frequently malaria, and lower mean hemoglobin concentrations, than children testing 
negative for chloroquine. Although chloroquine resistance is most likely to occur in the 
area, as in other parts of eastern Africa, this drug remains the most widely used 
antimalarial as assessed by blood test and as reported by mothers or carers. 
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TABLE 1 . Frequency distribution of antimalarial or analgesic drugs use as reported in the 
previous 14 days and antimalarial drug use detected by ELISA 
Antimalarials 
taken 
Amodiaquine 
Chloroquine 
None 
Total 
S+P 
0 
0 
3 
3 
Drug 
Amodiaquine 
0 
0 
0 
0 
use tests by ELISA 
Chloroquine, 
S+P 
0 
3 
7 
10 
Chloroq uine 
0 
37 
71 
108 
Negative 
2 
16 
178 
196 
Total 
2 
56 
259 
317 
S+P: combined sulfa drug plus pyrimethamine; no child was reported to have taken S+P in the last two weeks. 
TABLE 2. Frequency distribution of children with reported fever or malaria in the previous 
two weeks 
Child reported to have suffered from Child reported to have suffered from a raised 
'ndetema' in the last 2 weeks body temperature in the last 2 weeks 
Yes No Total 
Yes 177 13 190 
No 49 78 127 
Total 226 91 317 
TABLE 3. Frequency distribution of children with positive blood tests for chloroquine or 
sulfadoxine 
Chloroquine in blood Sulfadoxine in blood 
Positive Negative Total 
Positive 10 108 118 
Negative 3 197 200 
Total 13 305 318 
TABLE 4. Frequency distribution of children with malaria or testing positive for chloroquine 
among children testing negative for sulfadoxine 
Malarial parasitemia Chloroquine in blood 
Positive Negative Total 
Positive 28 23 51 
Negative 80 170 250 
Total 108 193 301 
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Chloroquine concentration, ug/L 
FIGURE 2. Relative frequency distribution of blood samples in relation to 
chloroquine concentrations 
0.40 
<0.5 0.5-0.9 1-1.9 2-2.9 
Distance, hr 
3-3.9 >3.9 
I Chloroquine-positive • Chloroquine-negative 
FIGURE 3. Relative frequency distribution of children in relation to the travelling 
time between their residence and the nearest health facility, as 
reported by their mothers or caretakers 
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The study concerned a representative sample of asymptomatic children born between 15 
April 1994 and 15 February 1997 (corresponding to age 2-37 months) and resident in the 
study area. Non-response was 11%, and increased after replacement by random selection 
of 14 children to 7%. Blood test results were missing for 4 children (1%). We therefore 
judge the conclusions to be valid for the study population. 
Our estimated prevalence of chloroquine use corresponds to a value of 35% for positive 
chloroquine tests by ELISA in Gambian children aged between 6 months and 5 years 
(Alonso et al. 1993; non-intervention group). Surveys in rural Zimbabwe (Stein et al. 1988) 
showed that 8% of urine samples tested positive for 4-aminoquinolines (a group of 
antimalarial compounds including chloroquine and amodiaquine), whilst 13% of urine 
samples were positive in Papua New Guinea (Cattani et al. 1986). The Dill-Glazko test that 
was used in these last two studies has a low sensitivity (Verdier et al. 1985), suggesting 
that the prevalence values are underestimates. Moreover, Stein et al. (1988) and Cattani 
et al. (1986) studied populations of all ages, whereas we studied children, in whom 
antimalarial drug use may be higher because they may be considered at greater risk of 
malaria or death from malaria. 
Why are children given antimalarials? Children testing positive for chloroquine were more 
frequently parasitemic, and had lower mean hemoglobin concentrations, than children who 
had negative chloroquine tests. This suggests that antimalarials are frequently given for 
treatment of malaria or malaria-associated illness, rather than prophylactically or for 
symptoms unrelated to malaria. Further studies would be needed to validate this 
hypothesis. 
To what extent are the blood chloroquine concentrations found in our study therapeutically 
meaningful? In a study among asymptomatic Tanzanian schoolchildren, Hellgren et al. 
1989) found that chloroquine administration at a WHO-recommended dosage (10, 10 and 
5 mg per kg body weight on days 0, 1 and 2, respectively) resulted in peak whole blood 
concentrations on days 2 and 3 with median values in the order of 500 ug/L. On day 7, 
median concentrations had receded to around 150-200 ug/L (Hellgren et al. 1989). The 
latter range corresponds to the therapeutically effective chloroquine concentration, which 
is in the order of 30 ug/L plasma against drug-sensitive falciparum malaria (Black et al. 
1986), or approximately 150 ug/L whole blood (Eggelte, personal communication). The 
whole blood chloroquine concentrations in our study ranged between 0 and 466 ug/L, with 
a median value of 56 ug/L. Only 15% of children who tested positive for chloroquine had 
concentrations exceeding 150 ug/L. These findings do not take into account when 
chloroquine was taken. They should not be interpreted as providing evidence to support 
the common supposition by field workers that self-treatment using antimalarial drugs often 
occurs at subtherapeutic dosages. 
Children whose blood tested positive for chloroquine were not found to be living at a 
greater distance from the nearest health facility than children who tested negative. 
Physical access to health care facilities did not appear to be an important constraint for 
chloroquine use, although it may act as a contributory factor for self-treatment and as a 
barrier for seeking health care. 
Additional motivation for self-medication with antimalarial drugs, and their implications for 
public health and clinical practice, has been discussed by many workers and are well-
summarized by Foster (1991a,b, 1995). The remainder of this paper will focus on the 
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usefulness of proxy reporting for detecting malaria episodes in children in our study and 
the implications of our findings for future research studies. 
Most studies on antimalarial drug use have relied on questionnaire surveys (Kaseje et al. 
1987, Mburu et al. 1987, Breman and Campbell 1988, Stein et al. 1988, Snow et al. 1992, 
Mnyika et al. 1995, Mwenesi et al. 1995, Ruebush et al. 1995, Ahorlu et al. 1997). One 
concern about the use of interview surveys to estimate morbidity and drug use is their 
amenability to bias (Kroeger 1985, Hardon et al. 1991). How well does the occurrence of 
illness episodes and drug use reported in questionnaire surveys correspond to the 
occurrence of such episodes measured using biomedical criteria? In our study, 60% and 
71% children were said to have suffered from 'ndetema' and elevated body temperature, 
respectively, in the two weeks prior to the interview. A similarly high 14-day cumulative 
malaria incidence (73%) was noted in children under four years of age in a questionnaire 
survey in western Kenya (Kaseje et al. 1987). Overreporting of fever is inevitable if body 
temperature is assessed without a thermometer, particularly at community level (Verhoef 
et al. 1998). In children aged below five years attending an outpatient service in 
Cameroon, mothers or carers correctly reported fever in 46% of cases, and the absence of 
fever in 92% of cases (fever defined as axillary body temperature >37.5 °C) (Einterz and 
Bates 1997). When these predictive values are applied to our study, the two-week 
cumulative incidence of fever drops from 72% to 35% (calculations not shown). 
This adjusted value is still higher than would be expected on the basis of previously 
conducted prospective studies. In Mali, the 9-day cumulative incidence of fever (oral 
temperature >38°C) in children aged 1-3 years who were examined daily was 14.2% in 
the wet season (Bouvier et al. 1997), which, extrapolated to a 14-day period, would have 
been 22.1%. This estimate is lower than ours, despite being measured during the wet 
season in an area where malaria was more endemic. Our reported values therefore appear 
overestimates of the cumulative incidence of fever measured by thermometer. 
One explanation for this bias is a desire for drugs by the respondents participating in the 
study. This may have caused them to exaggerate the frequency of illness and downplay 
prior use of drugs. The desire for drugs was obvious on various occasions during the 
survey and became even more apparent in mothers who did not receive drugs upon 
completion of the survey. Many remained dissatisfied even when explained that their 
child's condition did not require drug treatment. Antimalarial drug use, which was reported 
in 18% of children in the past two weeks, may have been further underestimated by the 
long recall period used in our study. For inconspicuous events, such as the use of drugs, 
Kroeger (1985) recommended to reduce the length of the recall time to several days. 
Schulpen and Swinkels (1980), in a study area close to ours, found 60% underreporting of 
self-medication when a recall period of two weeks was used instead of one day. 
To obtain valid information on antimalarial drug use, we recommend that questionnaires 
should be used in addition to biochemical markers, but not to replace them. Blood tests 
measure the prevalence of drug use, whereas interviews measure a cumulative incidence. 
Asking for history of antimalarial drug use as part of the medical examination has limited 
value. Biochemical markers, however, have the disadvantage of not being able to quantify 
the incidence or quantity of drug use, or to describe the social or cultural context in which 
people use drugs. 
The relationship between fever and the level of parasitemia is at the core of recent 
attempts to find suitable case definitions of malaria attacks for use in epidemiological 
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studies (Armstrong-Schellenberg et al. 1994, Smith et al. 1994, Greenwood 1997). Both 
antimalarials and antipyretics may influence this relationship. The finding that a large 
proportion of children may have antimalarials in their blood requires further research to 
assess if and how the presence of these drugs can be taken into account in case 
definitions. 
We conclude that antimalarials are frequently given for treatment of malaria or malaria-
associated illness, rather than prophylactically or for symptoms unrelated to malaria. 
Questionnaire surveys overestimate the occurrence of febrile episodes. They should be 
used in addition to biochemical markers, but not to replace them. 
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The path to be travelled towards better public health programmes is illuminated by well-
conducted, internally valid epidemiological studies. Although laboratory studies or 
observations made in clinical or public health practice may serve to predict health benefits 
or risks of interventions, such effects must ultimately be estimated in the target 
population. The findings presented in this thesis shed light on the benefits and risks of 
measures to alleviate anaemia in children aged 2-36 mo in an area of seasonal malaria. 
In a strict sense, however, health policies are always formulated for populations that have 
never been studied, or that have been inadequately studied. For example, the findings 
presented in this thesis may assist in formulating policies for children who are older, more 
exposed to malaria or other infections, or who may differ in other respects from the 
children studied. Even future generations of children growing up in the area studied may 
experience different levels of exposure to malaria (for example, during droughts or 
abundant rainfall), despite having the same distribution of characteristics such as age, sex, 
and so on. In addition, epidemiological studies are often limited by their tendency to 
consider study populations as homogenous. Later experience may show that there were 
sub-groups in the study population for which the conclusions were considered too broadly 
or do not apply. 
Thus, the ability to generalise the findings to other populations ultimately and necessarily 
depends on our understanding of the underlying biological mechanisms. This is particularly 
the case when considering diseases with such demonstrated variability in occurrence and 
effects as malaria. Evidence from internally valid studies forms the point of departure from 
which generalisations can be made. Understanding of biological mechanisms is provided 
not only by epidemiological field studies, but also by evidence accumulated from clinical 
experience and laboratory studies, both in humans and animals. This chapter aims to 
assist policy-makers in public health in the interpretation and extrapolation of the main 
findings, and to assist researchers in identifying and prioritising areas of future work. This 
discussion will be presented under three headings (lessons learnt and conclusions; 
implications for public health; and future research), and in the light of the four objectives 
presented in the introduction of this thesis: 
1. to measure the efficacy in improving haemoglobin concentrations of intermittent iron 
supplementation and intermittent administration of sulfadoxine-pyrimethamine (SP); 
2. to develop and evaluate survey methods for rapid assessment at community level of 
the burden anaemia and its risk factors; 
3. to contribute to improved methods for diagnosis of anaemia, iron deficiency, and 
malaria; 
4. to evaluate the role of impaired erythropoiesis in the pathogenesis of malarial 
anaemia. 
Administration of iron and sulfadoxine-pyrimethamine (SP) 
Lessons learnt and conclusions 
When judged by the effect on haemoglobin concentration, intermittent administration of 
SP resulted in marginal improvements when given alone, and in no gains when given in 
addition to iron supplementation (chapter 5). Iron supplementation markedly improved 
haemoglobin concentrations, and substantially reduced the prevalence of both iron 
deficiency and anaemia. There was no evidence that iron supplementation resulted in a 
substantially increased risk of malaria at the regimens and doses used. These findings 
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indicate that, when using the regimen employed, the benefits of iron supplementation may 
outweigh the associated risk of adverse effects caused by malaria. 
Implications for public health 
The findings from this study give little support for intermittent administration of SP. The 
observed protection against malarial attacks, however, corroborates findings from a recent 
study in Tanzania showing that SP, when given intermittently to infants alongside routine 
vaccinations against childhood diseases, may substantially reduce the frequencies of 
occurrence of symptomatic malaria and severe anaemia (Schellenberg et al. 2001). 
Although this could be further developed as a tool for malaria control, the switch of African 
countries to SP for first-line treatment of uncomplicated malaria justifies concerns that 
parasite resistance against SP may rapidly develop to levels where this intervention is no 
longer efficacious. 
The effectiveness of iron supplementation (i.e. how well the benefits can be achieved 
under operational conditions of public programmes) was not considered in this study, and 
neither was its cost-effectiveness. Both are key elements to judge the feasibility of 
intervention programmes (Yip 1997). 
Current guidelines for mass programmes recommend daily iron supplementation at 
preventive doses for anaemia (2 mg iron d"1 kg body weight"1) for all infants and young 
children in areas where anaemia is common (Stoltzfus and Dreyfuss 1998, 
UNICEF/UNU/WHO/MI1999). The rationale for administering iron at less frequent intervals 
but at therapeutic doses (twice weekly at 3 mg iron d"1 kg body weight"1) was 
controversial. When designing the trial, experience accumulated from many countries in 
pregnant women and preschool children had shown that iron supplementation 
programmes were not effective in improving iron status (ACC/SCN 1991). Reasons cited 
for this poor effectiveness included, among others, the failure of health care systems to 
deliver an adequate supply of tablets at the community level, and poor compliance by 
women for fear of adverse effects of iron (ACC/SCN 1991, Galloway and McGuire 1994). 
The occurrence and severity of side effects were generally accepted as major determinants 
of poor compliance in developed countries, and were known to be related to dose of the 
supplement (Beaton and McCabe 1999). 
Intermittent iron supplementation appeared as a possible alternative strategy that might 
improve the effectiveness of programmes. This hope was founded in controversial ideas 
that weekly supplementation could reduce side effects and increase compliance when 
compared to daily dosing while maintaining net iron absorption at similar or even higher 
levels (Stephenson 1995, Beaton and McCabe 1999). When designing the trial described in 
this thesis, it was considered that the published reports showed marginally but consistently 
higher efficacy when iron was supplemented daily instead of weekly. It was also judged 
that possible effects of iron supplementation on malaria were likely to depend on the dose 
and regimen in which iron was administered. Thus, a regimen using twice-weekly iron 
supplementation at therapeutic doses was a compromise to maximise the beneficial effects 
of iron supplementation whilst minimising possible adverse risks of malaria. 
In a recent analysis of the empirical evidence from 22 completed trials in pregnant women, 
adolescents and school children, and preschool children (Beaton and McCabe 1999), it was 
concluded that weekly supplementation is likely to be less effective than daily 
administration except in situations where supervision is feasible with weekly regimens and 
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not with daily supplementation. It was also concluded that weekly supplementation may be 
particularly disadvantageous in situations where the prevalence of anaemia is very high. 
Future research 
In the last decade, organisations such as the World Health Organization and UN Children's 
Fund have endorsed iron supplementation in preschool children (Stoltzfus and Dreyfuss 
1998, UNICEF/WHO 1994, UNICEF/UNU/WHO/MI 1999), whilst 22 countries have adopted 
public health policies calling for iron supplementation of preschool children 
(UNICEF/UNU/WHO/MI 1999). This growing commitment occurs despite the lack of 
documented instances of large-scale voluntary iron supplementation programmes 
significantly reducing levels of iron deficiency anaemia in a population 
(UNICEF/UNU/WHO/MI 1999). As a matter of urgency, ways should be explored by which 
iron can be effectively delivered to populations in need. 
Such assessments should include methods outside the conventional health care system. 
For example, supplements might be distributed at subsidised prices through commercial 
networks, with education being provided by health workers, shopkeepers and community 
volunteers. Compliance might be enhanced by screening for anaemia using the colour 
scale (chapter 6) and selective supplementation. Such an approach may be feasible 
judging the encouraging results achieved by social marketing programmes of insecticide-
treated mosquito nets and net treatment for malaria control in rural Tanzania 
(Schellenberg et al. 1999), and by the success of a programme to improve home 
treatment of childhood fevers through training of shopkeepers in rural Kenya (Marsh et al. 
1999). 
Beaton and McCabe (1999) recommended that a regimen of daily iron supplementation 
should continue to be used rather than weekly supplementation (see above). A further 
placebo-controlled trial might be considered to investigate whether the benefits of a daily 
regimen outweigh the risks of all-cause mortality in children with low levels of protective 
immunity in areas of seasonal malaria. This requires a large sample size, however, and the 
number of sites where such studies can be carried out is limited in Africa. 
The results do not preclude an increased risk of malaria or other infections from iron 
supplementation in some individuals (for example, children with HIV/AIDS - see Delanghe 
et al. 1998, De Monye et al. 1999, Savarino et al. 1999), or when iron is given at higher 
frequency or for longer periods of time. Priorities for additional research concern the safety 
of iron supplementation in low-birth-weight infants, and during refeeding of severely 
wasted children. In these cases, randomised controlled trials seem justified. 
Rapid community assessment of the burden of anaemia and its risk factors 
Lessons learnt and conclusions 
Cluster sample surveys are ideally suited for rapid assessment of the burden of anaemia 
and its risk factors. The methodology can be used in national surveys, with stratification as 
required to obtain precise estimates for individual provinces or districts (Bennett et al. 
1991). Although these surveys were originally designed to provide descriptive statistics, 
chapter 2 provides methods to expand their use to assess associations between exposures 
and health outcomes at a single point in time. 
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Implications for public health 
Both anaemia and malaria were geographically clustered between communities in the 
study area (chapter 2). When such clustering is ignored in design and analysis, surveys 
may produce biased estimates. An important consideration concerns the choice of 
indicators and measurement tools. Anaemia, in young children defined as haemoglobin 
concentration <110 g/L, is an indicator of particular interest because, when due to iron 
deficiency, it is strongly associated with impaired body functions (chapter 1). Less is known 
about the functional importance of iron depletion without anaemia, or of mild or moderate 
anaemia due to other causes, including malaria. In areas with a great burden of anaemia, 
lower cut-off values for haemoglobin concentration (for example, < 90 g/L) may be better 
to identify population groups in need of intervention and to monitor progress in anaemia 
control (Stoltzfus 1997). 
One drawback of using a cut-off point for haemoglobin concentrations is the tendency to 
regard individuals without anaemia as healthy, or insufficiently affected to warrant 
intervention, despite indications that iron depletion without anaemia may already impair 
mental development of children (chapter 1). One way to bypass this pitfall is to present 
the entire distribution of haemoglobin concentration against a reference distribution 
obtained from children free from iron deficiency (Yip et al. 1996). 
Haemoglobin concentrations or the presence of anaemia are ideally determined by 
photometer or haematocrit centrifuges. Particularly when several survey teams are 
deployed, this may be too expensive or - if electricity is required - not feasible. In those 
cases, the use of haemoglobin colour scales may give valid estimates of the prevalence of 
anaemia at virtually no material cost (chapter 6). Their use requires training of survey 
personnel to standardise measurements. Bias may occur when this device is used to 
estimate the prevalence of anaemia in (sub)populations with a low burden of anaemia (for 
example, in adult men), or when low scores are used to determine the prevalence of more 
severe degrees of anaemia (for example, using cut-off values for haemoglobin 
concentration <70 g/L or <90 g/L). 
The use of dipstick tests to diagnose malaria may save time and money, and is less 
cumbersome than microscopy (WHO 2000). Thus, one efficient strategy in surveys might 
be to screen for infection by dipstick test. A negative test result is highly predictive of the 
absence of infection (chapter 5), and indicates no need for further follow-up or microscopic 
examination. A positive test result indicates current or recent infection. Patients with such 
a test result may be presumptively treated; microscopic examination of the blood sample 
taken may be done at a later stage. 
Future research 
The degree of clustering, as expressed in the design factor or the intracluster correlation 
coefficient, may be of research interest because it may indicate genetic predisposition to 
certain diseases within families or within communities with a high degree of consanguinity, 
or to common environmental or behavioural factors leading to an increased prevalence of 
the health outcome within certain households or communities. The geographical clustering 
observed for malaria corroborates our understanding that the probability of infection in 
areas of seasonal transmission heavily depends on the availability of breeding sites for 
malaria mosquitoes. 
The use of haemoglobin concentration as an outcome variable allows for multivariate linear 
regression modelling to identify independent risk factors for anaemia, and to examine 
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biological interaction (non-additivity of effect estimates on an arithmetic scale) between 
factors. Logistic regression could be used to model the In-odds of anaemia, but such an 
approach has the disadvantage that exponentiation to calculate the odds of anaemia 
results in a multiplicative model. Thus observation of non-additivity in a In-odds model of 
anaemia can be easily misinterpreted as indicating the absence of biological interaction, 
whereas in fact it implies exactly the opposite, namely super-additivity and biological 
interaction. Because of these considerations, the assessment of biological interaction is 
more complicated in logistic regression models. For a more thorough discussion, the 
reader is referred to a review of this topic by Greenland and Rothman (1998). 
Improved diagnosis of anaemia, iron deficiency and malaria 
Lessons learnt and conclusions 
A newly introduced colour scale to estimate haemoglobin concentrations is inexpensive 
and does not require chemical reagents or electric power. Its diagnostic performance is 
satisfactory and for many purposes superior to all other methods for detection and 
treatment of anaemia at primary care level (chapter 6). Low scores of the scale may give 
unsatisfactory results when used to detect patients with severe anaemia and to decide on 
their management. 
Accurate detection of iron deficiency in individuals with malaria remains elusive. Absence 
of stainable iron in macrophages in bone marrow aspirates or biopsy specimens, or serum 
ferritin concentrations <15 ug/L have a fairly straightforward interpretation, as they are 
highly predictive for the absence of iron stores (chapter 1). Because serum ferritin 
concentrations react as acute phase proteins, there is currently no way to diagnose iron 
deficiency accurately in individuals with malaria and normal serum ferritin concentrations. 
Erythropoiesis is affected by malaria (chapters 3 and 6), so that serum transferrin receptor 
concentrations cannot be used to diagnose iron deficiency in individuals with malaria. 
Lastly, there were strong indications that a reported history of fever in afebrile children 
may poorly predict past fever episodes (chapters 7-10). Chemotherapy following such 
incorrect reports may unnecessarily expose children to adverse drug effects, and lead to 
selection and spread of drug-resistant parasite strains. In a representative community-
based survey, a large proportion (38%) of children tested positive for chloroquine or 
sulfadoxine, and only a minority of those testing positive for chloroquine had 
concentrations exceeding the estimated minimum therapeutically effective values (chapter 
10). 
Implications for public health 
The reported findings on the colour scale challenge anaemia control programmes to 
develop strategies for its use in various target groups. The methodology presented in 
chapter 6 may facilitate that process. 
The findings underscore the need to educate communities about the diagnostic signs of 
malaria and about proper use of drugs as part of strategies to reduce morbidity and 
possibly to stretch the 'life span' of antimalarials drugs. A report published subsequently to 
the report in chapter 10 shows the feasibility of such an approach in Kenya (Marsh et al. 
1999). Thermometers should be made available to community health workers to reduce 
the number of unnecessary treatments for fever. 
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Future research 
The finding that a reported history of fever in afebrile children may poorly predict past 
fever episodes emphasises the need for better case definitions for malaria, both for use in 
clinical practice and in epidemiological field studies. In the latter case, such poor prediction 
may lead to substantial underestimation (Rothman and Greenland 1998) of the effects of 
interventions on malaria attacks. 
Serum concentrations of sTfR might be useful to detect iron deficiency in Africans with 
inflammatory conditions other than malaria (for example, in those with HIV infection, 
worm infections or tuberculosis). Several authors, however, reported elevated serum 
transferrin receptor concentrations indicating increased erythropoiesis in cc+-thalassaemia 
(Rees et al. 1998, Mockenhaupt et al. 1999). If so, sTfR concentrations might not be useful 
to assess iron deficiency in persons with this disorder, in addition to those with malaria. A 
study among Africans, however, suggests that this effect might be marginal in 
homozygotes, and does not occur in heterozygotes (Mockenhaupt et al. 1999). Additional 
studies are needed to quantify this relationship. 
Impaired erythropoiesis in malarial anaemia 
Lessons learnt and conclusions 
Based on a literature review, new insights were gained in the possible role of inflammation 
as a cause of malarial anaemia (chapter 1). Thus it was anticipated that combined iron 
supplementation and SP might be more effective in improving haemoglobin concentrations 
than the added effects of the interventions alone. Contrary to this expectation, however, 
the findings pointed to a small antagonistic effect (chapter 5). 
Evidence was found that in asymptomatic malaria, the erythropoietic response is adequate 
for the degree of resulting anaemia. Thus, inflammation and the pathogenic mechanisms 
involved in the anaemia of chronic disease play no or only a minor role (chapters 3 and 6). 
Stunting might exacerbate the degree to which malaria produces anaemia (chapter 4). 
Nutritional inadequacies might explain the latter finding because several deficiencies -
notably of zinc, iron and possibly vitamin A - are known to cause stunting and are also 
known or suspected to impair host immunity. 
Implications for public health 
The conclusions drawn alleviate initial concerns (chapter 1) that malaria-induced 
inflammation might reduce the efficacy of iron supplementation programmes in endemic 
regions in Africa. 
Future research 
It appears likely that a relative deficit in erythropoietin production or decreased marrow 
responsiveness to erythropoietin may limit erythropoiesis in acute malaria, and that this 
mechanism contributes substantially to the resulting anaemia. This should be confirmed in 
studies that use serum concentrations of erythropoietin and sTfR as indicators of 
erythropoiesis (chapter 6). 
It was postulated that nutritional inadequacies causing stunting also impair host immunity, 
thus increasing the degree to which malaria is associated with decreased concentrations of 
haemoglobin (chapter 3). If this effect were due to impaired immunity resulting from iron 
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deficiency, then this would suggest that malaria and iron deficiency synergistically produce 
low haemoglobin concentrations. Conversely, iron supplementation might reduce stunting 
and nutritional anaemia, but also reduce malaria-associated anaemia. This seems in 
agreement with the findings from the randomised trial (chapter 5). 
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Despite observing a decrease in seizure frequency following phenobarbital prophylaxis in 
children with cerebral malaria, Joan Crawley and colleagues (2000) advise against such 
prophylaxis because of the associated increase in mortality. Their analysis suggests that 
the effect of phenobarbital on mortality is, at least in part, a result of diazepam being 
administered before or after being given phenobarbital. We are concerned that analysing 
data with diazepam use as a covariate may have produced severely biased effect estimates 
of phenobarbital on death and possibly on seizure frequency. In his commentary, Malcolm 
Molyneux (2000) questioned whether excess mortality would have occurred without using 
diazepam. Reanalysis may indicate the need for further investigations into the prophylactic 
use of phenobarbital (20 mg/kg) in combination with other therapeutic drugs. 
Crawley and colleagues report that phenobarbital reduces seizure frequency, thereby 
reducing diazepam use, whereas diazepam, used together with phenobarbital, increases 
mortality risk. If so, diazepam mediates the effect of phenobarbital on mortality. By 
reducing seizure frequency, phenobarbital may also reduce mortality directly and not via 
diazepam. In this situation, stratification for diazepam use will lead to biased effect 
estimates. Consider a randomised trial with 2000 children, in which 1000 receive 
phenobarbital and 1000 receive placebo (table). Let us presume, as did Crawley and 
colleagues, that phenobarbital leads to 50% reduction (from 30% to 15%) in seizure 
frequency. Hence, seizures occur in 150 children receiving phenobarbital, and subsequent 
use of diazepam leads to high mortality (say 90%). In those not receiving diazepam, 20% 
die. In the placebo group, seizures occur in 300 children, and subsequent use of diazepam 
leads to 10% mortality. In those not receiving diazepam, 30% die. Total mortality 
(including deaths caused by subsequent diazepam use) is higher in the phenobarbital than 
in the placebo group (305 versus 240 deaths, respectively). Biased effect estimates occur 
when stratifying for diazepam use. Mortality should be calculated by multiplying stratum-
specific estimates by the probability of ending up in each stratum. Comparison between 
groups 2 and 4 (table) shows that phenobarbital directly reduces mortality. The striking 
reduction in the proportion of children experiencing seizures could decrease the number of 
children with long-term neurological sequelae. Hence, if seizures occurring in the 
phenobarbital group could be safely treated by a drug other than diazepam, then 
phenobarbital prophylaxis would be effective and safe. 
TABLE . Estimated mortality in a randomised controlled trial, based on assumptions 
outlined in the text 
Phenobarbital use Group Diazepam use Deaths Mortality estimate 
Yes = 1000 
No = 1000 
1 
2 
3 
4 
Yes = 150 
No = 850 
Yes = 300 
No = 700 
Stratified Unbiased 
135 0.90 
170 0.20 
30 0.10 
210 0.30 
0.90x150/1000 
0.14 
0.20x850/1000 
0.17 
0.10x300/1000 
0.03 
0.30x700/1000=0.21 
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The confusion is compounded by the fact that Crawley and colleagues did not exclude 
from the analysis 75 children who received diazepam before admission to hospital. 
Mortality may have been higher in those children given phenobarbital. Hence, the 
increased mortality reported in the phenobarbital group may be explained by earlier 
diazepam use. Conventional testing for effect modification by diazepam using multiple 
regression techniques is inappropriate as discussed above. When using the methods we 
have outlined above, Crawley and colleagues may find decreased estimates of the total 
effects of phenobarbital on seizure frequency and mortality, a substantial reduction in the 
mortality estimate in children receiving both phenobarbital and diazepam, and possibly a 
reduction of the direct effect estimate of phenobarbital on mortality. 
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James Whitworth and colleagues (2000) present evidence that HIV-1 infection leads to 
increased frequency of both symptomatic and asymptomatic malaria. Among cohorts that 
were followed through repeated surveys, they found that malaria parasite density in HIV-
1-positive subjects tended to be higher with advanced immunosuppression, as indicated by 
nearest and previous CD4-cell counts. We believe that the figure presented is misleading, 
and we offer possible statistical methods to clarify the nature of the relationship between 
HIV-l infection and parasite density. 
First, there is a confusing error in the legend to the figure. Contrary to the information 
provided, it appears from the text that the solid line refers to HIV-1-positive people, and 
the dashed line refers to HIV-1-negative people. 
Second, if the effect of HIV-1 infection on parasite density were mediated by CD4-cell 
counts alone, then the regression lines in the figure (Whitworth and colleagues 2000) 
would be parallel and superimposed on one another. The negative slope of these lines 
would indicate an inverse association between CD4-cell count and parasite density. HIV-1 
infection is associated with a decrease in CD4-cell counts, as shown by the position of the 
closed circles towards the left side of the figure relative to the open circles. Thus, the HIV-
1-associated immunosuppression would be associated with increased parasite densities. 
However, the slopes of these regression lines were reported to be different (p=0.0076), 
with no or perhaps even a positive association between CD4-cell count and parasitaemia in 
HIV-1-negative subjects. The figure furthermore suggests that this difference in slopes 
occurred above 300 CD4-cells/uL blood. Thus, at a given CD4-cell count within the range 
of 300-1200/uL blood, parasitaemia would be higher in HIV-1-positive individuals than in 
their negative counterparts. On the other hand, at CD4-cell counts >1200/uL blood, 
parasitaemia would be lower in HIV-1 infected individuals. This findings implies that HIV-1 
infection, in addition to leading to decreased CD4-cell counts, also determines the activity 
of immune cells in limiting malaria parasitaemia. 
An alternative and more likely explanation is that the association between CD4-cell count 
and parasite density is the same for HIV-1-positive and HIV-1-negative subjects, and that 
the reported differences in slopes are the result of poor fit of the model for HIV-1-positive 
subjects. Visual inspection of the open circles and closed circles seems to support the 
notion that at more than 500 cells/uL, there is no substantial association between CD4-cell 
count and parasite density in either group. The increase in parasite density in HIV-1-
positive individuals seems only to occur at values lower than this range. Thus, 
immunosuppression would affect parasite density only when CD4-cell counts are lower 
than 500 cells/uL, which is a cut-off point used in the Centers for Disease Control and 
Prevention classification system of HIV disease (Anonymous 1993). This effect could be 
assessed statistically by multivariate regression of parasite density as a function of HIV-1 
infection and CD4-cell count, whereby the latter is categorised into two or three strata 
defined by strategically selected cut-off values. Alternatively, the association could be 
approximated by a second- or probably third-order polynomial. 
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Summary 
Approximately three quarters of east African children <5 y of age suffer from anaemia, 
which usually indicates malaria or other underlying infections, deficiencies of iron and 
other nutrients, or genetic disorders. These factors may cause serious adverse health 
effects, including reduced physical activity, impaired physical growth and mental 
development, and death. Successful interventions to control anaemia are therefore 
assumed to lead to better health. 
The potential benefits of iron supplementation depend on the prevalence of children with 
depleted iron stores and the deficit in functional iron in those children. In children in areas 
of seasonal malaria, these benefits may not outweigh possible inherent risks of adverse 
effects caused by malaria. Intermittent administration of sulfadoxine-pyrimethamine (SP) 
might improve haemoglobin concentrations while allowing children to develop protective 
immunity against severe disease and subsequent death caused by malaria. 
While methods are urgently needed to facilitate diagnosis of anaemia and malaria at 
primary care level, determination of iron status is complicated in children with infections. 
With the aim to contribute to the development of programmes for anaemia control in 
preschool children in Africa, the immediate objectives were as follows: 
1. to measure the efficacy in improving haemoglobin concentrations in children aged 2-
36 mo of intermittent iron supplementation and intermittent administration of SP, 
either alone or when given in combination; 
2. to develop and evaluate survey methods for rapid assessment at community level of 
the burden of anaemia and its risk factors; 
3. to contribute to improved methods for diagnosis of anaemia, iron deficiency, and 
malaria 
4. to evaluate the role of impaired erythropoiesis in the pathogenesis of anaemia 
associated with asymptomatic malaria. 
Chapter 1 examines published evidence of iron deficiency and malaria as determinants of 
anaemia and growth faltering in African children. For this purpose, the following topics 
were reviewed: the public health importance of growth faltering, anaemia, iron deficiency 
and malaria; the causal relationships between these factors, especially in relation to the 
aetiology and pathogenesis of anaemia; and the possibilities for interventions directed at 
solving the anaemia problem. 
Chapter 2 describes the results of a cluster sample survey was carried among 
asymptomatic children aged 2-36 mo in the study area (n=318). Although such surveys 
were originally designed to provide valid estimates of descriptive statistics, methods are 
described to expand their use to assess associations between exposures and health 
outcomes at a single point in time, also by regression modelling. 
Using data from this survey, it was estimated (chapter 3) that the prevalences of malaria, 
anaemia (haemoglobin concentration < 110 g/L), iron deficiency (serum ferritin 
concentration<12 mg/L) and iron deficiency anaemia were 18%, 69%, 53% and 46%, 
respectively. Malaria was associated with lower mean haemoglobin concentrations (92.7 
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compared with 104.1 g/L; difference: 11.3 g/L, 95% confidence interval, CI: 6.4-16.3 g/L). 
Analysis of serum transferrin receptor concentrations and haemoglobin concentrations 
yielded findings consistent with the notion that malaria-induced haemolysis is accompanied 
by increased erythropoiesis. Serum transferrin receptor concentration is not useful to 
detect iron deficiency in individuals with malaria. Individuals with high concentrations of 
serum C-reactive protein or similar acute phase reactants should be excluded if serum 
ferritin concentrations<12 mg/L are to be used for measuring the prevalence of iron 
deficiency in malaria-endemic areas. 
Data from the same study were used to examine whether they provided observational 
support for the hypothesis that stunting modifies the associations between malaria and 
haematological indicators of iron status and inflammation (chapter 4). When adjusted for 
age and wasting, the malaria-associated decrease in mean haemoglobin concentration was 
8.5 g/L and 15.8 g/L in non-stunted and stunted children, respectively (p-value of test for 
difference: 0.08). It was also found that children with malaria and who were stunted had 
higher serum concentrations of C-reactive protein and soluble transferrin receptor than 
would be expected from the combined effect of the two working independently. These 
results are consistent with the notion that the nutritional inadequacies causing stunting 
also impair host immunity, thus increasing the degree to which malaria is associated with 
decreased concentrations of haemoglobin, with increased inflammation, and with increased 
iron demand in developing erythroblasts. This would suggest that increased intake of 
micronutrients might not only reduce stunting and nutritional anaemia, but also reduce 
malaria-associated anaemia. 
In addition, the survey data were used to study antimalarial drug use, and to assess the 
validity of frequency of febrile episodes and drug use reported by mothers or carers 
(chapter 10). Of the children whose blood was studied, 38% (95% CI: 30-47%) tested 
positive for chloroquine or sulfadoxine. Of chloroquine-positive children, 15% had 
concentrations exceeding the estimated minimum therapeutically effective values. Among 
those testing negative for sulfadoxine, chloroquine-positive children were more frequently 
parasitaemic, and had lower mean haemoglobin concentrations, than chloroquine-negative 
children. Mothers probably overreported the frequency of malaria or fever episodes as 
usually defined in medical studies, and underreported antimalarial drug use. It was 
concluded that antimalarials are frequently given for treatment of malaria or malaria-
associated illness, rather than prophylactically or for symptoms unrelated to malaria. 
Questionnaire surveys cannot replace biochemical markers to obtain information on 
antimalarial drug use. 
The second field study concerned a trial with a 2x2 factorial design in which 328 
asymptomatic children (aged 2-36 mo; haemoglobin concentration 60-110 g/L) were 
randomly assigned tot receive either iron or placebo, and SP or placebo (chapter 5). The 
health surveillance of the children in the study was intense. The effect on change in 
haemoglobin concentration in the group receiving iron plus SP relative to the placebo 
group, adjusted for prognostic factors at baseline, was 12.5 g/L (95% CI: 8.5 to 16.4 g/L). 
In the former group, the estimated prevalence of anaemia reduced from 100% at baseline 
to 36% at 12 w, and prevalence of iron deficiency reduced correspondingly from 66% to 
8%. Administration of SP in addition to iron supplementation gave no haemoglobin 
response. Survival analysis indicated no evidence of increased risk of malaria following iron 
supplementation. These findings indicate that iron supplementation over a 12-week period 
results in a marked improvement of haemoglobin concentrations. Further studies should 
determine the possible benefits of intermittent administration of SP in reducing the 
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incidence of symptomatic malaria and associated severe anaemia in areas of seasonal 
malaria transmission. 
Malarial anaemia is associated with a shift in iron distribution from functional to storage 
compartments. This suggests a relative deficit in erythropoietin production or action similar 
to that observed in other infections. Longitudinal and baseline data were used from the 
trial to investigate whether malaria causes increased erythropoiesis in children with 
asymptomatic malaria, and whether the erythropoietic response appeared appropriate for 
the degree of resulting anaemia (chapter 6). Erythropoiesis was evaluated by serum 
concentrations of erythropoietin and soluble transferrin receptor. The findings indicated 
that the erythropoietic response to asymptomatic malaria is adequate for the resulting 
degree of anaemia. Inflammation probably plays no or a minor role in the pathogenesis of 
anaemia associated with asymptomatic malaria. Further research is needed to demonstrate 
the role of deficient erythropoietin production or action in the pathogenesis of the anaemia 
of acute malaria. 
Data collected during the trial also allowed an assessment of the utility of a new and 
inexpensive colour scale to facilitate anaemia diagnosis in developing countries (chapter 
7). Scores of the colour scale <10 indicated anaemia (haemoglobin concentration <110 
g/L) and severe anaemia (haemoglobin concentration <70 g/L) with sensitivities >0.68 
and >0.99, respectively. When used in populations with a heavy burden of anaemia, 
sensitivity estimates were higher, and the scale could provide valid estimates of the 
prevalence of anaemia. It was concluded that the colour scale is satisfactory and for many 
purposes superior to all other methods for detection of anaemia at primary care level. Low 
scores of the scale may give unsatisfactory results when used to detect patients with 
severe anaemia and to decide on their management. The methodology presented may 
facilitate development of strategies for its use in various target groups. 
Lastly, data collected during both the survey and the trial were used to examine the 
diagnostic utility of maternal reports of fever in children (chapters 8-10). Mothers were 
questioned whether their child had fever after they had palpated the child's forehead. 
Their reports were compared with axillary temperatures as recorded by electronic 
thermometer. The findings suggest that mothers can accurately diagnose the absence of 
fever without a thermometer. The use of reported fever alone will necessarily result in an 
unacceptably high proportion of false positives, especially at peripheral levels of health 
care. A large proportion of unnecessary treatments for malaria can be avoided by 
confirming the presence of fever by thermometer (chapter 8). 
In a subsequent study, mothers were questioned whether or not their child had fever, 
either directly or after they had palpated the child's forehead (chapter 9). Either of these 
two methods of assessment was randomly allocated. Palpation had similar sensitivity 
(>90%) but better specificity in sick children (50% versus 34%; p=0.05). Fever was more 
prevalent in children reported sick to a health facility than at community level, where early 
detection takes place. Mothers' reports of fever are therefore more reliable in sick children. 
It was shown that, regardless of actual body temperature, mothers are more likely to 
report fever in sick children. This corroborates earlier findings that mothers probably 
overreport the frequency of malaria or fever episodes (chapter 10; see above). Teaching 
mothers to palpate their child's forehead cannot improve the sensitivity of detecting fever 
in sick children, but is likely to increase specificity, thus avoiding unnecessary treatment for 
febrile diseases. 
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Finally, the research produced as a spin-off two published letters that are included as 
annexes to this thesis. The first letter was written in response to an earlier published 
report that phenobarbital prophylaxis in children with cerebral malaria leads to an 
increased risk of death. The analysis in this report suggested that the effect of 
phenobarbital on mortality is, at least in part, a result of diazepam being administered 
before or after being given phenobarbital. It was shown that stratification for diazepam 
use, which mediates the effect of phenobarbital on mortality, leads to severely biased 
effect estimates on death and possibly on seizure frequency (annex 1). Subsequent 
reanalysis by the authors of their data confirmed the occurrence of this bias, but did not 
result in different conclusions from those originally reported. 
The second letter was in response to an earlier published report that HIV-1 infection is 
associated with an increased frequency of symptomatic malaria and parasitaemia. The 
findings reported can be interpreted as evidence that the relationship between HIV-1 and 
immunosuppression, as indicated by nearest and previous CD4-cell counts, is modified by 
malaria. Thus the data would suggest that HIV-1 infection, in addition to leading to 
decreased CD4-cell counts, also determines the activity of immune cells in limiting malaria 
parasitaemia (annex 2). As surmised from the authors' reply, the interpretation of these 
data remains inconclusive. 
Samenvatting 
(summary in Dutch) 
Ongeveer driekwart van de kinderen jonger dan 5 jaar in oost Afrika lijdt aan 
bloedarmoede, hetgeen meestal duidt op malaria of andere onderliggende infecties, 
gebrek aan ijzer en andere voedingsstoffen, of genetische afwijkingen. Deze factoren 
kunnen ernstige schade toebrengen aan de gezondheid door verlaagde lichamelijke 
activiteit, groeiachterstand en geremde geestelijke ontwikkeling, en sterfte. Succesvolle 
interventies ter bestrijding van bloedarmoede worden daarom geacht de gezondheid te 
bevorderen. 
De werkzaamheid van ijzersuppletie hangt af van de prevalentie van kinderen met 
ijzergebrek, en het tekort aan functioneel ijzer in die kinderen. In gebieden met seizoens-
gebonden malaria kan ijzersuppletie van kinderen tot een verhoogd risico van malaria 
leiden, zodat de baten mogelijk niet opwegen tegen de nadelen. Door regelmatig (elke 4 
weken) toedienen van sulfadoxine-pyrimethamine (SP) kan mogelijk de hemoglobine-
concentraties worden verhoogd, terwijl kinderen in staat blijven om immuniteit op te 
bouwen tegen ernstige malaria. 
Er is een dringende behoefte aan betere methoden ter diagnose van bloedarmoede en 
malaria op het niveau van de eerstelijnsgezondheidszorg, en ook is bepaling van 
ijzerstatus moeilijk in kinderen met infecties. 
Het onderzoek dat wordt beschreven in dit proefschrift was erop gericht een bijdrage te 
leveren aan de ontwikkeling van programma's ter bestrijding van bloedarmoede onder 
jonge kinderen. De doelstellingen waren als volgt: 
1. het meten van de werkzaamheid ijzersupplementen en SP die met tussenpozen 
werden toegediend - zowel afzonderlijk als in combinatie - ter verbetering van 
hemoglobine-concentraties in kinderen in de leeftijd tussen 2 en 36 maanden; 
2. het ontwikkelen en evalueren van steekproefmethoden waarmee op dorpsniveau het 
probleem en de determinanten van bloedarmoede snel kunnen worden bepaald; 
3. het bijdragen aan verbeterde methoden ter diagnose van bloedarmoede, ijzergebrek, 
en malaria; 
4. het onderzoeken in hoeverre onderdrukte vorming van rode bloedcellen een rol speelt 
in het ontstaan van bloedarmoede als gevolg van asymptomatische malaria. 
Hoofdstuk 1 onderzoekt de gegevens die zijn gepubliceerd over ijzergebrek en malaria 
als determinanten van bloedarmoede en groeiachterstand in Afrikaanse kinderen. Voor dit 
doel werden de volgende onderwerpen besproken: het belang voor de volksgezondheid 
van groeiachterstand, bloedarmoede, ijzergebrek, en malaria; de oorzakelijke verbanden 
tussen deze factoren, vooral met betrekking tot de oorzaken van bloedarmoede; en de 
mogelijkheden ter bestrijding van bloedarmoede. 
Hoofdstuk 2 beschrijft de resultaten van een clustersteekproefonderzoek onder kinderen 
in de leeftijd van 2-36 maanden in het studiegebied (n=318). Zulke onderzoeken zijn 
oorspronkelijk ontworpen om geldige schattingen te verkrijgen van beschrijvende 
statistische gegevens. In dit hoofdstuk worden methoden beschreven waarmee zulke 
studies bovendien kunnen worden gebruikt om de verbanden te bepalen tussen 
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blootstellingen en gevolgen voor de gezondheid op een bepaald tijdspunt. Hierbij kunnen 
ook regressiemodellen worden gebruikt. 
Met behulp van data van dit steekproefonderzoek (hoofdstuk 3) werden de prevalenties 
van malaria, bloedarmoede (hemoglobine-concentratie <110 g/L), ijzergebrek (serum-
concentratie van ferritine <12 ug/L) en ijzergebreksbloedarmoede geschat op 
respectievelijk 18%, 69%, 53%, en 46%. Malaria was geassocieerd met lagere 
hemoglobine-concentraties (gemiddelde waarden 92.7 vergeleken met 104.1 g/L; verschil 
11.3 g/L, 95%-betrouwbaarheidsinterval, BI: 6.4-16.3 g/L). Analyse van de 
serumconcentratie van transferrine-receptoren en hemoglobine-concentratie gaven 
resultaten die in overeen-stemming waren met de idee dat door malaria gei'nduceerde 
hemolyse gepaard gaat met een verhoogde erytropoiese. Serumconcentratie van 
transferrine-receptoren zijn niet bruikbaar om ijzergebrek aan te tonen in mensen met 
malaria. In gebieden waar malaria endemisch voorkomt, moeten mensen met hoge 
serumconcentraties van C-reactive protein of vergelijkbare acute fase-eiwitten worden 
uitgesloten als het criterium van serumconcentratie van ferritine <12 ug/L wordt 
gehanteerd om de prevalentie van ijzergebrek te meten. 
Gegevens van dezelfde studie werden gebruikt om te onderzoeken of ze observationele 
steun boden voor de hypothese dat achterstand in lengtegroei de associates tussen 
malaria en bloedindicatoren van ijzerstatus en ontsteking beinvloedt (hoofdstuk 4). 
Wanneer leeftijd en vermagering in aanmerking werden genomen, was malaria 
geassocieerd met een verlaging van de gemiddelde hemoglobine-concentratie van 
respectievelijk 8.5 g/L en 15.8 g/L voor kinderen zonder en met achterstand in lengtegroei 
(p-waarde voor test voor verschil: 0.08). Kinderen die malaria hadden maar ook waren 
achtergebleven in lengtegroei hadden hogere serumconcentraties van C-reactive protein 
en transferrine-receptoren dan verwacht op grand van het gecombineerde effect van deze 
factoren afzonderlijk. Deze resultaten zijn in overeenstemming met de idee dat de 
voedingsgebreken die achterstand in lengtegroei veroorzaken ook de immuniteit van de 
kinderen ondermijnen. Deze verminderde immuniteit zou ertoe leiden dat malaria in deze 
kinderen in sterkere mate is geassocieerd met verlaagde hemoglobine-concentraties, met 
verhoogde ontsteking, en met verhoogde ijzerbehoefte van erytroblasten. Dit zou erop 
wijzen dat een verhoogde inname van micronutrienten niet alleen kan leiden tot een 
verminderde achterstand van de lengtegroei en voedingsgerelateerde bloedarmoede, maar 
ook tot een vermindering van malaria-geassocieerde bloedarmoede. 
Het steekproefonderzoek werd bovendien gebruikt om het gebruik van 
antimalariamiddelen te bestuderen, evenals de validiteit van het voorkomen van 
koortsincidenten en medicijnengebruik zoals gerapporteerd door moeders of zorggevers 
(hoofdstuk 10). Van de kinderen wiens bloed werd getest, was 38% (95% BI: 30-47%) 
positief voor chloroquine of sulfadoxine. Van de kinderen die positief testten voor 
chloroquine, had 15% bloedconcentraties die de minimum therapeutisch werkzame 
waarden overschreden. Kinderen met chloroquine in hun bloed waren vaker geTnfecteerd 
dan kinderen zonder chloroquine in hun bloed, en ook hadden ze lagere gemiddelde 
hemoglobine-concentraties (bij deze analyse weren diegenen die positief testten voor 
sulfadoxine uitgesloten). Het is waarschijnlijk dat moeders overschatten hoe vaak malaria 
of koortsincidenten voorkwamen, althans deze gewoonlijk in biomedische studies worden 
gedefinieerd, en dat ze het gebruik van geneesmiddelen tegen malaria onder-
rapporteerden. De conclusie was dat deze geneesmiddelen veelal worden gegeven tegen 
malaria of malaria-gerelateerde klachten, in plaats van profylactisch of tegen klachten die 
niet gerelateerd zijn aan malaria. Steekproefonderzoek gebaseerd op vragenlijsten kunnen 
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niet gebruikt worden ter vervanging van biochemische metingen om informatie te 
verkrijgen over het gebruik van geneesmiddelen tegen malaria. 
De tweede veldstudie betrof een experiment met een 2x2 factoriele proefopzet waarin 328 
kinderen zonder gezondheidsklachten (leeftijd 2-36 maanden; hemoglobine-concentratie 
60-110 g/L) random werden toegewezen aan behandeling met ijzer of ijzerplacebo, en SP 
of SP-placebo (hoofdstuk 5). De medische begeleiding van deze kinderen was intens. Het 
effect op de verandering in hemoglobine-concentratie in de groep die ijzer plus SP ontving 
ten opzichte van de placebo-groep, gecorrigeerd voor prognostische factoren bij aanvang 
van de studie, was 12.5 g/L (95% BI: 8.5-16.4 g/L). In de eerstgenoemde groep werd de 
prevalentie van bloedarmoede teruggebracht van 100% bij aanvang van de studie tot 36% 
na 12 weken, en de prevalentie van ijzergebrek werd overeenkomstig teruggebracht van 
66% tot 8%. Het toevoegen van SP aan deze behandeling bracht geen verandering 
teweeg in hemoglobine-concentratie. Er was geen aanwijzing dat het risico van malaria 
was verhoogd als gevolg van de ijzersuppletie. Deze bevindingen duiden erop dat 
ijzersuppletie over een periode van 12 weken resulteert in een duidelijke verhoging van 
hemoglobine-concentraties. Verdere studie is nodig naar de mogelijke baten van het 
regelmatig toedienen van SP in gebieden waar de overdracht van malaria 
seizoensgebonden is. Met name dient te worden onderzocht of zo'n toediening de 
incidenties van symptomatische malaria en ernstige bloedarmoede verlaagt. 
Malaria-geassocieerde bloedarmoede gaat gepaard met een verschuiving van ijzerverdeling 
over het lichaam van functioned compartementen naar opslagcompartimenten. Dit wijst 
op een ontoereikende productie of werking van erytropoietine, vergelijkbaar met wat is 
waargenomen in andere infecties. Waarnemingen in de tijd of bij aanvang van de 
experimentele studie werden gebruikt om te onderzoeken of malaria leidt tot een 
verhoogde aanmaak van rode bloedcellen in kinderen met asymptomatische malaria, en of 
deze verhoogde aanmaak in verhouding was tot de ernst van de bloedarmoede 
(hoofdstuk 6). De aanmaak van rode bloedcellen werd hierbij beoordeeld met behulp van 
de serumconcentraties van erytropoietine en transferrine-receptoren. Het bleek dat bij 
malaria de erytropoiese passend was in verhouding tot de mate van bloedarmoede. 
Ontsteking speelt waarschijnlijk geen of hooguit een ondergeschikte rol in het ontstaan 
van bloedarmoede in asymptomatische malaria. Verder onderzoek is nodig om de rol aan 
te tonen van gebrek in de aanmaak of werking van erytropoietine in de ontwikkeling van 
bloedarmoede in acute, symptomatische malaria. 
De gegevens die tijdens het experiment werden verzameld, maakten het ook mogelijk om 
de diagnostische waarde vast te stellen van een nieuwe en goedkope kleurenschaal ter 
bepaling van bloedarmoede in ontwikkelingslanden (hoofdstuk 7). Waarden <10 van 
deze schaal hadden sensitiviteiten van >0.68 en >0.99 voor het aantonen van 
respectievelijk bloedarmoede (hemoglobine-concentratie <110 g/L) en ernstige bloed-
armoede (hemoglobine-concentratie <70 g/L). Bij gebruik van de schaal in populaties 
waarin bloedarmoede veelvuldig voorkomt, waren deze waarden hoger, en werden zuivere 
schattingen verkregen van de prevalentie van bloedarmoede. De conclusie was dat de 
kleurenschaal bevredigend werkte, en voor menig doeleinde beter was dan alle andere 
beschikbare methoden voor het aantonen van bloedarmoede op het niveau van 
eerstelijnsgezondheidszorg. Lage waarden van de schaal kunnen ontoereikende resultaten 
geven om ernstige bloedarmoede vast te stellen, en om te beslissen over de verdere 
behandeling van zulke patienten. De aangevoerde methodiek kan worden gebruikt ter 
ontwikkeling van strategieen voor gebruik van de schaal in verschillende doelgroepen. 
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Zowel tijdens het steekproefonderzoek als het experimentele onderzoek werden gegevens 
verzameld die gebruikt werden om de diagnostische waarde van koortsmeldingen door 
moeders te bepalen (hoofstukken 8-10). De moeders werd gevraagd of hun kind koorts 
had nadat ze eerst het voorhoofd van hun kind hadden gevoeld. Hun meldingen werden 
vergeleken met de okseltemperaturen die werden geregistreerd met een elektronische 
thermometer. Het Week dat moeders de afwezigheid van koorts betrouwbaar kunnen 
vaststellen zonder thermometer. Als koorts slechts wordt vastgesteld op basis van de 
melding daarvan door de moeder, dan zal dat - mede gezien de relatief lage prevalentie -
onvermijdelijk leiden tot een onaanvaardbaar hoog percentage van fout-positieve 
uitkomsten, vooral op het niveau van de eerstelijnsgezondheidszorg. Een groot aantal 
onnodige malariabehandelingen kan worden vermeden door het bevestigen van de 
aanwezigheid van koorts met een thermometer (hoofdstuk 8). 
In een vervolgstudie werd moeders gevraagd of hun kind koorts had, ofwel direct, ofwel 
nadat ze eerst het voorhoofd van hun kind hadden gevoeld (hoofdstuk 9). Een van deze 
twee methoden werd telkens random toegewezen. Voelen had een vergelijkbare 
sensitivitelt (>90%) maar een hogere specificiteit in zieke kinderen (50% vergeleken met 
34%; p=0.05). Koorts kwam vaker voor in kinderen die ziek werden gemeld bij een 
gezondheidsfaciliteit dan op dorpsniveau, waar de vroegtijdige diagnose veelal plaatsvindt. 
De melding van koorts door moeders zijn daarom meer betrouwbaar in zieke kinderen. Het 
bleek dat - onafhankelijk van de feitelijke lichaamstemperatuur - de kans dat moeders 
koorts meldden groter was als hun kind ziek was. Dit komt overeen met eerdere 
bevindingen dat moeders waarschijnlijk het voorkomen van malaria- of koortsincidenten 
overrapporteren (hoofdstuk 10; zie vorige paragraaf). Het leren van moeders zal niet 
leiden tot een verhoogde sensitiviteit van het vaststellen van koorts in zieke kinderen, 
maar het verhoogt waarschijnlijk de specificiteit, zodat daarmee onnodig behandelen van 
koorts wordt voorkomen. 
Het onderzoek leverde tenslotte als nevenresultaat twee gepubliceerde brieven op die 
ingesloten zijn als bijlagen in dit proefschrift. De eerste brief was een reactie op een eerder 
gepubliceerd verslag dat profylactisch gebruik van fenobarbital in kinderen met cerebrate 
malaria leidt tot een verhoogd sterfterisico. De analyse die in dit verslag wordt 
gepresenteerd, duidde erop dat het effect van fenobarbital op sterfte, althans minstens 
gedeeltelijk, wordt veroorzaakt doordat diazepam werd toegediend voordat of nadat 
fenobarbital werd gegeven. Het bleek echter dat stratificatie voor het gebruik van 
diazepam - hetgeen in de causale keten van het effect van fenobarbital op sterfte staat -
tot ernstige bias kan leiden in de geschatte effecten op sterfte en mogelijk op het 
voorkomen van stuipaanvallen (bijlage 1). Een hernieuwde analyse van de gegevens die 
daarop volgde door de oorspronkelijke auteurs bevestigde het bestaan van deze bias, 
maar leidde niet tot andere conclusies dan die oorspronkelijk werden gerapporteerd. 
De tweede brief was een reactie op een eerder gepubliceerd verslag dat infectie met HIV-1 
is geassocieerd met een verhoogde frequentie van symptomatische malaria en van de 
aanwezigheid van parasieten in het bloed. De gerapporteerde bevindingen kunnen worden 
gei'nterpreteerd als aanduidingen dat de relatie tussen HIV-1 en onderdrukking van de 
immuniteit, zoals geduid door de meest recente tellingen van CD4-cellen, wordt bepaald 
door malaria. Deze gegevens zouden zodoende erop wijzen dat infectie met HIV-1, 
behalve dat het leidt tot verlaagde aantallen van CD4-cellen, ook bepaalt in hoeverre de 
immuuncellen in staat zijn om de aantallen parasieten in het bloed te verlagen (bijlage 
2). Zoals kan worden afgeleid van het antwoord van de oorspronkelijke auteurs blijft de 
interpretatie van deze gegevens onbeslist. 
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